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Abstract 
Abstract 
 
Inductively Coupled Plasma Mass Spectrometry (ICP-MS) is used already for 
many biological applications. Apart from qualitative analysis, this technique offers 
quantitative information of elements in proteins which is important in determining the 
state and changes of the biological system. Utilizing this advantage, two different 
approaches were investigated in this work to detect and quantify phosphorylated and 
labelled proteins using Laser Ablation (LA) ICP-MS. The first approach is based on 
direct detection of natural hetero-elements being present in nearly all proteins, especially 
31P+, and the second one involved the detection of proteins via controlled labelling by 
means of lanthanides using chelating complexes and staining methods.  
LA-ICP-MS was used in this work for detection of phospho-proteins after 
separation with sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-
PAGE) and transfer onto a membrane. Measuring phosphorus in proteins by this method, 
linearity of the calibration in the range from 20 to 380 pmol was achieved with good 
reproducibility and sufficient sensitivity to realize a detection limit of 1.5 pmol. 
Quantification of phospho-proteins was performed with standards by 1) dotting onto 
membranes and 2) SDS-PAGE separation and blotting. The latter quantification 
procedure was applied to study the changes of the phosphoproteome induced by 
epidermal growth factor and hydrogen peroxide of an urothelial cell line 5637.  
 In the second part of the work, a procedure was developed to simultaneously 
detect and quantify multiple proteins in a mixture via labelling techniques using LA-ICP-
MS in Western blots. Different labelling procedures were investigated using bi-functional 
chelating agents namely, 2-(4-Isothiocyanatobenzyl)-1,4,7,10-tetraazacyclododecane-
1,4,7,10-tetraacetic acid (DOTA) and diethylenetriaminepentaacetic acid dianhydride 
(DTPA). The assay, using DOTA and iodination for labelling of proteins and antibodies, 
was optimised for ICP-MS detection and were combined to investigate different enzymes 
of Cytochromes P450 concomitantly. By this method a generic approach for detecting 
different proteins simultaneously could be established. 
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Zusammenfassung 
 
Die induktiv gekoppelte Plasma-Massenspektrometrie (ICP-MS) wird bereits für viele 
biologische Anwendungen eingesetzt. Diese Methode liefert qualitative und quantitative 
elementspezifische Informationen, die zur Bestimmung des Zustands und der 
Veränderung eines biologischen Systems wichtig sind. Diese Fähigkeit wurde in dieser 
Arbeit genutzt, um zwei unterschiedliche Methoden zu untersuchen, die dazu dienen 
sollen, phosphorylierte und markierte Proteine durch Laserabtrags- (LA) ICP-MS zu 
bestimmen. Die erste Anwendung basiert auf der direkten Detektion natürlich 
vorkommender Hetero-Elemente in Proteinen, wie z.B. 31P+ in phosphorylierten 
Proteinen. Die zweite Anwendung beinhaltet den Nachweis von Proteinen durch 
kontrolliertes Markieren mithilfe der Lanthanide unter Einsatz von Chelat-Komplexen 
und Färbe-Methoden. 
 
Die Laserabtrags-ICP-MS wurde zum Nachweis von Phosphor-Proteinen nach Trennung 
mittels Natrium Dodecyl Sulfat Polyacrylamid Gel Elektrophorese (SDS-PAGE) 
eingesetzt. Mit dieser Methode konnte eine Linearität im Bereich von 20 bis 380 pmol 
Phosphor in Proteinen mit guter Reproduzierbarkeit erreicht werden und außerdem eine 
ausreichende Empfindlichkeit um eine Nachweisgrenze von 1,5 pmol zu verwirklichen. 
Eine Quantifizierung von phosphorylierten Proteinen wurde durch zwei unterschiedliche 
Methoden versucht: Auftrag von Phosphorstandards auf die zu messende Membran und 
durch Verwendung eines Standardproteins während der Trennung. Dieses 
Quantifizierungsverfahren wurde angewandt, um die Veränderungen des Phosphor-
Proteoms zu untersuchen, das durch den Epidermalen Wachstumsfaktor (EGF) bzw. 
durch Hydrogenperoxid (H2O2) in der Harnblasen-Zelllinie 5637 erzeugt wurde.  
 
In dem zweiten Teil der Arbeit wurde ein Verfahren entwickelt, um mehrere Proteine in 
einer Mischung gleichzeitig nachzuweisen und zu quantifizieren, und zwar durch 
Markierungstechniken unter Einsatz der LA-ICP-MS an Western Blots. Unterschiedliche 
Markierungsverfahren wurden untersucht, basierend auf der Verwendung von bi-
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funktionalen Chelatbildnern, nämlich 2-(4-Isothiocyanatobenzyl)-1,4,7,10-
tetraazacyclododekan-1,4,7,10-tetraessigsäure (DOTA) und Diethylen-triamin-
pentaessigsäure Dianhydrid (DTPA). Die Proteine und Antikörper wurden mit DOTA 
und Lanthaniden markiert, jodiert und für den ICP-MS Nachweis optimiert, um 
unterschiedliche Enzyme von Cytochrom P450 gleichzeitig zu untersuchen. Durch diese 
Methode konnte ein allgemeines Verfahren zum gleichzeitigen Nachweis verschiedener 
Proteine ausgearbeitet werden. 
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Abbreviations 
Abbreviations 
 
1D One-Dimensional 
2D GE Two-Dimensional Gel Electrophoresis 
2D DIGE Two-Dimensional Differential Gel Electrophoresis 
3-MC 3-Methylcholanthrene 
Ab Antibody 
APS Ammoniumperoxodisulphate  
Ar Argon 
ATP Adenosine triphosphate 
BSA Bovine serum albumin 
Cer Cerium 
cps counts per second 
CYP Cytochromes P450 
DIGE  
DNA Deoxy-ribonucleic acid 
DTPA Diethylenetriaminepentaacetic acid dianhydride 
DTT Dithio-DL-threitol 
ECL Electrochemiluminescence  
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h hour(s) 
He Helium 
HEPES (4-(2-hydroxethyl)-1-piperazineethanesulfonic acid) 
Ho Holmium 
HR-ICP-MS High Resolution – Inductively Coupled Plasma –Mass 
Spectrometry 
I Iodine 
ICP-QMS Inductively Coupled Plasma – Quadrupole Mass Spectrometry 
ICP-SF-MS Inductively Coupled Plasma – Sector Field – Mass 
Spectrometry 
IgG Immunoglobulin 
kDa kilo Daltons 
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LA-ICP-MS 
Laser Ablation – Inductively Coupled Plasma – Mass 
Spectrometry 
LC Liquid Chromatography 
LOD Limits of detection 
LR Low Resolution 
MALDI TOF-MS Matrix Assisted Laser Desorption Ionization Time of Flight 
Mass Spectrometry 
MCN Microconcentric nebulizer 
min minute(s) 
MR Mass Resolution 
MW Molecular weight 
NC Nitrocellulose 
P Phosphorus 
PAH Polycyclic aromatic hydrocarbons 
PBS Phosphate buffer saline 
PE Polyethylene 
PFA Perfluoroalkoxy 
PMT Photon Multiplier Tube  
ppb parts per billion 
p-SCN-Bn-DOTA 
(referred as DOTA in 
this work) 
2-(4-Isothiocyanatobenzyl)-1,4,7,10-tetraazacyclododecane-
1,4,7,10-tetraacetic acid  
PTFE Polytetrafluoroethylene 
PVDF Polyvinylidene fluoride 
RNA Ribonucleic acid 
RT room temperature 
s second(s) 
S Sulphur 
SDS-PAGE Sodium Dodecyl Sodium Sulphate Polyacrylamide Gel 
Electrophoresis 
SEM Secondary Electron Multiplier 
SILAC Stable isotope labelling by amino acids in cell culture 
Tb Terbium 
TEMED Tetramethylethylendiamine 
TXRF Total Reflection X-ray Fluorescence 
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Chapter 1 
Introduction 
1.1 Inductively Coupled Plasma Mass Spectrometry 
 Inductively Coupled Plasma Mass Spectrometry is a highly sensitive mass 
spectrometry technique that is used for elemental analysis. It was developed in the late 
1980s by Houk et al.1 and Gray.2 The instrumentation is capable of multielemental 
analysis often at the parts per trillion levels in solutions. It is widely used in the fields of 
geochemistry, environmental, life and forensic sciences and archaeology.3 It is also the 
method of choice in the speciation analysis of certain metals such chromium and arsenic. 
In ICP-MS samples are introduced to an argon plasma torch which has very high 
temperatures (6000-10000 K) sufficient to vaporize, atomize, ionize and excite all 
elements in the periodic table.4 The plasma is a highly ionized argon gas maintained via 
the high frequency electrostatic and magnetic fields generated by an induction coil in a 
symmetrically flowing argon gas. In the plasma all molecular information of the analyte 
is lost, but on the other hand the ionization process is more or less decoupled from the 
matrix, so that substance independent calibration procedures can be used for 
quantification. This ease of quantification is one of the most important features of ICP-
MS and is one of the reasons for this feasibility study.  
A fraction of the ions formed in the plasma is extracted into a low pressure 
interface containing both a sampler and a skimmer cone. The ions are then focused and 
transmitted to a mass analyser via an ion lens system prior to detection by either an ion 
counting or an analogue detector.  
In recent times due to the improvements in its instrumentation ICP-MS is more 
and more used in the biological research for the determination of metals in the biological 
environment. The advantages of using ICP-MS in biological applications are 1) its ease 
of quantification due to compound independent elemental response, 2) high sample 
throughput, 3) low detection limits of many elements of the periodic table, 4) wide linear 
dynamic range, 5) concomitant elemental detection, 6) minimal matrix interferences, 7) 
high sensitivity and 8) hyphenation capabilities. Because of these advantages this 
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technique is already used for trace metal analysis in a wide variety of biological samples, 
for e.g. bones and teeth,5 blood, hair and urine,6 tablets7 etc. The benefit of ICP-MS is 
that it is useful for detecting elements at very low levels in complex sample mixtures. 
Utilizing these features, this technique looks promising in new application areas for 
instance in biological research, and in particular in proteomics.  
Being a metal detector, ICP-MS can be used to detect and analyse proteins via 
their hetero-element compositions, and for instance ICP-MS is already used for 
qualitative detection of metalloproteins present in a biological environment.8 However, 
the interactions of the metals with the proteins are always not strong, they can be lost 
during the sample preparation steps and it cannot be used efficiently for experiments 
where quantification is needed. Alternatively hetero-element tagged proteins (naturally 
present or labelled) where elements are covalently bound to the proteins can be utilized 
for indirect quantification of proteins using ICP-MS. Thus inorganic MS is extremely 
suitable for calibration and quantification of proteins since it shows high sensitivity for 
detection of elements and wide dynamic detection range.9 Since it detects only the 
amount of element present in the proteins simple standards can be used for the 
quantification of proteins avoiding other complex methods. Considering these aspect 
ICP-MS can be applied as one of the complementary tools in the field of proteomics 
related research, especially in quantitative proteomics. 
1.2 Definition and Methods in Proteomics 
The term `Proteomics’ describes the study of the proteome of an organism (or 
cell) expressed by its genome.10 It represents the large scale study of proteins, their 
structures, functions and also their post translational modification such as 
phosphorylation. The proteome is a highly dynamic system which changes in response to 
various intra and extracellular environmental signals which can lead to different 
signalling pathways. The protein composition present in a system varies qualitatively and 
quantitatively. In addition to the qualitative detection, quantification of proteins is 
important to determine the biological states of the system.11 For instance in medicine, 
quantification of proteins can be used to compare 2 different systems such as healthy and 
diseased patients which can lead to biomarker discovery.12 There exist different methods 
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to evaluate these qualitative and quantitative processes. Some of them will be discussed 
in the following paragraphs. Many of these methods are tedious and time consuming and 
do not always give reproducible results. New developments are necessary in this area in 
addition to the improvements in the presently available methods. There is also lack of 
comparable and complementary methods which can reinstate the findings.  
As mentioned before, the basic aim of the proteomic methods is to identify, detect 
and quantify the whole proteins of a cell, tissue or organism. Depending on the 
complexity of the protein samples and the requirement different combinations of methods 
can be chosen. Initially proteins are separated by using gel electrophoresis, high 
performance liquid chromatography (HPLC) or capillary electrophoresis. Sodium 
dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) and two-dimensional 
gel electrophoresis (2D GE) are the traditional gel separation techniques and size 
exclusion, reverse phase, ion exchange etc. are the established HPLC based methods.  
The most powerful tool for protein separation is 2D GE which can separate 
proteins in 2 dimensions, first by isoelectric focusing and second by SDS-PAGE. The 
protein spots can be picked and subjected to tryptic digestion and the resulted peptides 
are identified using organic MS and databank research.13 This combination of methods 
requires large amounts of proteins and it is a laborious process and has drawbacks such as 
low resolution.14 In another way, these 2D gels can be stained for visualization of the 
proteins with different techniques such as silver nitrate staining, fluorescent reagents, 
Coomassie blue etc. With the specific gel stains up to 4 different patterns can be 
compared and up and down regulated proteins can be identified. For example by 
comparing the total protein stained gels with the phosphorus stained gels the 
phosphorylation degree could be determined.15 But the sensitivity and detection limit of 
these methods rely on specific gel stains. 
Alternatively after separation by 1D or 2D GE, these proteins can be visualized by 
radioactivity or luminescence methods. Traditional methods such as radioactive labelling 
involve hazardous material handling and the experiments can be performed only at 
specialized labs. The proteins can then be identified after proteolytic digestion and 
sequenced using Edman degradation.16 But this method also requires abundant protein 
samples.  
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As mentioned earlier organic mass spectrometry such as Electrospray Ionization 
Mass Spectrometry (ESI-MS) and Matrix Assisted Laser Desorption Ionization Time of 
Flight Mass Spectrometry (MALDI-TOF MS) can help to identify proteins after 2D 
separations.13  
For introduction of protein samples in the MS liquid chromatography methods are 
often used. Molecular mass of the proteins can be estimated because of its soft-ionization 
nature. Peptide mass fingerprinting is the combination of separation techniques with 
organic MS based methods. With the help of databank search it is used to identify the 
proteins. It has many advantages such as it works over wide mass ranges. But the 
disadvantage of peptide mass fingerprinting is that it is less accurate for non purified 
proteins and cannot handle complex protein mixtures.17 It has little success for 
identification of proteins which are not in the database and hence it is limited to certain 
protein sequences. 
The quantification of proteins is also an important parameter needed in the 
clinical proteomics field, e.g. in biomarker discovery and diagnostics of various diseases. 
ESI-MS and MALDI–TOF-MS are increasingly used in combination with isotopic 
labelling methods for relative quantification of proteins.18 Proteins can be labelled via 
chemical, enzymatic and metabolic methods. Their advantages are discussed in chapter 4. 
Alternatively for naturally presented trace metals in proteins the labelling step can be 
avoided by directly detecting by ICP-MS. For example using ICP-MS 31P+ can be directly 
detected and quantified in proteins where it is covalently bound to it. Some of the 
drawbacks of using organic mass spectrometry for quantification of phospho-proteins are 
discussed in section 3.1.1.  
1.3 Previous Work 
At the “Institute of Analytical Sciences - ISAS” in the past 20 years ICP-MS was 
used for trace metal analysis and speciation studies. For the past 10 years hetero-elements 
have been investigated to be used for detection of bio-molecules. First examples are 
presented for DNA analysis where phosphorus of the DNA backbone was used as a 
natural occurring tag for quantification of DNA-adducts formed with styrene oxide19 and 
melphalan.20 
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 The concept of analysing protein phosphorylation using capillary LC coupled 
with ICP-MS for 31P+ detection was demonstrated by Wind et al.22 The sample used was 
a complex mixture of synthetic phosphopeptides and a set of tryptic digests of three 
phospho-proteins. The identification of phosphopeptides was performed using capillary 
LC interfaced alternatively to ICP-MS and ESI-MS. With the ICP-MS a detection limit of 
approximately 0.1 pmol could be achieved using this method. With this method using 
31P+ detection high selectivity could be achieved and the signal intensity obtained was 
directly proportional to the molar amount of 31P+ in the capillary LC eluate. Thus it 
should be studied in more detail how feasible this new approach is for 
phosphoproteomics studies.  
After phosphopeptide identification, the use of ICP was extended to phosphorus 
detection of phospho-proteins after SDS-PAGE separation and blotting onto 
membranes.21 Laser ablation was used as the hyphenation technique for ablation of the 
membrane material and the dry sample is then transported to the ICP-MS. The LA cell 
used in this study had a length of 100 mm and a width of 10 mm into which the 
membranes were fixed. So each lane of the membranes had to be cut in order to fit to the 
geometry of the cell and only small fractions of the whole membrane can be used for the 
detection at the same time. For the next sample the membranes had to be exchanged and 
it is a very time consuming step. Apart from these limitations this method was well suited 
for the detection of a mixture of myoglobin, α-casein and the subunits of fibrinogen. 
Normalizing the 31P+ detection signal from a single laser ablation trace by the total 
amount of phospho-protein applied to the gel, a detection limit of 5 pmol of phosphorus 
could be estimated.  
Due to the success of these first experiments a new laser ablation cell was 
constructed in which the whole membrane can be analysed in one run. And it was the 
main aim of this study to explore the capabilities of this new cell and to develop novel 
applications in the area of proteomics. 
1.4 Aim of the Study 
The use of LA-ICP-MS in proteomics can be exploited in 3 different ways, 1) by 
way of naturally tagged proteins, e.g. phosphorus, sulphur etc., 2) by staining with metal-
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containing stains and 3) through bio-conjugation, i.e. labelling of proteins with elements 
via chelating agents, thereby proteins can be detected and quantified. This work is aimed 
at improving ICP-MS based applications in proteomics research and can be broadly 
classified into three topics.  
1) Phosphoproteomics 
The first objective of the work is to develop a generic approach for 
phosphoproteomics allowing the analysis of phospho-proteins using LA-ICP-MS and gel 
electrophoresis. As mentioned before, in a previous work of Wind et al.22 it was already 
demonstrated that linear relationship between the 31P+ intensity and the amount of a 
standard phospho-protein exists, but it was not sure if this could be elaborated to a new 
concept for phosphoproteomics. Thus it was one aim of this study to develop methods for 
quantification of the phosphorylation status of proteins, and test them at hand of a model 
system, the human urothelial carcinoma cell line 5637. 
2) Labelling and staining of proteins 
The second objective is to try different staining and labelling methods in order to 
simultaneously detect and quantify the target protein which does not contain an LA-ICP-
MS detectable element. In this part it is necessary to investigate different labelling 
strategies using chelating complexes such as 2-(4-Isothiocyanatobenzyl)-1,4,7,10-
tetraazacyclododecane-1,4,7,10-tetraacetic acid (p-SCN-Bn-DOTA, referred as DOTA in 
this work) and eventually the diethylenetriaminepentaacetic acid dianhydride (DTPA). 
For this purpose the procedures for labelling of proteins via p-SCN-Bn-DOTA have to be 
optimised for detection by LA-ICP-MS. 
3) Labelling of antibodies 
The third objective is to detect and quantify multiple antigens after SDS-PAGE and 
Western blotting using differentially labelled monoclonal antibodies and by employing 
LA-ICP-MS as the detection method. A standard procedure for labelling of antibodies 
using DOTA and iodination described in literature will be applied too. Antigen samples 
(groups of structurally similar enzymes) and purified monoclonal antibodies were 
provided by PD. Dr. Peter Roos from IfADo, Dortmund and this work was done in close 
collaboration. 
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Finally it should be mentioned that at the beginning of this thesis work, ISAS was 
just starting its bioactivities and thus the expertise and experience with biochemical work 
flows in proteomics was not available. In particular there was little experience with 
protein separations based on SDS-PAGE and detection of proteins by conventional 
staining and detection assays. Therefore it was one of the main goals of this thesis to 
build up the infrastructure needed and to test different procedures described in textbooks 
and literature and to optimise some of these procedures for ICP-MS detection strategies. 
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Chapter 2 
Principle, Instrumentation and Experimental 
2.1 Principle 
2.1.1 Inductively Coupled Plasma Mass Spectrometry  
ICP-MS is a highly developed analytical technique used for elemental 
determinations. It combines the high temperature argon plasma with the mass 
spectrometer. The ions that are produced by the plasma source are separated and detected 
by the mass spectrometer. The majority of ICP-MS instruments utilise quadrupole based 
mass analysers. But the resolution that is offered by these mass analysers is not sufficient 
for analysing elements which are prone to argon plasma, solvent or sample based spectral 
interferences. For instance detection of phosphorus with its only isotope at mass 31 is 
hindered by various polyatomic interferences such as 15N16O+, 13C18O+, 12C18O1H+, 
14N16O1H+ and 15N16O+. To overcome the problem of these interferences high resolution 
sector field mass spectrometer was developed and this was used mainly in this work.  
Inductively Coupled Plasma Sector Field Mass Spectrometry (ICP-SF-MS) uses a 
magnetic sector as mass analyser which can be operated in a high mass resolving mode to 
overcome limitations by spectral interferences. In this mode it can separate masses with 
much smaller mass differences often needed to identify an isotope of an analyte element 
with high accuracy. ICP-SF-MS instruments can either be operated in a low mass 
resolution mode with high sensitivity or in a high mass resolution mode with moderate 
sensitivity.  
A typical setup of a reverse design Nier-Johnson HR-ICP-MS is shown in Figure 2.1 and 
consists of the components: 1) Nebulizer and spray chamber, 2) Inductively coupled 
plasma, 3) Interface, 4) Lens system, 5) Magnetic and electrostatic sector and 6) 
Detector. 
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Figure 2.1: Schematic representation of a reverse design Nier-Johnson high-resolution ICP-MS.23 
2.1.1.1 Nebulizer and Spray Chamber 
Samples are introduced into the ICP-MS either as solids or liquids. The liquid 
samples are introduced into the plasma via nebulizers as a fine aerosol by assistance of a 
peristaltic pump.24 Nebulizers are used to produce aerosol droplets of less than 10 µm 
diameter. Solid samples are generally introduced via laser ablation which generates 
particles which are introduced into the Ar plasma. Some pneumatic nebulizers generate 
droplets of diameters greater than 10 µm in addition to small droplets. These droplets can 
affect the plasma discharge conditions or are not fully evaporated so that they have to be 
removed by use of a spray chamber.  
It depends on the analytical requirement which types of nebulizers are used, such 
as concentric and cross flow designed nebulizers. For example for good sensitivity and 
stability concentric design can be employed. The other types of nebulizers are microflow, 
microconcentric, ultrasonic, membrane desolvation, electrothermal vaporization etc. 
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Microconcentric nebulizer (MCN) and cinnabar spray chamber were used in this work for 
sample introduction in HR-ICP-MS. MCN is a highly efficient nebulizer for limited 
sample volumes and the matrix effects are reduced by using it with a cyclonic spray 
chamber. This spray chamber operates by centrifugal forces and droplets are 
discriminated according to their size by means of a vortex produced by the tangential 
flow of the sample aerosol and argon gas inside the chamber. Meinhard type concentric 
nebulizer and Scott double pass spray chamber were used for liquid sample introduction 
into a quadrupole based ICP-MS. The spray chamber selects the small droplets by 
directing the aerosol into a central tube, where they enter into the sample injector of the 
plasma torch.24 The larger droplets emerge from the tube and by gravity, exit the spray 
chamber via a drain tube.  
2.1.1.2 Inductively Coupled Plasma 
These small droplets reach the inductively coupled high temperature argon plasma 
(6000 to 8000 K). This plasma is capable of atomizing and ionizing all analytes and it 
generates mainly positively charged ions. The plasma is formed in a stream of argon gas 
flowing through a quartz torch, which consists of three concentric quartz tubes. An 
induction coil is connected to a radio frequency generator and is used for plasma 
generation. 
Even complex samples such as biological materials are fully atomized and ionized 
in the plasma without any influence on the analytical signal, thus allowing a substance 
independent calibration. This specific feature is most important for all calibration 
strategies developed in this work. 
2.1.1.3 Interface 
An interface in the ICP-MS is used to transfer ions generated in the argon sample 
at atmospheric pressure into the low pressure region. The interface consists of vacuum 
chamber in which a sampler cone, skimmer cone and a gate valve are arranged. The 
sampler and skimmer are metal cones with a small orifice of typically 1 mm diameter. 
The ions first pass through the sampler cone and then through the skimmer cone. These 
cones are used to sample the centre portion of the ion beam coming from the plasma. 
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Behind the sampler and the skimmer a vacuum of about 10-6 mbar is maintained by 
molecular turbo pumps.  
2.1.1.4 Lens System 
The ions from the ICP source are then focused into the entrance slit by the 
extraction lenses. The extraction lenses allow the ions to get extracted and accelerated 
and then focused. The focus lens is used to focus the beam of ions to the transfer lens 
system. The transfer lens system is then used to extract the ions from the orifice of the 
cones and to focus and shape the ion beam to pass the entrance slit.25  
2.1.1.5 Magnetic and Electric Sector 
For the high resolution ICP-MS two analysers are used. First one is an 
electromagnet and the other one is an electro static analyser (ESA). In a standard reverse 
Nier-Johnson geometry setup a magnetic analyser is followed by an ESA as shown in 
Figure 2.1. The ion beam from the plasma is accelerated in the ion optic region to 8 kV 
and focused into the entrance slit before it enters the magnet. Mass separation is achieved 
in the magnetic field. The mass separated ions then enter the ESA where they are filtered 
with respect to their energy and focused into the exit slit, where the detector is positioned.  
The mass resolution can be changed by adjusting the width of the entrance and the 
exit slit in the spectrometer. For achieving different resolution, different slits with varying 
widths are used. For achieving low resolution wide slits are used and for high resolution 
narrow slits are used. The system operates at fixed resolution modes, low resolution 
mode m/Um ~ 300-400, medium resolution mode m/Um ~ 3,000-4,000 and a high 
resolution mode m/Um ~ 8,000-10,000.  
2.1.1.6 Detector 
 The ion detection behind the exit slit is realized by a conversion dynode and a 
secondary electron multiplier (SEM). Ion passes the exit slit and hits the conversion 
electrode. Secondary electrons are released from the surface of the conversion dynode, 
which are attracted and multiplied by the SEM. The detectors can be operated in 2 
modes, pulse counting and analogue mode. A pulse counting mode is used for 
applications where extremely low current ions are needed to be detected and it requires a 
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multiplier with a very high gain (~107). In order to achieve a higher dynamic range, 
detectors with dual mode are used. It is applied in this study where both pulse counting 
and analogue modes are operated simultaneously. Large signals up to 109 cps are 
measured using analogue mode and ion signals from a few cps up to 106 cps are 
measured using a pulse counting mode.  
2.1.1.7 Quadrupole based Mass Analysers 
For analysis of elements that are not prone to spectral interferences, conventional 
ICP-MS based on quadrupole mass analysers can be used. This ICP-MS differs mainly 
with the mass analyser compared to the HR-SF-ICP-MS. A quadrupole consists of four 
cylindrical metallic rods of the same length and diameter aligned parallel to each other 
(Figure 2.2). Each opposing rod pair is connected together electrically and a DC and a 
radio frequency (RF) voltage are applied to adjacent rods creating an alternating electric 
field between the rods; only ions of a selected m/z ratio are allowed to reach the detector 
for a given ratio of voltages, while the others are ejected from the quadrupole. 
2.1.2 Aridus Sample Introduction System with Desolvation 
In this work Aridus sample introduction system with desolvation was used to 
introduce liquid samples to the HR-SF-ICP-MS. It uses the combination of Aspire 
perfluoroalkoxy PFA nebulizer and a heated PFA spray chamber. The Aridus consists of 
a nebulizer which has adjustable outer tip and capillary which is easily replaceable. It has 
a sample uptake rate of 50 or 100 µl/min which enables the analysis of elements with low 
amount of samples typically less than 1 ml. The schematic of the Aridus system is shown 
in Figure 2.3. The sample vapour from the heated PFA chamber is passed to the heated 
fluoropolymer membrane where a counter-current of argon sweep gas is used to remove 
solvent vapour that permeates the membrane.  
The main benefit of using the Aridus system is that solvent based interferences 
are reduced with membrane desolvation. A micro-autosampler can be coupled to the 
Aridus for automated sample analysis at low volumes. 
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Figure 2.2: Schematic of quadrupole mass analyser. 
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Figure 2.3: Schematic of the Aridus system.26 
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2.1.3 Laser Ablation  
In the year 1985 A. L. Gray first used LA as a solid sampling technique.27 This is 
developed to analyse solid materials via ICP-MS. It is a microanalytical technique used 
for the determination of trace elements in solid materials. It avoids the dissolution step 
normally required for preparing the sample. The principle of this method is to use the 
high powered laser to ablate the surface of a solid material and transport the dry aerosol 
into the ICP-MS. The main advantages of using LA are that it involves less interferences 
due to the absence of solvents and its superior detection limit.  
When light energy from a laser with high power density focused onto a solid 
material inside a chamber, the photon induced energy is converted into thermal energy 
resulting in vaporization and removal of the material from the surface of the solid.28 
There are different types of lasers used. The first ones to be used were the ruby lasers 
producing IR laser light.27 But due to the drawbacks of ruby lasers such as low sensitivity 
and poor precision, solid state Nd:YAG lasers were introduced later which are the most 
commonly used ones till now. They operate at 1064 nm and the generated energy is 
sufficient enough for ablating solid materials at various spatial resolutions. Nd:YAG 
lasers can be frequency-quadrupled so that UV laser light can be generated which is 
suitable for ablating most solid material and was used throughout this work.4  
There are various advantages of using laser ablation. Samples can be directly 
analysed without the need of lengthy dissolution steps; the resulting dry aerosol generates 
less polyatomic interferences in comparison to liquid samples. Due to these advantages 
there are various applications of LA together with ICP-MS such as biological, 
environmental and geological fields. One of the latest biological applications is imaging 
of biological tissues for toxic elements.29 It is also used recently in pharmaceutical 
studies, as a comparative study for determination of fake drugs.7  
Nielsen et al.30 first introduced the combination of gel electrophoresis technique 
with LA-ICP-MS for speciation of metal binding serum proteins. Human serum was 
enriched with Co and subjected to agarose gel electrophoresis in two dimensions. Nd: 
YAG laser (1064 nm) interfaced to ICP-MS was used for the analysis of these gels. The 
identification of the main Co binding serum proteins was performed by comparing the 
distribution map for Co with the protein distribution map obtained via Coomassie 
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Brilliant Blue staining. The capabilities of LA-ICP-MS for the detection of trace elements 
especially selenium in a gel after gel electrophoresis were studied by Chery et al.31 
Limits of detection, linearity and repeatability were evaluated for various elements (Li, 
V, Cr, Mn, Ni, Cu, Zn, As, Se, Mo, Pd, Ag, Cd, Pt, Tl and Pb). The detection limits 
ranged from 5 x 10-2 for 95Mo to 90 fmol for 77Se. Two ablation strategies were used for 
the identification of selenoproteins: single hole drilling relevant for spot ablation of 2D 
separation gels and line rastering relevant for 1D separation. The detection limit for Se 
was found to be 0.07 µg/g for spot ablation and 0.15 µg/g for line rastering. 
In most of these applications, protein spots in gels were directly ablated and 
introduced to the ICP-MS for the detection of hetero-elements in proteins which is the 
straightforward method. But in order to reduce the high blank values obtained from direct 
analysis of gels, membranes after electroblotting can be used as an alternate method to 
analyse elements especially phosphorus. Even though an additional step is involved for 
blotting of proteins from gels, this method can be particularly used to achieve trace 
matrix separation. Since proteins are present in the upper layer of the membrane material 
after blotting they can be easily targeted by the laser. Additionally to this technique, LA-
ICP-MS can be combined with immunoblotting method where multiple antigens can be 
concomitantly analysed with single labelled antibodies. The total analysis time of 
samples can be relatively reduced in comparison to the Electrochemiluminescence (ECL) 
method.  
2.1.4 Calibration and Quantification Strategies in ICP-MS 
ICP-MS is the most powerful technique for the analysis and quantification of 
trace elements in both solid and liquid samples. Proteins can be quantified either 
relatively or absolutely based on the quantification approach and the method adopted. 
The quantification of proteins based on relative quantification is usually performed by 
comparing the intensities in a test sample relative to the corresponding intensities in a 
standard used for calibration whereas absolute quantification gives the real absolute 
quantitative data within the unknown sample. 
In analytical perspective, calibration forms the basis to perform quantification. 
Different types of calibration strategies such as internal, external, matrix-matched, 
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standard addition, isotope dilution and calibration by internal normalization are used with 
ICP-MS based methods.28 The evaluation of simultaneous use of some of the methods as 
potential calibration methods was discussed in detail in literature.32 Generally ICP-MS 
based calibrations are mainly based on internal standards, i.e. by adding known amount 
of elemental standard which is not usually present in the sample. For this purpose an 
element is selected similar to the analyte element in mass, ionization potential and 
chemical behaviour.33 These standards are useful for analysis where the quantity of the 
sample analysed and the instrument response varies from run to run and is difficult to 
control. The concentration of the unknown can be determined by plotting analyte to 
internal standard signal ratio as a function of the analyte concentrations in the standard. 
For quantification of phosphorus using ICP-MS based methods sulphur has been often 
used as the internal standard, e.g. in the work of Becker et al. it was applied for the 
quantitative determination of phosphorus and other elements in proteins of yeast 
mitochondria using LA-ICP-MS.34 
Commonly internal standardization is applied in combination with external 
calibration strategy for accurate quantification of analytes. In an external method, 
experiments are performed first with the full range of calibration standards and blanks 
and then the unknown samples are quantified with the calibration curve. This method is 
usually used when there is very little difference between the matrix in the standards and 
the unknown samples. When there are matrix effects or drifts in sensitivities of the 
instrument, standard addition or matrix-matched methods could be used an alternative. In 
the matrix matched method the matrix of the standard can be adjusted to match that of the 
sample and used for quantification. Recently matrix-matched laboratory standards were 
used by Becker et al. for quantitative determination of copper, zinc and other elements 
distributed in thin slices of human brain samples measured by LA-ICP-MS.35 In standard 
addition method samples are spiked with known concentrations of analytes and the 
resulting regression line, which is obtained after plotting intensities against the 
concentration of the added spikes, gives the analyte concentration as the intercept of the 
x-axis. In isotope dilution analysis the sample is spiked with a solution of known quantity 
of a rare but highly enriched isotope and the concentration of the element of interest in 
the sample can be calculated using the isotopic ratio of the resulting solution and the 
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known isotopic ratio of the spike and the natural abundances. This method was used 
recently by Schaumlöffel et al.36 for absolute quantification of sulphur-containing 
peptides after tryptic digestion and analysis by nanoHPLC-ICP-MS. Calibration can also 
be performed by normalizing the resulting intensities with the help of internal standards. 
In this study using LA-ICP-MS, the use of proteins and inorganic compounds as matrix-
matched standards externally in blots as one of the calibration strategy was explored. In 
addition, by measuring internal standards in blots, the potential of calibration by internal 
normalization together with external calibration with labelled proteins was also tried for 
quantification of proteins. 
2.1.5 Protein Quantification Methods 
Three spectrophotometric methods were used in this work to determine the 
concentration of proteins in a solution. These include measurement of the proteins’ 
intrinsic UV absorbance and 2 methods which generate a protein-dependent colour 
change; the Lowry assay (2.1.5.3) and the Bradford assay (2.1.5.2). The protein 
concentration using Lowry and Bradford assay was obtained using an UV/VIS 
spectrophotometer. 
2.1.5.1 UV Absorbance at 280 nm 
This method is applicable to purified proteins with exhibiting absorbance at 280 
nm. Amino acids with aromatic rings, tyrosine and tryptophan are primarily responsible 
for the absorbance peak at 280 nm. Since these amino acid contents of various proteins 
vary within a narrow limit, the absorption peak at 280 nm has been used as a fast and 
sensitive method for protein concentration estimations. This method does not need any 
standard calibration curve, it is simple to perform and the sample is recoverable. The 
Beer-Lambert law states that  
Absorbance A = E x C x L 
where E is the extinction coefficient, C the concentration in mol/l and L the optical path 
length in cm. If the extinction coefficient is known, the absorbance gives the 
concentration of the protein for a 1 cm path length.  
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2.1.5.2 Bradford Assay 
The Bradford dye assay is based on the equilibrium between three forms of 
Coomassie Blue G dye, i.e. absorbance shift in this dye when bound to basic (primarily 
arginine, lysine and histidine) and aromatic residues. Under strong acid conditions the 
dye exists in a stable doubly-protonated red form.37,38 Upon binding to protein; however, 
it is most stable in an unprotonated, blue form. The three different absorbance maxima of 
the dye-protein complex correspond to three forms of the dye present, the red form which 
absorbs light at 470 nm, the single protonated neutral green form at 650 nm and the 
anionic (deprotonated) blue dye-protein complex at 595 nm. 
 The detection limits of this method range from 1-20 µg for micro assay and 20-
200 µg for macro assay. It is faster, involves fewer mixing steps and gives a more stable 
colorimetric response compared to Lowry assay. However, there are limitations such as it 
is non-linear over wide ranges and its response to different proteins can vary widely.  
2.1.5.3 Lowry Assay 
The Lowry assay is based on reduction of Cu2+ to Cu1+ amides. Under alkaline 
conditions, Cu2+ deposits itself to the peptide bonds of protein to form the protein Cu2+ 
complex, which subsequently reduces Folin-Ciocalteu phosphomolybdic/phosphotungstic 
acid to heteropolymolybdenum blue by the copper catalyzed oxidation of aromatic 
acids.37 The product can be detected colorimetrically by absorbance between 550 and 750 
nm. The Lowry method is sensitive to pH changes and therefore the pH of the assay 
solution should be maintained at 10-10.5. The limitation of using this method is that it 
can’t be used in presence of strong acids or ammonium sulphate which can interfere with 
the assay. The detection limit ranges from 2-100 µg. 
2.1.6 Electrophoresis 
2.1.6.1 Principle of Electrophoresis 
Electrophoresis is a technique used to separate and sometimes purify 
macromolecules especially proteins and nucleic acids that differ in size, charge or 
conformation. As such it is one of the most widely used techniques in biochemistry and 
molecular biology. When charged molecules are placed in an electric field, they migrate 
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toward either the positive or negative electrode according to their charge. Proteins and 
nucleic acids are electrophoresed within a matrix or gel. The generally used support 
medium is cellulose or thin gels made up of either polyacrylamide or agarose, each of 
which has attributes suitable to particular tasks.39 Cellulose is used as support medium 
for low molecular weight biochemical’s such as amino acid and carbohydrates whereas 
agarose and polyacrylamide gels are widely used for larger molecules like proteins. 
2.1.6.2 Polyacrylamide Gels 
Polyacrylamide is a cross-linked polymer of acrylamide. Polyacrylamide gel is 
prepared by the free radical polymerization of acrylamide and the cross linking agent N 
N´ methylene bis acrylamide (bis). The structures of the compounds acrylamide and bis 
are shown in Figure 2.4a and b. The polymerization is started when ammonium per 
sulphate and tetramethylethylendiamine (TEMED) are added to the mixture. The length 
of the polymer chains is dictated by the concentration of acrylamide used, which is 
typically between 3.5 and 20%. Polyacrylamide gels are significantly more annoying to 
prepare than agarose gels. Acrylamide is a potent neurotoxin and should be handled with 
care. Polyacrylamide gels have a rather small range of separation, but very high resolving 
power. In case of DNA, polyacrylamide is used for separating fragments of less than 
about 500 bp. However, under appropriate conditions, fragments of DNA differing in 
length by a single base pair are easily resolved. In contrast to agarose, polyacrylamide 
gels are used extensively for separating and characterizing mixtures of proteins.40 In 
addition to the properties of the molecules of interest, the gel pore size and buffer systems 
are the important parameters which need to be optimised in electrophoresis.  
The pores in the gel are created by crosslinking of polyacrylamide with the bis to 
create a network of pores and their size is determined by the total amount of acrylamide 
present (%T) and the amount of the cross linker (%C). A schematic of a polyacrylamide 
network is shown in Figure 2.5. The pore size decreases when the total amount of 
acrylamide increases. The relative pore size of the gel is indicated by the %T which is the 
weight percentage of the total monomer including the crosslinker. %C is the 
crosslinker:acrylamide monomer ratio of the monomer solution. For example 8.5%T 
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means that there is a total of 8.5 g of acrylamide and bis per 100 ml of gel and 
8.5%T:6%C means that a total of 8.5% acrylamide and bis and bis is 6% of the total.  
The buffer system affects the migration of proteins and is used in the gel and the 
running buffer. There are continuous and discontinuous buffer systems. In continuous 
buffer system the same buffer is used at constant pH and concentration throughout for the 
preparation of the gel. It is made of one continuous %T. But most of the today’s systems 
use discontinuous buffer systems where 2 types of buffer ions are used. Two types of 
gels, stacking and resolving gels are prepared with 2 types of buffer systems so that 
samples are compressed into a thin starting band and individual proteins are finely 
resolved and separated. In Native PAGE conditions, pH of the buffer systems is 
important as the migration of protein depends on both the size and charge of the protein. 
It should be maintained in such a way that the protein of interest is stable.  
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Figure 2.4: (a) Monoacrylamide and (b) Bis. 
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Figure 2.5: Polyacrylamide network. 
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2.1.6.3 Sodium Dodecyl Sulphate–Polyacrylamide Gel Electrophoresis  
The general electrophoresis techniques cannot be used to measure the molecular 
weight of the biological molecules because the mobility of a substance in the gel is 
influenced by both charge and size. In order to overcome this, the biological samples are 
treated so that they have a uniform charge and the electrophoretic mobility which then 
depends primarily on size. The molecular weight (MW) of proteins may be estimated if 
they are subjected to electrophoresis in the presence of a detergent sodium dodecyl 
sulphate and a reducing agent Dithiothreitol (DTT). SDS disrupts the secondary, tertiary 
and quaternary structure of the protein to produce a linear polypeptide chain coated with 
negatively charged SDS molecules. 1.5 g of SDS binds per gram of protein. DTT assists 
the protein denaturation by reducing all disulfide bonds.41,42 The general principle of the 
SDS-PAGE is shown in Figure 2.6. After linearization proteins are transferred to a gel 
and when electric current is applied they migrate towards the anode because of the 
negative charge imparted on them by SDS. Usually 8 to 10 sample wells are present in 
each gel that is casted. A section of it is shown in the Figure 2.6.  
MW of a protein can be determined by separating the protein sample on the same 
gel with a set of MW standards especially pre stained markers. After staining, gels are 
analysed to obtain the relative migration distance (Rf) values. Rf is the distance of the 
protein migrated through the gel divided by the migration distance of the dye front. The 
distance should be measured from the sample wells to the band of interest. The MW of 
the unknown protein is calculated using the standard curve obtained from plotting of log 
MW versus Rf values.  
SDS-PAGE with discontinuous buffer system developed by Laemmli54 is the 
most commonly used electrophoresis method. Preparations involve casting of two 
different layers of acrylamide between glass plates. The lower layer (separating or 
resolving gel) is responsible for actually separating polypeptides by size. The upper layer 
(stacking gel) includes the sample wells, and has the composition that causes the samples 
to become compressed (stacked) in order to have sharper bands and correspondingly 
better resolution among bands. The bands obtained from this technique are very specific 
even within a low range.  
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SDS-PAGE separates proteins according to the primary structure or size but not 
amino acid sequence. Hence different proteins with same number of amino acids or 
molecular weight cannot be separated with this method that results in inferior resolution.  
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Figure 2.6: Principle of SDS-PAGE. 
 
Electrophoresis can be performed in 2 ways, either by using horizontal or vertical 
systems. Horizontal systems can be used where it is affordable to use precast gels. Precast 
gels are available with different %T concentrations and in different formats. In this work, 
horizontal SDS-PAGE electrophoresis using precast gels was used and they were 
performed on the Multiphor II Flatbed Electrophoresis System (Amersham, Biosciences, 
Freiburg, Germany) connected to the power supply (2197, Amersham, Freiburg, 
Germany). Vertical SDS-PAGE separation system, Miniprotean III from Bio-Rad was 
used in this work where proteins are separated in smaller gels and in addition to the pre 
cast gels, manual casting of gels can also be performed with this device. 
2.1.7 Blotting 
The transfer of biological samples from a gel to a membrane and the detection on 
the membrane surface is termed as blotting and also referred as electroblotting. The 
transfer of protein in this way and its subsequent detection is referred to as Western 
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blotting. It is evolved from the term Southern blot which is a technique used for DNA 
detection and Northern blotting which is used for the detection of RNA on membranes. It 
is also referred as immunoblotting because an antibody can be used to detect the antigens 
on the membrane. This technique was first introduced by Towbin et al.43 in 1979 who 
used this method for the electrophoretic transfer of ribosomal proteins from 
polyacrylamide gels to nitrocellulose (NC) membranes. By either using autoradiography 
or the peroxidase reaction product, the specific proteins could be detected. 100 pg of 
protein can be detected using the latter method. Two types of membranes are generally 
used for the transfer. One is nitrocellulose and the other is polyvinylidene fluoride 
(PVDF). Nitrocellulose membranes are mostly used as it provides high sensitivity with 
low background and binding is irreversible. Membranes are available in 2 pore sizes, 0.2 
µm and 0.45 µm, and their use is dependent on the application. 0.2 µm is used for 
transfer of low molecular weight (<20 kDa) and 0.45 µm for transfer of high molecular 
weight proteins (>20 kDa).  
Proteins can be transferred onto the membranes via semi-dry (SD) blotting or wet 
blotting techniques. As the name suggests, semi dry is done under dry conditions using 
filter discs and the wet blotting is done in complete wet conditions. Both methods have 
their own advantages and disadvantages, but the semi dry method is better suited as it 
requires less volume of buffer than wet (also known as tank) blotting. As lower volumes 
of buffer used there is lower background while detecting the proteins via their elemental 
composition by LA-ICP-MS which can further reduce the detection limits of the method. 
Hence SD blotting was mainly applied in this study and a comparison was performed 
with contact blotting method. SD blotting method offers fast as well as homogenous 
transfer of proteins and it can be used with discontinuous buffer system, so that smaller 
proteins as well as protein mixtures of very different sizes can be blotted more uniformly. 
Another advantage of semidry blotting is that it is highly efficient in quantitatively 
transferring large proteins of >200 kDa. The semidry blotting experiments in this study 
were performed using the graphite anode and cathode plates connected to the power 
supply (2197, Amersham, Freiburg, Germany).  
Western blotting is the combination of above explained protein blotting methods 
with immunodetection methods. This technique is applied in various applications for 
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example in detection of protein expressions in cells and tissues. It is primarily used in 
medical diagnostic applications like HIV testing. Immunoblotting can be performed once 
the specific antibodies are available for the detection of antigens on membranes. 
Generally there are 2 ways of detection, direct and indirect detection. After separation of 
proteins using SDS-PAGE or 2D separation and blotting onto membranes, 
immunoblotting by use of antibodies can be applied to probe specific proteins. In the 
direct method, the applied primary antibody is already enzymatically labelled (Figure 
2.7a). So after the substrate addition, the antigen can be directly detected. In the indirect 
method, two antibodies are used, primary and secondary antibody where the latter is 
labelled with an enzyme (Figure 2.7b). The substrate is then added which gives a 
detectable product. The first method is the quickest as it employs only one antibody and 
the cross reactivity of the secondary antibody can be eliminated. But with the second 
method, the sensitivity can be improved due to the fact that more than one secondary 
antibody can bind to the different epitopes of the primary antibody.  
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Figure 2.7: (a) Direct and (b) indirect detection of proteins using antibodies. 
2.1.7.1 Electrochemiluminescence Detection 
In Western blotting techniques different detection methods are applied such as 
Colorimetric, chemiluminescent, fluorescent or radioactivity based detection methods can 
be used. The sensitivity of the technique can be improved by using enhanced 
chemiluminescent (CL) based methods. One of the CL methods, 
electrochemiluminescence is used commonly in a variety of biological detection assays. 
ECL is a kind of luminescence caused by an electrochemical reaction. For the antigen 
detection, immunoblotting is performed with the primary or the secondary antibody 
which is linked already to the labelled enzyme horseradish peroxidase (HRP). When the 
blot is incubated with a luminol based substrate it results in the emission of light which 
can be captured and visualized by exposing the blot to a film or to an appropriate CCD 
camera. The substrate luminol is oxidised in presence of the enzyme HRP and hydrogen 
peroxide which results in the product 3-aminophthalate that emits light at 425 nm. The 
detection limit can be improved with the help of various other enzymatic detection 
methods such as using biotin-streptavidin peroxidase system. The benefits of using this 
method is that it is sensitive, fast, easy and inexpensive and it has a high dynamic range 
and low detection limits. Nevertheless there are disadvantages like only one specific 
antigen can be probed at the same time and one may not detect all low affinity antibodies. 
In this work the Western Lightning Chemiluminescence Reagent Plus was used to 
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visualize the bands of the labelled-antibody and images were acquired by the ChemiLux 
gel imager CSX-1400M (INTAS, Göttingen, Germany).  
2.1.8 Gel Scanner 
The imaging of the stained gels was performed using the fluorescent laser scanner 
FLA-5100 and a 532 nm laser (Fujifilm Life sciences, Duesseldorf, Germany). The 
system includes a red laser (635 nm) as standard and green (532 nm), blue (473 nm) and 
near infrared (670 nm) as optional lasers. A resolution of 10 to 200 microns (1 micron 
corresponds to a pixel size of 1 µm) can be set according to the requirement and it has a 
dynamic range of 5 orders of magnitude. The Coomassie stained gels are placed on a 40 x 
46 cm stage (Fluor stage in Figure 2.8) and a specialized fluorescent board is placed over 
it. The laser light is reflected by a mirror into the optical head which moves under the 
stage. The optical head directs the laser light onto the sample. When the green second 
harmonic generation laser (532 nm) at photon multiplier tube (PMT) setting of 250 V is 
applied, the excitation and fluorescence are decreased at parts of the gel according to the 
density of the stain. The light emitted from the sample travels via a mirror through the 
filter to the PMT which is placed besides the optical head on the left side and detected. A 
positive image can be obtained from the negative image using the Image reader software. 
The schematic of the gel scanner is shown in Figure 2.8.  
Fluor stage 
Sample 
Optical head 
Secondary scan 
direction 
Main scan direction
Filter 
PMT 1 
Laser Diode
(670nm) 
Laser Diode 
(635nm) 
SHG Laser  
(532nm) 
SHG Laser  
(473nm) 
 
Figure 2.8: Schematics of the FLA-5100 gel scanner. 
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2.1.9 White light Interferometer 
The craters of the laser scanned blot membranes were measured with a white-light 
interferometric (WLI) microscope NewView 5010 (Zygo, Middlefield, USA).WLI is a 
powerful tool for optical measurements and works with a light source with broad spectral 
bandwidth. Due to that the coherence length of the source is short and good contrast 
fringes will be obtained only when the two paths of the interferometer are closely 
matched in length. WLI is a technique for non-contact measurement of surface 
topography at high vertical and moderate lateral resolution. It provides fast, quantitative, 
surface texture measurement and analysis on many types of surfaces, in just seconds. The 
major drawback of scanning WLI measurement is that only a single surface height is 
being measured at a time and a large number of measurements and calculations are 
required to determine a large range of surface height values. Nevertheless modern 
computers with specialized software can solve these problems. The main applications are 
for the measurement of chromatic dispersion and distances. 
2.1.10 Antibody Structure 
Antibodies are proteins produced by the immune system for the defense of the 
organism against foreign species. They consist mainly of amino acids but also contain 
carbohydrate residues. An antibody is approximately 150 kDa protein consists of two 
heavy (50 kDa) and two light chains (25 kDa) couple to each other by disulfide bonds, 
forming a characteristic Y-shape (Figure 2.9). When subjected to SDS-PAGE, antibody is 
split into heavy and light chain fragments and thus it should give two bands, one at 
approximately 50 kDa and another at approximately 25 kDa. 
A small region of 110-130 amino acids at the tips of the Y-shaped antibody varies 
with different antibodies. This part of the antibody determines the specificity of the 
antibody which is designed to specifically bind antigens by a lock-and-key mechanism. 
Each target requires a different recognition structure and therefore a greater variability is 
observed at the tips of the antibody. The rest of the antibody shows little variation. 
Antibodies are also called as immunoglobulins and classified into five classes IgG, IgA, 
IgM, IgD and IgE depends on the composition of their constant region. A wide variety of 
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commercially available pre labelled specific antibodies can be purchased for quantitative 
assays.  
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Figure 2.9: Schematic of an antibody structure. Two heavy chains (dark) are linked by disulfide 
bridges in the central part, Hinge region. Light chains are bound to the heavy chains by other 
disulfide bridges. a) Fragment antigen binding (Fab) region, b) Fragment crystallisable (Fc) region, 
c) variable and d) constant regions. The tips of the variable regions (denoted by circle) interact with 
the antigen strongly. 
2.1.11 Labelling using Bioconjugation Chemistry 
The covalent attachment of chelating compounds to antibodies and other proteins 
is termed as the labelling of proteins. It enables the detection of proteins and among 
different methods, labelling with chelating compounds has been widely studied and used 
in the medical, biological and analytical fields. The term chelate is generally reserved for 
complexes in which the metal ion is bound to two or more atoms of the chelating agent, 
although the bonds may be any combination of coordination or ionic bonds. There are 
numbers of chelates available of which 2 were chosen for detecting proteins via LA-ICP-
MS using well established biochemical methods. The first one used here is 
diethylenediaminepentaacetic acid dianhydride and second one is 2-(4-
isothiocyanatobenzyl)-1,4,7,10-tetraazacyclododecane-tetraaceticacid. They are bi-
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functional, which means that they have a reactive functional group for targeting the 
proteins and a metal chelating group. 
2.1.11.1 Diethylenediaminepentaacetic Acid  
DTPA is the chelating agent that is used extensively in medical sciences for the 
removal of radioactive materials from the human body. It can be used to label the protein 
with elements. It was previously used for radiolabelling of antibodies.55 The structure of 
this molecule and the DTPA-protein complex are shown in Figure 2.10a and b. It consists 
of a diethylenetriamine backbone modified with five carboxymethyl groups. Its conjugate 
base has a high affinity for metal cations. After binding to the lanthanide it exists in a 
penta anionic form, i.e. all five carboxylic acid groups are deprotonated. This bi-
functional chelating agent contains 2 amine reactive anhydride groups. It can react with 
the N terminal amine groups of the proteins to form amide linkages. The anhydride rings 
open to create multivalent metal chelating arms able to bind tightly to metals in a 
coordination complex. A study with respect to LA-ICP-MS detection was performed in 
this work for detection of compounds which do not have detectable hetero-elements. This 
labelling strategy can be used for optimising the detection conditions for LA-ICP-MS 
method and also for the potential multielemental determination.  
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b) 
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Figure 2.10: (a) Diethylenetriaminepentaacetic acid dianhydride and (b) DTPA-protein complex. 
2.1.11.2 2-(4-Isothiocyanatobenzyl)-1,4,7,10-tetraazacyclododecane-1,4,7,10 -
and contrast 
prov
tetraaceticacid  
The second method used here is based on chelating compounds in particular p-
SCN-Bn-DOTA. These chelating agents are bi-functional, i.e. they contain a metal 
chelating group and a second functional group which is chemically reactive in nature, 
which binds to a specific biological target molecule, here to proteins and antibodies. In 
medicine they are very often used in combination with radiopharmaceuticals 
im ing agents for instance in cancer therapies or imaging applications.44  
 The reaction scheme of the mechanism of labelling proteins followed in this work 
using p-SCN-Bn-DOTA is shown in Figure 2.11. The chelating compound is bi-
functional; the first one involved in binding a metal, for instance europium, and the other 
function is used to bind to a protein via a reactive linker molecule, SCN in this case. This 
type of linker molecule binds covalently preferable to amino groups of the protein. The 
reactive group of DOTA is an isothiocyanate group attached to a benzene ring. As shown 
in Figure 2.11 in the first step the amino group of the protein reacts with the SCN group 
to form a phenyl thiocarbamoyl group. This reaction strongly depends on the pH value 
because below a pH of 7.5 only the end-terminal amino group is charged and will bind, 
whereas with increasing pH value above 9 the lysine residue will react and at even higher 
pH values also the arginine residue is charged. In the second step a three valent metal 
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cation is added to the protein-DOTA complex and 3 of the 4 carboxyl groups of the 
macrocyclic DOTA will form a coordinative binding with the threefold charged metal. 
The remaining fourth carboxyl group is then carrying still a negative charge.  
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2.11: Schematics of labelling procedure (adopted from45). 
2.1.11.
Figure 
3 Iodination 
Iodination of proteins has been well known for a long time and has already often 
been applied, but mainly in combination with radioactive 125I labels, for instance in the 
pioneering work of Markwell46. The chemistry is very well described in textbook47 and 
in original publication48. The scheme of a protein is shown in literature of Jakubowski et 
al. 49 which contains two binding sites for iodine. The reaction is based on electrophilic 
substitution of iodine to histidine and tyrosine. Starting with NaI and a protein in 
solution, the reactive species I+ is generated by use of an oxidizing compound. Reaction 
is then possible at two different reaction sites of both amino acid residues: at the ortho-
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positions of tyrosine and at the 2,5 positions of the imidazole-ring in the histidine residue. 
This method is applied in combination with LA-ICP-MS for detection of the stable iodine 
isotope 127I, thus minimizing the risk of radioactive compounds and extending the 
application to a conventional laboratory environment. It was used here for labelling 
antibodies which was then applied for detection of antigens by LA-ICP-MS methods.  
2.2 Experimental 
.2.1 
The elemental analysis was carried out using two ICP-MS systems, 
(1) innigan Element-2 (Thermo Fisher Scientific, Bremen, Germany) 
c spray chamber (Cinnabar, Glass Expansion Ltd., 
Melbourne, Australia).  
 
2 Inductively Coupled Plasma Mass Spectrometry 
 
 
F
 
It is a high resolution double focusing magnetic sector field ICP-MS. Laser 
ablation was coupled to this system for analysing blot membranes and liquid 
sample analysis was performed with Aridus desolvation system using 
microconcentric nebulizer (Micromist, Glass Expansion Ltd., Melbourne, 
Australia) and cycloni
 
Figure 2.12: Element-2 ICP-MS.50 
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(2) lasmaQuad II/III (Thermo Fisher Scientific (formerly Fisons/VG-Elemental), 
ed only for liquid sample analysis of certain 
ements. Liquid sample analysis was performed using Meinhard concentric 
nebulizer and Scott spray chamber.  
  
P
Bremen, Germany) 
 
It is a quadrupole ICP-MS. It was us
el
 
Figure 2.13: Plasma Quad III ICP-MS.51 
ation Methods 
y 500 UV/VIS 
meter (Varian Deutschland GmbH, Darmstadt, Germany). All solutions 
orking solution: Bio-Rad Coomassie solution in ethanol and phosphoric acid 
rotein Standard: 1.0 mg/ml Bovine Serum Albumin (BSA) in water 
 
2.2.2 Protein Quantific
2.2.2.1 Bradford-Assay 
The protocol for this protein quantification method is described in more detail in 
the manual of the company Sigma Aldrich.52  
The UV absorbance was carried out using the Car
spectrophoto
were prepared using ultra pure water (Millipore, Bedford, MA, USA). 
1) Solution 
W
P
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2) Protocol 
In order to obtain the standard curve the BSA solution was prepared in the following 
concentrations – 2.5, 5.0, 7.5, 15.0 and 20 mg/ml. For zero value only water was used. 
 cuvettes. 
Table 2  sample used d Assay. 
Samples BSA standards Zero value 
Experiments were performed in polystyrene micro
-1: Amount of  for Bradfor
Solutions 
Samples 80 l 0 µ - - 
BSA standards 800 µl - - 
water   800 µl 
Coomassie solution 200 µl 200 µl 200 µl 
 
After a gentle mix solutions were incubated at room temperature for 3 min. Then the 
 measured with the photometer at wavelength 595 nm. 
curve then samples were diluted with different dilution factors and again 
measured. 
2.2.2.2
m, measures the protein absorbance 
at 280 nm and calculates the concentration (mg/ml). 
2.2.3
 protocol is described in more detail in the biochemical methods book of 
extinction was
3) Evaluation 
The calibration curve was directly obtained from the photometer software or by using 
Excel application. If the measured extinctions of the sample lie beyond this standard 
calibration 
 Protein Absorbance Assay (280 nm) 
This assay was used for low amounts of samples. 2 µl of sample was enough for 
the measurement. For that purpose Nanodrop ND-1000 spectrophotometer (Thermo 
Fisher Scientific, Bremen, Germany) was used. It has in built calibration available for 
many proteins. This instrument gives the UV spectru
2.  Lowry-Assay 
 The
Cooper.53 
1) Solution 
Solution A:   100 g/l Na2CO3 
Solution B:   10 g/l CuSO4 . 5H2O 
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Solution C:   20 g/l K-Na-Tartrate . 4H2O 
W g o 1 part solution B, 1 part solution C and 2orkin  soluti n:  0 parts of solution A  
’s phenol reagent 
ard: 1.0 mg/ml BSA in water 
ero value water was used. 
Table 2  sample and s teps invo . 
Samples BSA standards Zero value 
    mixed together (done just before use)  
FCP reagent:  10% (v/v) Folin-Ciocalteu
Protein stand
2) Protocol 
In order to obtain the standard curve the BSA solution was prepared in the following 
concentrations – 0.25, 0.50, 0.75 and 1.00 mg/ml. For z
Polystyrene micro cuvettes were used for the measurement.  
-2: Amount of equence of s lved in Lowry assay
Solutions 
Samples 20 l 0 µ - - 
BSA standards 200 µl - - 
water   200 µl 
Working soluti 200 µl on 200 µl 200 µl 
It was then incubated at room tempe r 15 min rature fo
FCP reagent 600 µl 600 µl 600 µl 
Then incubated at room temperature for 45 min 
Extinction was measured at wavelength 550 nm  
 
3) Evaluation 
The calibration curve was directly obtained from the photometer software or by using 
Excel application. If the measured extinctions of the sample lie beyond this standard 
calibration curve then samples were diluted with different dilution factors and measured 
again. For samples and standards with concentrations less than 100 µg/ml, extinction was 
measured at 650 nm.  
2.2.3 
n this work 
and the protocols of the experiments were designed according to Laemmli.54  
Gel Electrophoresis 
Two types of electrophoresis, vertical and horizontal were followed i
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2.2.3.1 Vertical Electrophoresis  
2.2.3.1.1 Preparations of Buffer and Solutions 
Separating buffer: 181.5 g/l Tris-HCl 
Stacking buffer:  60.5 g/l Tris-HCl 
10% SDS solution: 100 g/l sodium dodecyl sulphate 
10% APS-solution: 100 µg/ml ammoniumpersulphate (freshly prepared) 
Acrylamide/Bis (30%T, 2.67%C)  29.2 g Acrylamide 
0.8 g N’N’-bis-methylene-acrylamide 
Diluted in 100 ml water, filtered and stored at 4 °C in the dark (maximum 30 days) 
Sample buffer (SDS reducing buffer)  
(twofold):     30.3 g/l Tris-base 
      40.0 g/l sodium dodecyl sulphate 
      240.0 g/l Glycerine 
      6.2 g/l Dithiothreitol  
      pH 8.8 (3M HCl) 
      little grains of bromophenol blue 
Electrode buffer (tenfold):   30.3 g/l Tris-base 
      144.0 g/l Glycin 
      10.0 g/l sodium dodecyl sulphate 
      Stored at 4 °C 
50 ml was diluted with 450 ml water for each electrophoresis run. 
TEMED 
2.2.3.1.2 Preparation of Gels 
a) Separation gel: 
Dependent on the required pore size of the gels homogenous gel was prepared 
using the following chemicals (Table 2-3) and poured into the gel chamber immediately 
after 50 µl 10% APS solution and 10 µl TEMED were added (for a 10 ml monomer 
solution). It was poured in such a way that roughly 1 cm area was left free so that 
stacking gel can be added later prior to placing of the comb for sample loading. 
Immediately after pouring the solution, water was added in the free area left to avoid 
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contacting with air. The contact of air with the solution may cause abnormal 
polymerization reactions. The polymerization time for the reaction was 1 h. 
b) 6% stacking gel: 
After the removal of water, stacking gel was prepared using the following 
chemicals and poured into the gel chamber immediately after 50 µl 10% APS solution 
and 10 µl TEMED were added (for a 10 ml monomer solution). 
5.4 ml water 
2.0 ml 30% Acrylamide / Bis – stock solution 
2.5 ml stacking buffer (0.5 M Tris HCl, pH 6.8) 
100 µl 10% (w/v) SDS 
Then a comb was inserted into the stacking gel solution carefully without making 
any air bubbles. The polymerization reaction time was 45 min. If the gel was shrunken 
during this time then some more stacking gel solution were added.  
Table 2-3: Preparation of separating gel. 
Percent gel 
(%) 
H2O 
(ml) 
30% degassed acrylamide / bis
(ml) 
Separating buffer 
(ml) 
10% w/v SDS
(ml) 
10 4.1 3.7 3.1 2.4 
11 3.3 3.7 4.3 5.0 
13 2.5 2.5 2.5 2.5 
15 0.1 0.1 0.1 0.1 
2.2.3.1.3 Sample Preparation 
The sample and the marker were mixed with SDS-sample buffer (1:1 by volume) 
and kept in a water bath for 3 min at 95 °C. This step was to denature the proteins. If it 
was necessary to isolate native proteins the heat denaturation and addition of DTT in the 
sample buffer were avoided.  
A dual colour molecular weight marker (Bio-Rad, Munich, Germany) was used 
for calibration of the molecular weight scale in SDS-PAGE. It contains ten highly pure 
recombinant protein bands with 10, 15, 20, 25, 37, 50, 75, 100, 150 and 250 kDa. It was 
mixed 1:1 (by volume) with water and about 10 µl was used for electrophoresis. 
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2.2.3.1.4 Running Conditions for Electrophoresis 
The gel cassette sandwich after casting the gel was removed from the casting 
chamber, rinsed with water and placed carefully into the electrode assembly. It was then 
filled with the electrode buffers. 20 - 30 µl sample or marker was taken in a pipette and 
injected into the wells carefully. The electrophoresis was started with constant current of 
20 mA and continued until the protein enters the separating gel. Then a current of 40 mA 
was applied with a voltage of around 150 - 200 V. The electrophoresis was stopped when 
the bromophenol blue dye front in the sample buffer reaches the end of the gel. 
2.2.3.2 Horizontal Electrophoresis 
2.2.3.2.1 Preparation of Gel, Buffer and Solutions 
Rehydration buffer: 36.34 g/l Tris 
1.0 g/l SDS 
0.1 g/l sodium azide 
pH 8.0 (adjusted with acetic acid) 
Anode buffer:  36.34 g/l Tris 
1.0 g/l SDS 
0.1 g/l sodium azide 
pH 8.4 (adjusted with acetic acid) 
Cathode buffer: 9.69 g/l Tris 
   143.34 g/l Tricine 
   1.0 g/l SDS 
   0.1 g/l Sodium azide 
Sample buffer (stock solution): 3.0 g/100 ml Tris 
     pH 7.5 (adjusted with 96% acetic acid) 
SDS sample buffer: 5 ml stock solution 
   0.5 g SDS 
   7.7 mg DTT 
Diluted in 50 ml water, freshly prepared  
Precast CleanGels (T = 10%) were purchased from Electrophorese Technik (ETC, 
Kirchentellinsfurt, Germany). Before the running of the electrophoresis the dry readily 
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available clean gel must be rehydrated. The gel was submerged in 25 ml rehydration 
buffer with the plastic part facing upwards for about 60 min. The gel was placed in such a 
way that there are no air bubbles. After 60 min the gel was dried with filter paper before 
placing on the horizontal electrophoresis running apparatus.  
2.2.3.2.2 Sample Preparation 
A total volume of 20 µl was prepared with 10 µl of the SDS sample buffer and 10 
µl of the sample protein. It was then heated up to 95 °C for 3 min for denaturation 
experiments.  
2.2.3.2.3 Running Conditions for Electrophoresis 
Initially the electrophoresis plate of the unit was water cooled for 15 min. For the 
positioning of the gel 500 µl of benzene was placed on the cooled plate. After that the gel 
was placed on the plate with the sample pocket positioned on the cathode side. The anode 
and cathode stripes were soaked with 20 ml respective buffers. The cathode stripe was 
placed on the cathode side where the sample pocket was positioned and the anode stripe 
was placed on the anode side of the gel so that 5 mm of the gel is covered. Any air 
bubbles present were removed by pressing the stripes with the gel gently. 8 µl of the dual 
colour marker was loaded in the first and the last pocket in each of the experiments. 10 µl 
of sample was loaded onto each sample pocket. The electrode cables were connected and 
the whole unit was covered. Initially 20 mA current was used for around 15 min. The 
actual current to be used was calculated according to the size of the gel and maintained 
for 2 h. 
2.2.4 Staining of Gels 
2.2.4.1 Coomassie Blue Staining 
Two types of Coomassie blue staining were used. The first one was prepared 
according to the protocol of Westermaier.39 
1) Solutions 
Fixing solution: 12% (v/v) Trichloro acetic acid 
Stock solution: 980 ml 2% Phosphoric acid 
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   100 g Ammonium phosphate 
   1 g Coomassie Brilliantblue G250 in 20 ml water 
   Solutions not filtered 
Colouring solution: 160 ml Colouring stock solution 
   40 ml Methanol 
Washing solution: 12.1 g/l Tris-base 
   pH 6.5 (2% Phosphoric acid) 
Rinsing solution: 25% (v/v) Methanol 
 
2) Protocol 
The gel was kept in a box and about 50-100 ml each of the above mentioned solutions 
was added. 
Table 2-4: Procedure for Coomassie Blue staining of gels. 
Step Solutions Duration 
Fixing Fixing solution 60 min 
Colouring Colouring solution Over night 
Washing Washing solution 1-3 min 
Rinsing Rinsing solution Max. 1 min 
 
Another type of Coomassie staining method was followed in this work using Roti-
Blue solution. After electrophoresis, gel was transported to the staining box where the 
complete staining of the gel took place with incubation of the gel in 100 ml staining 
solution for 2 to 15 h. The staining solutions contained 20 ml Roti-Blue (Coomassie 
Blue), 20 ml methanol and 60 ml water. The staining is based on the electrostatic 
interaction between the anion of Coomassie solution and the protonated amino groups of 
proteins. The gel was destained in a destaining solution for 5 min. The destaining solution 
contained 25 ml methanol with 75 ml water. The gel with the blue bands was scanned 
with a scanner and quantified or it was placed in a stabilizing solution in order to preserve 
it for a long time. The stabilizer solution is a 20% ammonium sulphate solution. In order 
to dry the gel it was placed in a solution for 30 min with 10 ml glycerine (99.5%), 20 ml 
ethanol and 70 ml water. It was placed in a cellophane sheet for future reference.   
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2.2.5 Semidry Blotting 
2.2.5.1 Preparation of Buffers and Solutions 
Anode I: 0.3 mol/l Tris (18.15 g) and 20% methanol (100 ml), filled up to 500 ml with 
water. 
Anode II: 25 mmol/l Tris (3.03 g) and 20% methanol (200 ml), filled up to 1000 ml with 
water. 
Cathode: 40 mmol/l 6 aminohexanacid (2.6 g) and 20% methanol (100 ml) filled up to 
500 ml with water. 
2.2.5.2 Running Conditions for Blotting 
After resolving the proteins by SDS-PAGE, separated proteins were transferred 
onto nitrocellulose or PVDF membranes. The membrane binds and immobilizes the 
proteins in the same pattern as in the gel. The following procedure was optimised and 
used for all Western blotting experiments.  
After electrophoresis the gel was placed in blotting buffer (anode II). 
Nitrocellulose membrane and filter papers were cut with respect to the gel size. Filter 
papers were soaked in the corresponding buffer solutions. The gel and membrane were 
placed in an Anode II containing box. The graphite anode was wetted with water. The 
membrane and gel, sandwich termed as transfer unit (Trans) and filter papers were placed 
on the graphite as shown in Figure 2.14 with the gel surface facing downwards. Air 
bubbles were removed by gently rolling a glass rod over the top. It was then covered 
finally with a cathode graphite electrode. The blotting current used was calculated 
accordingly with 0.8 mA/cm2 typically 235 mA and it was run for 1 h at RT. The transfer 
of proteins was complete after 1 h and then followed either by staining or by further 
reaction with primary antibodies for the Western blotting experiment. 
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Anode
cathode
+
Cathode buffer
Anode I buffer
Anode II buffer
Blot membrane
Gel Trans unit
 
Figure 2.14: Semi dry blotting assembly. 
2.2.6 Contact Blotting  
After separation the gel and the membrane were soaked in anode II buffer 
(explained in section 2.2.5.1) for 3 - 5 min. The gel was then placed on a glass plate. Next 
the membrane was placed on the gel surface. Then the filter papers were placed over the 
blotting-foil. Above the filter papers another glass plate was placed. Finally a weight was 
placed on top of the upper glass plate. It was performed from 4 hours (h) to overnight. 
2.2.7 Immunoblotting 
The semi dry blotting experiment was followed by the immunoblotting 
experiment for the detection of proteins using labelled antibody experiments. After 
blotting, the nitrocellulose sheets were incubated over night in PBS (9.5 mM sodium 
phosphate buffer, pH 6.9, 137 mM NaCl, 2.7 mM KCl), 0.1% Tween 20, 5% milk 
powder followed by 2 short washing steps with water and then 3 washing steps with 
PBS/0.1% Tween 20 for 10 min each. The blot membrane was then exposed for 2 h to the 
labelled antibody (anti-CYP1A1 or anti- CYP2E1) diluted in PBS at a concentration of 1 
μg/ml. After that it was washed again with PBS/0.1% Tween 20 3 times.  
2.2.8 Indian Ink Staining  
After the transfer of proteins from the gel to the membrane, the membranes were 
stained in order to visualize the protein spots. Although originally needed for 
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visualization, we found out that metal contaminations being present in the stain can be 
applied for LA-ICP-MS based detection.  
Buffer:  0.05 M Tris HCl, pH 8.0 
9.76 g NaCl / l 
0.5 ml Tween 20 / l 
Staining solution: 250 ml above buffer, 2.5 ml acetic acid 96%, 250 µl Pelican Fount 
ink, pH 4.0 
The membrane after blotting was kept in a plastic box with 0.2 M NaOH for 5 
min without shaking. After that it was washed with water. It was then washed 4 times 
with buffer for 10 min with in between washing with water. Then it was kept in 70 ml 
staining solution overnight or for a minimum time of 5 h. It was then washed with water 
for a short time. It was then air dried and ready for LA-ICP-MS measurements. PBS 
buffer was avoided for experiments where also phosphorus needs to be measured.   
2.2.9 Labelling of Proteins  
2.2.9.1 Labelling with DOTA and Lanthanides 
2.2.9.1.1 Buffers and Stock Solutions 
0.5 M Tris-HCl, pH 9.0 – 9.5 
0.1 M Tris-HCl, pH 7.5 
0.5 M acetate buffer, pH 7 – 7.5  
Carbonate-bicarbonate buffer, pH 9 
A) 0.1 M sodium carbonate solution 
B) 0.1 M sodium hydrogen carbonate solution  
C) 10 ml A and 115 ml B were mixed together with 375 ml water. 
DOTA stock solution: DOTA (Macrocyclics, Dallas, USA) was diluted in 1 ml 
carbonate-bicarbonate buffer. The DOTA stock solution was further diluted according to 
the requirement. 200 µl of stock solution was diluted with carbonate-bicarbonate buffer 
solution in order to obtain a 40% solution which was used for further steps.  
 56
Chapter 2 
 
Europium stock solution: 3.664 mg EuCl3·6 H2O (Holmium: 2.699 mg HOCl3.6H2O and 
Terbium: 2.732 mg TbCl3.6H2O) was diluted in 1 ml acetate buffer. 1 µl of the stock 
solution thus contained 10 nmol europium (holmium and terbium). 
BSA stock solution: 1 mg BSA was diluted in 1 ml carbonate-bicarbonate buffer. The 
concentration was thus 15.1 nmol/ml. 
2.2.9.1.2 Procedure 
2.2.9.1.2.1 Reaction of Proteins and antibodies with DOTA (Step 1) 
In the first step the reaction of the linker with the protein was optimised in the 
following way. 397.3 µl (BSA) stock solution (= 6 nmol), 411 µl DOTA solution (= 240 
nmol; 40 times cprotein) and carbonate-bicarbonate buffer (pH 9) were added in an 
Eppendorf vessel as to give a final volume of 1 ml. Alternatively 10, 20, 80 and 100 
times of DOTA in molar excess to protein amount were used. In case of antibody about 
0.4 mg antibody was used for labelling corresponding to about 2.7 nmol antibody. A 
shaker was used for the whole reaction time. For stopping the reaction 1 ml of 0.5 M 
Tris-buffer was added.  
 The excess DOTA was removed from the protein solution by application of a size 
exclusion column (PD-10 Desalting column, Amersham, Freiburg, Germany). This 
column was conditioned and cleaned by 10 times washing with 3.5 ml 0.5 M acetate 
buffer. The volume of the reaction solution was increased to 2.5 ml by adding acetate 
buffer and loaded onto the column. The eluent was discarded and the DOTA protein 
complex was eluted in 3.5 ml acetate buffer. In the next step ultra-filtration was applied 
using ultra-filtration tubes (Ultracel YM-10 membrane; cut-off 10 kDa, Millipore, 
Schwalbach, Germany) at 3,000 to 4,000 rpm and 15 °C. For further washing two times 
400 µl acetate buffer was used. The ultra-filtration was stopped once a final volume of 
about 400 to 500 µl was reached. Due to possible protein losses the total amount of 
protein was determined by use of the Bradford Assay, which is not interfered by the 
labelling compounds. 
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2.2.9.1.2.2 Reaction of Lanthanide with DOTA (Step 2) 
The molar amount of the protein from the above reaction step was calculated from 
the resulting concentration and different ratios of excess lanthanide were added for 
different experiments. The reaction between lanthanides and DOTA protein complex was 
performed with acetate buffer (pH 7 - 7.5) for 30 min at 37 °C unless otherwise 
mentioned and loaded onto a purified PD 10 column. The reaction time chosen was 30 
min at 37 °C unless otherwise mentioned. The eluent was discarded and the labelled 
protein was eluted when 3.5 ml of 0.1 M Tris buffer (pH 7.5) was applied onto the 
column. In the next step the sample was concentrated using the ultra-filtration tubes (15 
°C, 3,000 to 4,000 rpm, 1 h). It was washed more than 5 times with 0.1 M Tris buffer. 
The final volume obtained was around 500 µl. The whole procedure of the above 2 
reaction steps is shown in the Figure 2.15 for antibody labelling. 
2.2.9.2 Labelling using DTPA 
For a comparative study labelling of protein was performed using DTPA. The 
procedure was followed as explained in literature.55 BSA with a final amount of 3.03 
nmol was buffered at pH 7.0 with 0.05M bicarbonate buffer and added to the solid 
anhydride (6.06 nmol and 12.12 nmol for 2 separate experiments) and the mixture was 
agitated for 2-5 min. The free DTPA from the mixture was removed by using the gel 
filtration column. Europium solution was added to the resulting product from the column 
so that the molar amount was in 4 fold excess compared to the BSA amount. The buffer 
used was 0.5 M acetate buffer at pH 6.0. The reaction time was 1 min.  
 
Eu-tagged Ab
Antibody
(Ab)
DOTA
Europium 
pH 9 
Carbonate-
bicarbonate buffer
Acetate buffer
Acetate buffer
pH 7 - 7.5
Tris buffer
 
Figure 2.15: Schematics of the whole procedure followed for the labelling of protein and antibodies 
using DOTA compound. 
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2.2.10 Quantification of Elements by Means of Quadrupole ICP-MS 
s and Solutions 
uropium concentration of 0.01 mg/ml 
in 0.1 M
l water  
um stock solution from the 
n to be 0 to 500 ng/ml europium. It was 
prepare
 were diluted with 0.1 M Tris buffer and made up to 5 ml. 
Each sa
cted into the ICP MS via the nebulizer. The flow rate of the 
peristal
2.2.10.1 Sample Preparation 
2.2.10.1.1  Preparation of Buffer
Europium stock solution: A solution with e
 Tris buffer was prepared. 
1% TritonX stock solution: 100 ml TritonX in 10 m
Internal standards: The concentration of indium and ceri
manufacture is 1 µg/µl. From this 100 µl was taken, diluted and made up to 10 ml with 
3% nitric acid. 10 µl of this solution thus contained 100 ng indium (cerium).  
2.2.10.1.2  Calibration and Quantification 
The range for calibration was chose
d from the stock solution with 0.1 M Tris buffer and the final volume was 
adjusted to be 5 ml. Apart from that each europium standard solution had 20 ppb indium 
(cerium), 0.05% Triton X and a pH of 5.0 was maintained with 0.1 M nitric acid. 
2.2.10.1.3  Protein Samples 
100 to 200 µl samples
mple solutions had 20 ppb indium (cerium) and 0.05% Triton X prepared from 
the stock and a pH of 5.0 was maintained with 0.1 M nitric acid. 
2.2.10.1.4  Measurements 
The sample was inje
tic pump was fixed at 0.4 ml/min. There were frequent washes between the 
standard and sample measurement with a blank solution and also after each complete 
experiment.  
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2.2.11 Quantification of Elements by Means of ICP-SF-MS 
2.2.11.1 Sample Preparation 
2.2.11.1.1  Preparation of Buffers and Solutions 
Phosphorus stock solution: A solution with PO4 concentration of 1 mg/ml in 0.1 
M Tris buffer was prepared.  
1% TritonX stock solution: 100 ml TritonX in 10 ml water  
Internal standards: The concentration of rhodium solution from the manufacture was 1 
µg/µl. From this 100 µl was taken, diluted and made up to 10 ml with 3% nitric acid. 10 
µl of this solution thus contained 100 ng rhodium.  
2.2.11.1.2  Calibration and Quantification 
The range for calibration was chosen to be 0 to 200 ng/ml phosphorus. It was 
prepared from the stock solution with 0.1 M Tris buffer and the final volume was 
adjusted to be 10 ml. Apart from that phosphorus standard solutions had 10 ppb rhodium, 
0.05% Triton X and a pH of 5.0 was maintained with 0.1 M nitric acid.   
2.2.11.1.3  Phospho-protein Samples 
The phospho-protein samples used were α-casein, β-casein, ovalbumin (Sigma 
Aldrich, Taufkirchen, Germany) and pepsin (Dunn Labortechnik, Asbach, Germany). 100 
to 200 µl samples were diluted with 0.1 M Tris buffer and made up to 5 ml. Each sample 
solution had phosphorus, 20 ppb rhodium and 0.05% Triton X prepared from stock and a 
pH of 5.0 was maintained with 0.1 M nitric acid.   
2.2.11.1.4  Measurements 
The sample was injected into the ICP-SF-MS via the Aridus system. The flow rate 
of the peristaltic pump was fixed at 0.1 ml/min. There were frequent washes between the 
standard and sample measurement with a blank solution and also after each complete 
experiment.  
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2.2.12 Laser Ablation ICP-MS 
Ion selective 
determination after 
mass separation with 
respect to the m/z ratio
ICP-MS
Helium
Argon
Nd:YAG Laser, quadrupled to 266 nm; 
max. 4 mJ Energy/pulse (Minilite II, 
Continuum)
Mirror
Aperture
 
Figure 2.16: Schematic setup of the laser ablation system with the cell used in this work. 
For laser ablation a flash lamp pumped Nd:YAG laser operated at the fourth 
harmonic wavelength was used (266 nm), achieving sufficient laser energy of about 3 mJ 
and a pulse width of 3 to 5 ns (Minilite II, Continuum, Santa Clara, USA). The laser was 
operated in a Q-switched mode and with its maximum repetition rate of 15 Hz. The 
general setup of a LA system used in this study is shown in Figure 2.16.  
The homebuilt laser ablation chamber and its optimisation were already 
described.56 The cell was equipped with a polytetrafluoroethylene (PTFE) cylinder which 
has a diameter of 38.16 mm and a length of 140 mm (Figure 2.17). Membranes were 
mounted on this cylinder. This cylindrical format allowed free rotation around the axis 
with a help of a cylindrical knob and gave access to ablation of all positions on the 
membrane surfaces in 2 directions (linear translation and rotation). At the same time low 
cell volume could be maintained to 11.3 cm3. The cylinder was placed inside a closed 
chamber and the cell volume was reduced further with a PTFE insert. There was a 
rectangular quartz window at the top of the chamber with a length of 140 mm, a width of 
20 mm and a thickness of 5 mm (Figure 2.18). The length of the channel was 120 mm so 
that membranes with a size up to 120 mm X 120 mm could be analysed in one run. The 
blot membranes were placed on the PTFE cylinder with the surface of the membrane in 
the focus of the laser beam. The cell was mounted on an X-Y-Z table with µm resolution. 
The laser was focussed onto the membrane in the chamber using a mirror and a lens 
system. The photo of the cell and the lens system used is shown in Figure 2.18. 
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Figure 2.17: Ablation cell, (1) PTFE insert, (2) quartz window, (3) gas inlet, (4) gas outlet, (5) 
membrane holder, (6) rotary knob.56 
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Figure 2.18: Photo of the cell, (1) quartz window, (2) rotary knob, (4) gas inlet and (5) gas outlet and 
(3) lens system. 
The cell was coupled to the ICP torch via polyethylene (PE) tubing with a length 
of 50 cm and an internal diameter of 4 mm. Helium (He) was used as a carrier gas with a 
flow rate of 1.3 l/min. It was used as it has a positive effect on reducing the temporal 
signal dispersion.57 It also has a positive effect on the laser plume expansion dynamic, 
the transport of the aerosol to the ICP and guarantees a more efficient vaporization in the 
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ICP due to a higher thermal diffusivity.58 For daily tuning of the instrumental conditions, 
the Aridus (Cetac) was used as a sample introduction system producing a nearly dry 
aerosol, thus plasma conditions should be not equal but similar to the dry aerosol 
produced by the laser. The sample outlet of the nebulizer was mixed with the He flow 
behind the chamber by use of a T-connector. The argon flow rate of the Aridus was set to 
l/min
was adjustable between 100 and 600 µm which was influenced by the laser 
e 
stain ar
 used for 
different experiments are shown under experimental sections of each chapter.  
1 . 
 To establish a good spatial resolution during line-scanning, a small crater 
diameter is advantageous, while for highest signal intensity a larger crater volume would 
be better to increase the amount of ablated material. To solve this problem beam shaping 
was used to produce a laser beam of oval shape, with higher width than length. For beam 
shaping, two planar-convex cylindrical lenses were used, mounted one upon the other in 
crossed direction. The length of the resulting crater was about 100 µm in scan direction 
and the width 
energy used.  
 The whole chamber was moved relative to the fixed laser beam with a forward 
speed of 1 mm/s. The blot membranes were subsequently rastered line by line with a 
distance of 1 mm in-between, e.g. a blot after laser ablation is shown in Figure 2.19. It is 
an Indian ink stained membrane which had the protein marker spots after SDS-PAGE and 
semi dry blotting. 8 scans with 1 mm distance were needed in order to ablate the whole 
electrophoretic lane. The blot was not damaged after one scan and the time taken to 
complete this experiment was 20 min. It can be seen that the black spots coming from th
e completely ablated by creating a crater with a depth of approximately 65 µm.  
For ICP-MS a sector field instrument type Element-2 was used. Due to the 
spectral interferences being present at m/z 31 phosphorus was detected at a medium 
resolution (MR) of 4,000 if not mentioned otherwise. Rhodium, lithium, europium, 
terbium, iodine and holmium were measured at low resolution. Carbon (13C+) was 
measured at medium resolution. The instrumental parameters which were
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Figure 2.19: Photo of a laser ablated Indian ink stained membrane. 
2.2.12.1 Data Acquisition 
For all the experiments unless and otherwise stated the following parameters were 
chosen for the method. Both pulse counting and analogue modes were chosen as the 
detection type and Escan mode was selected as the scan type as it requires virtually no 
magnetic settling time. In this scanning mode magnetic field is constant and the 
accelerating voltage can be varied. For the phosphorus intensity measurement at MR 10 
channels per peak were chosen with an integration window of 60% and mass window of 
100%. Hence, 6 channels per peak from the centre of the maximum peak height were 
selected for a single data point. For the Low resolution (LR) experiments an integration 
window of 80% was chosen with 8 channels per peak which were taken into account for 
a single data point. The segment duration (data acquisition duration per mass) was varied 
according to the number of elements measured and the mass resolution required. For 
example for 10 channels with sample time of 10 ms and 100% mass window, the total 
segment duration will be 100 ms. The number of data points was chosen according to the 
length of the blot. For example for a blot of 58 mm length with a scan speed of 1 mm/s, 
with the above set of conditions for the MR measurement, the total calculated data points 
were 665.  
For imaging, all separated intensity data sets for each laser trace were copied 
together by means of a Matlab software routine (The MathWorks, USA) developed by 
Ingo Feldmann and Peter Lampen from ISAS, which additionally enables a fast preview 
imaging of the elemental distribution of the measured blot membrane during 
measurement. The measured intensity time profile data of the ICP-MS was exported to 
the program Origin (Additive GmbH, Friedrichsdorf, Germany), where intensity time 
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profiles as well as colour-coded surface plots were obtained by transforming time into a 
millimetre scale using the translation velocity selected. 
 For quantitative evaluation of the results, the intensities for each y-data point 
(time interval) of all laser traces belonging to one protein spot were averaged - again by 
means of a Matlab routine - resulting in the intensity-time relation of one electrophoretic 
lane. In a second step, all peaks of interest were integrated over time or distance using 
commercially available chromatography software (EuroChrom 2000, Knauer, Berlin).  
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Chapter 3 
Method Development for Application of LA-ICP-MS in 
Phosphorylation Studies 
As was already mentioned, a new LA cell was developed and used for imaging of 
elemental distribution in electrophoretic protein spots blotted onto membranes.56 Initially 
with this cell a calibration approach by use of standard phosphorus containing proteins 
for quantification of phospho-proteins has been described. But most of the other 
analytical figures have not been investigated in detail yet.  
Thus it was the aim of this study 1) to optimise the working conditions to achieve 
good detection limits, 2) to develop a quantification scheme for phosphoproteomic 
studies, 3) to investigate the analytical figures of merit such as reproducibility, sensitivity 
of the method and 4) to apply the method for a typical application in phosphoproteomics. 
For the latter topic the human urothelial carcinoma cell line 5637 was selected and time 
resolved measurements were performed. 
3.1 Introduction 
Phosphorylation is the most important post-translational modification of proteins 
and therefore quantitative measurement of the phosphorylation state of proteins is a key 
issue in many life science applications. The significance is underlined by the fact that a 
new term and research field, namely phosphoproteomics, has been established.59,60,61 
Dynamics and activity of the proteome are not merely defined by expression levels of 
proteins, because phosphorylation has a fundamental impact on their activity and life-
span. When a phosphate group is added it becomes a phosphorylated protein changing its 
confirmation and reactivity. Phosphorylation occurs mainly on the serine, tyrosine and 
threonine, and to a minor extend on the histidine, arginine or lysine residues of the 
protein. Phosphorylation of specific amino acid residues in enzymes functions as a 
molecular switch either turning on or turning off the catalytic activity.62 The enzyme 
kinase is involved in the addition of the phosphate group to the protein and the enzyme 
phosphatase is involved in the removal of the phosphate group from the protein. Cellular 
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signal transduction processes are largely a cascade of protein phosphorylation starting at 
the receptor level down to transcription factors and proteins control the function of 
transcription factors.63 At last, phosphorylation may result in accelerated or retarded 
degradation of proteins by the proteasome complex. In this case, the phosphorylation 
status determines the steady state level of a protein.64 This enumeration of protein 
phosphorylation effects clearly demonstrates the significance of the phosphorylation 
status of the proteome for assessing the biochemical activity status of cells or tissues. 
Thus, quantitative methods in phosphoproteomics are needed in order to identify 
characteristics of different physiological and pathological states.  
3.1.1 Detection Methods for Phospho-proteins  
 Determination of the phosphorylation status of the proteome or of specific sub-
proteomes requires 1) separation of proteins and 2) quantitation of the phosphorylation 
degree of discrete proteins. Overall detection of phosphorylated forms of proteins is 
based on reaction of blotted proteins with fluorescence dye labelled antibodies directed 
against phospho-serine, phospho-threonine and phospho-tyrosine residues. While anti-
phospho-tyrosine-antibodies work well, antibodies directed against phospho-serine and 
phospho-threonine often show weak affinities for their antigens.63 Besides this, there are 
some more facts that aggravate the quantitative analysis of the phosphorylation status of 
proteins only by means of available antibodies. This concerns phosphorylation of amino 
acid residues other than serine, threonine and tyrosine such as histidine, lysine, 
hydroxylysine and hydroxyproline. 
Some of these problems can be overcome by the use of molecular mass 
spectrometry in combination with electrophoretic separation of protein samples and 
techniques for enrichment of phospho-proteins.65 Molecular mass spectrometry is most 
often applied for phosphoproteomics after an enzymatic digest of the protein spot in the 
gel, followed by analysis of the resulting polypeptides including scanning for 
phosphorylated forms.66 This can be laborious and time consuming. Additionally, the 
mass spectrometric response of a phospho-peptide may be suppressed by the presence of 
other peptides in a complex mixture. This was shown by Wind and co-workers, who 
analysed a mixture of a tryptic digest of two recombinant proteins after LC separation by 
 68
Chapter 3 
 
electrospray ionisation mass spectrometry and by ICP-MS.67 They could show, that the 
signal measured by ICP-MS was very well representing the expected content of the 
observed peptides and by that they could compare the ICP-MS sensitivities with those 
measured by ESI-MS using identical LC conditions. From this comparison they found 
that the ESI ionisation efficiency of tryptic peptides increases in proportion to the LC 
retention time and decreases by the presence of an additional basic residue, which makes 
it difficult to use ESI-MS for quantification. This demonstrates that for quantification of 
phosphorylated polypeptides and proteins ICP-MS looks very promising and it has 
already been applied for this purpose, as it is discussed in the following.  
A sector field ICP-MS coupled to reversed phase high performance liquid 
chromatography was already used for the first time at ISAS as an element specific 
detector for quantitative detection of phosphorylated polypeptides.22 By use of sulphur, 
being present in the amino acids methionine and cysteine of the peptides, as an internal 
standard this method was extended by Wind et al. where sulphur was measured together 
with phosphorus for improved quantification. After calibration by use of standards an 
easy and straightforward determination of the phosphorylation state was possible by 
measuring the P/S ratio.68 
An alternative approach was presented by Bandura et al. and with their LC 
approach they could detect sub nano-molar amounts of phosphorylated polypeptides in a 
digest. In the investigation of total protein extracts from cultured malignant cells and 
from human malignant tissue they found an increased global degree of phosphorylation 
compared to controls.69  
 Pröfrock et al. investigated various nebulizers for application of nano and 
capillary liquid chromatography and measured the phosphorylation state of tryptic digests 
of β-casein using a reaction cell instrument in an energy discriminating mode and sub-
pmol detection of the digests was possible.70 
 These examples show that LC-ICP-MS plays already an important role for 
detection of phosphorylated polypeptides in enzymatic digests most often of protein 
standards only. For many applications standards are not available and therefore 
techniques are needed which can measure, qualitatively and quantitatively, the 
phosphorylation status already in the gel or directly on a blot membrane. 
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 Sample introduction from a gel or a blot membrane into an ICP-MS is in principle 
possible by use of laser ablation. This sample introduction technique was used first for 
metalloproteins separated by immuno-electrophoresis by McLeod and co-workers.30 LA-
ICP-MS for qualitative detection of phosphorus in β-casein was first presented by 
Marshall and co-workers in protein separation by SDS-PAGE and blotted onto a 
membrane71 using a reaction cell instrument pressurized with hydrogen and helium. The 
limits of detection (LOD) for phosphorus were dominated by high blanks.  
 Becker et al. applied LA to detect phosphorylated proteins qualitatively and 
quantitatively by drilling a hole into the gel just in the centre of the electrophoretic spot, 
which was made visible by silver staining.72 They applied this method for analysis of the 
human tau protein, which is a key protein in the formation of neurofibrillary tangles in 
Alzheimer disease. By this method 17 phosphorylation sites of the tau protein were 
quantified. 
More recently LA was also applied for 1D and 2D electrophoretic gel separation 
to detect cadmium-binding proteins,73 metalloproteins74 and selenoproteins,31 as to 
mention a couple of applications. More details and a more complete overview are given 
in a review, which was published recently.75 Becker et al. applied laser ablation for direct 
detection of metals, sulphur and phosphorus in human brain proteins using again the 
medium resolution of the sector field device.76 Semi-quantitative calibration was 
performed by standards nebulised in a pneumatic nebulizer and added to the laser ablated 
aerosol. A limit of detection of 0.18 µg/g for phosphorus was determined in the gel 
blank.34 The group of McLeod applied whole gel elution of phosphorylated proteins as an 
alternative to LA for quantification by application of calibration strategy using liquid 
standards.77 An additional LC coupling by use of activated alumina was also applied for 
reduction of phosphate contaminations from the gel and from the buffers.77 
Krüger et al.78 applied laser ablation ICP-MS for detection of phosphorylated 
proteins after separation by SDS-PAGE and blotting onto membranes. This technology 
was used in the meantime to determine the phosphorylation state of the cytoplasmic 
proteome of selected bacterial and eukaryotic cells.78 The finding in this case was that the 
eukaryotic cells exhibit a significantly higher phosphorylation degree compared to the 
bacterial proteome. Sulphur was used here as an internal standard. 
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Phosphorylated proteins were not only detected in gels but after blotting onto 
membranes. This looks promising due to several reasons. Most important a trace matrix 
separation can be achieved to reduce phosphate blanks from phosphate buffers used for 
sample preparation in sodium dodecyl sulphate polyacrylamide gel electrophoresis. 
Additionally the proteins were enriched in a thin surface layer, which looked promising if 
laser ablation was used for sample introduction. Nevertheless losses during blotting were 
often mentioned as a limiting factor.79 In a previous work LA-ICP-MS was already 
applied at ISAS for detection of phosphorylated proteins separated by SDS-PAGE and 
blotted onto membranes.21 A linear relation between the measured intensity and the total 
amount of β-casein protein loaded onto the gel was measured and could be used as a 
calibration for quantification of identical proteins. From the calibration curve a limit of 
detection of about 5 pmol was estimated from the signal to noise ratio.21 A new laser 
ablation cell was applied in this work to achieve promising levels of detection from blot 
membranes using high resolution mode of the HR-ICP-MS. The 31P+ signal obtained 
could give quantitative information both with respect to relative and absolute amounts of 
phosphorus present in phospho-proteins.  
3.1.2 Application  
3.1.2.1 Dynamic and Steady State Phosphorylation at Cellular Level  
Dynamics and function of the cellular proteome are not merely defined by protein 
expression levels which can be adapted to the cell’s needs by induction or suppression of 
gene activation. In addition to transcriptional regulation, post-translational modifications 
of proteins have an important impact on protein function. Such modifications can be 
reversible or irreversible and can influence the activity, the turn-over or the sub-cellular 
localization of a protein. Protein phosphorylation appears to play the major role among 
protein modifications with respect to regulation of protein function, and nearly 30% of all 
proteins expressed in eukaryotic cells are phosphorylated to some extent.80 Very sensitive 
cellular processes such as cell cycle control are largely governed by kinase-mediated 
protein phosphorylation events. Thus phosphorylation is highly a dynamic and complex 
process and since it is important for cell function, there is a demand on methods which 
allow analysing the alterations in the phosphorylation state of the proteome. With respect 
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to analytical strategies and methods to be developed, one is confronted with the following 
facts: 1) the number of known proteins which are modified by phosphorylation is high 
and increases continuously. 2) Phosphorylation within proteins occurs at different amino 
acid residues such as serine, threonine, tyrosine and histidine. 3) One and the same 
protein molecule can be phosphorylated at multiple sites.  
3.1.2.2 Epidermal Growth Factor and Phosphorylation 
Effects on cells by extra cellular stimuli can be mediated by membrane bound 
receptors. As a consequence of ligand binding to the receptor, a cascade of intracellular 
biochemical responses is elicited. This is also the case for effects evoked by epidermal 
growth factor (EGF) which was so far well investigated and was used here as a reference. 
When this EGF binds to its receptor (EGFR) signals are transmitted via phosphorylation 
and dephosphorylation events which are then involved in regulating tumour growth and 
metastasis. EGFR is overexpressed for instance in the majority of solid tumours including 
breast cancer. Such overexpression causes intense signal generation and activation of 
downstream signalling pathways, resulting in cells that have more aggressive growth and 
invasiveness characteristics. When the receptor gets activated the tyrosine kinase part of 
the receptor in turn gets activated which phosphorylates proteins in the signal 
transduction pathway leading to activation of genes that regulate cell proliferation, 
angiogenesis, motility and metastasis. The most comprehensive characterization 
concerning the EGF stimuli was presented by Olsen and co-workers.81 This group 
detected quantitatively by use of organic mass spectrometry 6,600 phosphorylation sites 
on 2,244 proteins and also determined their temporal dynamics (after 0, 5 and 10 min) 
after stimulating HeLa (human cervix epithelial adenocarcinoma) cells.  
Intracellular signalling is significantly based on post-transcriptional modifications 
of proteins already present in the cell at the time point of stimulation either in the active 
or inactive form resulting in fast enzyme-driven responses. In the course of reactions, 
involved proteins can be altered at multiple sites by multiple types of modifications 
including phosphorylation, acetylation, methylation, ubiquitination and sumoylation.82 
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3.1.2.3 Oxidative Stress by H2O2 and Phosphorylation 
Different pathways are switched on by hydrogen peroxide and by EGF. 
Interestingly, H2O2 is able to induce tyrosine-phosphorylation of the EGF-receptor. 
Because serine and threonine remain non-phosphorylated upon H2O2–action, specifically 
only the phosphoinositol pathway via phospholipase gamma is initiated, while the MAPK 
pathway remains unaffected.83 Thus, although H2O2 and EGF show distinct effects and 
act on different processes there are also common pathways influenced by both, but a 
direct comparison is not available because never ever the same cell system was 
investigated under identical conditions.  
3.2 Experimental 
3.2.1 Protein Purification 
 Most proteins from the stock, which were used as standards, contain inorganic 
phosphorus and therefore had to be purified if used for calibration. Protein 
purificiation was performed by using the Centriprep ultrafiltration column with a cut-
off of 3,000 Da. The proteins in 0.125% ammonia solution were initially centrifuged 
at 3,000 g for 20 min. The sample was washed with 0.125% ammonia solution various 
times. When the retentate volume in the Centriprep columns reached around 0.5 ml 
the centrifugation was stopped and the sample was decanted quantitatively into a 
separate flask. After purification the concentration of the protein was measured with 
the Bradford assay. Stock solutions of β-casein, α-casein, ovalbumin and pepsin were 
prepared with 13.2, 11.8, 11.6 and 16.2 mg/ml. For storage, the filtrate and the 
retentate solutions were freeze dried at –20 °C for 24 h until they became a solid 
residue. 
 The phosphorus content of the purified proteins was quantified by means of 
ICP-MS in diluted protein solutions as described in section 2.2.11, and in all cases the 
value measured was lower than the theoretical value. The estimated values are given 
in the Table 3-1.  
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Table 3-1: Measured amount of phosphorus quantified by ICP-MS in-solution measurements. 
Protein Amount 
Detected 
pmol/ml 
Measured value 
pmol phosphorus/pmol 
of protein 
Theoretical value 
pmol phosphorus/pmol 
of protein 
α-casein 930 7.4 8 
β-casein 761 3.8 5 
Pepsin 1415 1.4 1 
ovalbumin 762 1.5 2 
3.2.2 Gel Electrophoresis  
 Vertical electrophoresis was performed as explained in section 2.2.3.1 using a 
discontinuous buffer system with 10% separating and 6% stacking gels. Different 
concentrations of separating gels were tried for the cell culture experiments. The one 
which was used in section 3.3.4.1 had 11% of separating gel so that proteins with 
broader molecular weight range can be separated. Different concentrations of protein 
(Table 3-1) from the phospho-protein stock (section 3.2.1) were prepared so that a 
final volume of 20 µl (10 µl sample + 10 µl sample buffer) had the required 
phosphorus amounts and this volume was applied for most of the vertical 
electrophoresis experiments (section 2.2.3.1.3) if not mentioned otherwise. Only for 
the experiments discussed in section 3.3.4, 8 µl from each cell lysate sample was used 
for separation. The horizontal electrophoresis with 10% precast gels was used for 
separating proteins in section 3.3.4.2 as gels of large size can be used.  
 Nitrocellulose membrane was used for the transfer of proteins from gels for all 
experiments except the comparison experiment in section 3.3.1.4 where 
polyvinylidene membrane was used. The semidry and contact blotting procedures 
were performed as explained in section 2.2.5 and 2.2.6, respectively. 
3.2.3 Cell Culture 
 The human urothelial carcinoma cell line 5637 (CLS Cell lines Service, 
Heidelberg, Germany) was provided by PD Dr. P. Roos from IfADo. This cell line 
was grown in medium sized culture flasks on RPMI 1640 (with glutamine) 
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supplemented with 10% FCS and 1% penicillin/streptomycine in an incubator (37 °C, 
5% CO2). For the experiments, culture flasks containing 2 million cells in 25 ml 
culture medium were used. After 24 h of culture, if there was enough growth, cells 
were serum deprived for another 24 h. In independent experiments, cells were 
subsequently treated either with hydrogen peroxide (100 µM), EGF (100 ng/ml = 8.1 
nM) for 7.5 min or hydrogen peroxide (100 µM) for 2, 4 and 7.5 min. Effector 
concentrations and incubation times were selected according to Li et al.,84 Wilson et 
al.85 and Olsen et al.81 Incubations were stopped by discarding the culture medium, an 
intermediate quick washing step with ice-cold 20 mM Tris-buffer (pH 7.5) and by 
final disruption of cells in SDS-containing electrophoresis sample buffer diluted 1:2 
with 20 mM Tris-buffer (pH 7.5). The resulting suspension was heated for 5 min at 95 
°C. Aliquots were used for subsequent analysis or kept frozen at –20 °C until use. The 
protein concentrations were determined by Lowry assay as explained in section 
2.2.2.3. It is important to note that no additional sample pre-treatment was performed 
with the cell lysate in order not to alter the phosphorylation state or the protein 
profile. But this has a severe consequence: all phosphorus containing bio-molecules 
such as ATP, DNA or RNA are still present in the samples and can contribute to 
blank values. The experiments were performed at IfADo in collaboration with the 
group of PD Dr. Roos. 
3.2.4 Laser Ablation ICP-MS Optimisation 
For optimisation, Aridus (Cetac) was used as a sample introduction system 
producing a nearly dry aerosol, thus plasma conditions should be not equal but similar to 
the dry aerosol produced by the laser. To optimise the analytical conditions of the LA-
ICP-MS, several parameters such as gas flow rates, applied power of the ICP-MS, torch 
position and multiplier voltages were varied. The instrumental parameters for the laser 
ablation and the ICP-MS used for better optimised performance are shown in Table 3-2. 
Between the experiments laser energy was controlled using a laser energy meter. From 
time to time ICP-MS instrument was calibrated over the entire mass spectrum using 
multielemental standards. An overview about the laser setup, real time analysis, scan 
settings, detection mode and data acquisition was given in section 2.2.12. For the 
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experiments, the absolute intensities obtained for different blot membranes can only be 
compared when they were measured with similar optimisation conditions. The 
positioning of the laser ablation cell, the starting up of the cell movement and the 
triggering of laser were manually performed except experiment shown in section 3.3.4.1, 
where a microprocessor control unit was used for positioning the laser cell and the whole 
procedure of ablating a full membrane was automated including the triggering of laser. . 
Table 3-2: Instrumental parameters. 
Laser ablation system  
Laser energy  
Make-up gas flow rate (Ar)  
Carrier gas flow rate (He)  
Repetition rate, shots per second 
Translation velocity  
Distance between line scans  
Crater diameter 
3.5 mJ 
1 l/min 
1.05 l/min 
15 Hz 
1 mm/s 
1 mm 
~500 µm 
ICP-MS system ELEMENT 2 
Torch position 
X,Y,Z 
Incident power  
Cooling gas flow rate  
Auxiliary gas flow rate  
Ni skimmer cone diameter  
Ni sampler cone diameter  
Isotopes measured  
Total measurement time per peak including 
settling time  
Mass resolution 
 
 
2.85 mm, 0.85 mm, -5 mm 
1,200 W 
16 l/min 
1.3 l/min 
1 mm 
0.7 mm 
31P+, 13C+ 
 
101 ms 
4,000 (MR) 
400 (LR) 
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3.3 Results and Discussion 
3.3.1 Optimisation of LA 
3.3.1.1 Scanning Conditions 
In principle, the ablation cell, which was already developed56 and which is used 
for the imaging of 31P+ distribution after blotting onto large size membranes, should have 
the following features. It should provide a reasonable local resolution so that adjacent 
electrophoretic spots can be separated for which a sufficient lateral resolution is required. 
Additionally, it should provide an as high as possible but constant sensitivity independent 
of the location of the electrophoretic spot in the cell. All these conditions had been 
successfully optimised. An optimisation of generator forward power, carrier and make-up 
gas flow rates for the cell had been performed. It is advantageous to use high He gas flow 
rates as they have a positive influence on the basis peak width and enable fast sample 
wash-out from the cell. Continuous ablation with high laser repetition frequencies was 
preferred since it showed less intensity losses from gas inlet to gas outlet than single shot 
ablation56 and in addition a better representation of the electrophoretic spots could be 
acquired. The cell can be used with a fastest laser scan velocity of 2 mm/s. But in order to 
have more data points from the electrophoretic spots investigated and to maintain a good 
local resolution, the line-scan velocity of 1 mm/s was used. This line-scan speed is much 
faster in comparison to values from literature71 (60 µm/s) and it can be used to reduce the 
total analysis time for the detection of separated electrophoretic spots. The optimised 
parameters were given in the section 3.2.4 which resulted in highest peak area and thus in 
a signal with moderate peak width. 
In order to reduce the measurement time, back and forth scanning of the laser 
beam looks advantageous. Thus, at the beginning bi-directional scanning was checked 
using 13C+ as a marker for laser ablation conditions and signal dispersion. This element is 
present in the membrane materials and can be utilised to see if this element can be used 
as an internal standard. 
 Two measurements were performed at one end of an NC membrane where there 
are no protein spots present after subjected to blotting. The first one was by scanning in 
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direction from the gas inlet to the outlet (forward), the next in the reverse direction 
(Figure 3.1). The 13C+ intensity measured in forward direction shows a constant signal for 
a length of the scan line of about 6 cm. But when the membrane was scanned in a reverse 
direction, a certain drift in the 13C+ intensities could be seen. This phenomenon can 
possibly be attributed to particles trapped in the dead volume in a turbulent zone. 
Although time can be saved for the whole measurement, scanning in reverse direction 
was not performed to avoid this drift effect of the signal intensity.  
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Figure 3.1: 13C+ trace on an NC membrane in the forward and the reverse direction.86 
 Concerning this measurement, 13C+ can possibly be used as an internal standard 
particularly for experiments where measurements are performed in both directions. As a 
proof for using 13C+ as the internal standard, another second element should be available 
for comparison. 13C+ was not applied here as to spend most time of our relatively slow 
scanning sector instrument to measure the analytical element. But it will be applied in 
experiments for quantification of Cytochromes P450 isozymes shown in chapter 5. In 
these experiments a line scan of 13C+ was measured at medium resolution at the end of 
each of the NC membranes before start of the experiment. The obtained intensities were 
averaged and can be used to normalize with the resulted sample intensities from different 
blots. Sulphur is an important marker element present in most proteins, but can not be 
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used as an internal standard for calibration and determination of the phosphorylation state 
here, because a very high S blank signal was caused from the SDS used for separation in 
PAGE. This problem can only be overcome if a native PAGE is applied. 
3.3.1.2 31P+ Intensity Measured with Low and Medium Mass Resolution 
Detection of 31P+ is hampered in plasma-based spectrometry, since it features a 
high first ionization potential (10.484 eV) and therefore low ionization efficiency in an 
argon-based plasma and various polyatomic interferences in particular 15N16O+ are 
limiting as well. However, the commercial availability of high-resolution instrumentation 
and collision/reaction cell ICP-MS has essentially solved this interference problem.69,87,88 
 In principle a MR of 4,000 as it is provided with the Element 2 used here is 
sufficient to overcome the most prominent interferences. However, due to the 
nitrocellulose matrix also matrix related spectral interferences such as from 15N16O+, 
13C18O+, 14N16O1H+ and 14N17O+ can be expected and therefore the mass window of 
phosphorus at m/z 31 was detected by using a magnetic scan and the medium resolution 
mode. A mass range covering the most important interferences of phosphorus, 15N16O+, 
13C18O+ and 14N16O1H+, was measured using medium mass resolution. The result is 
shown in Figure 3.2 for an NC membrane on which β-casein with a total amount of about 
150 pmol of phosphorus was blotted after 1D SDS-PAGE separation. This spectrum was 
obtained from the data points measured during ablation of the blank area of the 
membrane. Three peaks are seen, the first one belongs to phosphorus at 30.973 Da, the 
second one can be attributed to 15N16O+ at mass 30.995 Da and the third is 14N16O1H+ at 
mass 31.0053 Da. From Figure 3.2 it can be seen that the interfering signals of 15N16O+ 
and 14N16O1H+ are below 1% of the intensity of phosphorus blank. This is surprising, 
because by ablation of the NC membrane all critical elements like C, N and O were 
introduced into the plasma. Nevertheless, it seems that the amount of oxygen from the 
membrane is not high enough to form oxides at the levels of phosphorus signals. 
 To compare the detection limits in low (R = 400) and medium (R = 4000) 
resolutions, two spots of above mentioned standard proteins were measured. Per spot 8 
line scans were summed up and the results are shown in Table 3-3. The peak height 
measured at low resolution was 8 times higher than those of the medium resolution. 
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Nevertheless, at medium resolution a limit of detection of 1.5 pmol could be achieved 
which is lower than those of 4 pmol calculated for the low resolution mode. This is the 
reason why in this study the medium resolution mode was used further on. Nevertheless, 
this measurement also shows that phosphorylation of proteins can be studied with 
quadrupole instruments even without reaction cell if LA is used for sample introduction. 
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Figure 3.2: Mass window of 31P+, 15N16O+, 13C18O+ and 14N16O1H+ during measurement of the blank of 
an NC membrane using LA-ICP-SFMS (medium resolution mode).86 
Table 3-3: Intensity and estimated limits of detection in medium resolution and low resolution: 
application of 152 pmol of phosphorus in β-casein. 
Parameters Low resolution Medium resolution 
Peak height (cps) 38 ⋅ 106 4.81 ⋅ 106 
Standard deviation 0.33 ⋅ 106 0.015 ⋅ 106 
Background level (cps) 2.6 ⋅ 106 2.2 ⋅ 105 
LOD (pmol) 4  1.5 
3.3.1.3 Reproducibility 
Reproducibility means the quality of giving reproducible and consistent results 
from adopting a specific experimental procedure. It was not known at the beginning of 
the study how reproducible PAGE separations like sample preparation, dilution steps and 
sample application into the wells are. It is important to know how signal generation by a 
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pulsed laser ablation and drift effects of the ICP-MS might contribute additionally to 
worsening of the standard deviation of signals. Therefore, the reproducibility of signal 
responses from LA processes of the blots analysed with ICP-MS is necessary to prove the 
accuracy of this method. For this purpose 7 samples of 20 pmol β-casein each 
(corresponding to a total phosphorus content of 76 pmol) were separated by 1D SDS-
PAGE and blotted onto an NC membrane using conditions described in section 3.2.2. The 
31P+ intensity of the protein spot area was measured during a line scan with a length of 57 
mm. The whole membrane area (57 mm x 53 mm) was covered by 53 line scans with a 
distance of 1 mm in-between. In addition to the return back time of the chamber and dead 
time of around 1 min (required for synchronization with data acquisition of ICP-MS) a 
total instrumental analysis time of 65 min was necessary. From this measurement (Figure 
3.3) the peak area of the phosphorus signals with those of single line scans was 
compared. The single line scans for the measurement were chosen from the centre of the 
protein spot. The mean value of all the integrated peak profile areas of the accumulated 
signal of 7 single line scans was found to be 2.5 ⋅ 106 compared to 4.5 ⋅ 105 counts of the 
single line scan. The relative standard deviation over all 7 spots comparing the mean 
values resulting from multiple spots with single scan amounted to 6.1% which was 
surprisingly low and demonstrated that laser ablation and SDS separations are quite 
reproducible. When only single line scans were evaluated the relative standard deviation 
was increasing to 10%. This is the reason, why integration is always performed with 
multiple scans across a protein spot in the following experiments. Apart from the laser 
scanning conditions on the same blot, reproducibility of the gel electrophoresis and 
blotting conditions are also necessary to prove the accuracy of the method. So two 
different electrophoretic separations and blotting were performed with 152 pmol β-
casein, as explained in section 3.2.2 using vertical electrophoresis. 31P+ intensity of the 
protein spot areas was measured for the two blots using LA-ICP-MS on the same day and 
shown in Figure 3.4. The intensities of the whole area of the protein spots obtained from 
the multiple scans were summated and found to have 7.56 ⋅ 106 cps and 8.77 ⋅ 106 cps for 
blots a and b shown in Figure 3.4, respectively. The relative standard deviation over 2 
spots comparing the mean values resulting from multiple spots amounts to approximately 
11% which is low and demonstrates that electrophoresis and blotting is quite 
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reproducible. But more blots should be compared and it should also be measured together 
in the same laser ablation experiment with less time interval in order to avoid any other 
effects. Alternatively internal standards such as 13C+ can be used for normalization of 
obtained intensities from different blots irrespective of the electrophoresis and blotting 
procedures.  
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Figure 3.3: 31P+ intensity distributions of 7 samples of 20 pmol β-casein each (76 pmol phosphorus 
amount) measured by LA-ICP-MS on an NC membrane after SDS-PAGE and blotting.86 
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Figure 3.4: 31P+ intensity distributions of 40 pmol β-casein (152 pmol phosphorus amount) on 2 
different membranes measured by LA-ICP-MS after SDS-PAGE and blotting. 
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3.3.1.4 Comparison of PVDF and NC Membrane Characteristics for LA on 
Phosphorylated Proteins 
For blotting, different membrane materials are commercially available but most 
often either PVDF or NC are applied, because they provide a stable binding of proteins 
on the surface, so that losses of proteins penetrating the membrane material are reduced 
as much as possible. The binding capacity of both materials is similar but depends on the 
manufacturer. Typical values are 70 - 150 µg/cm for NC and 125 - 300 µg/cm for PVDF. 
Additionally, from the analytical point of view, the material should have a couple of 
features with respect to laser ablation, laser energy and detection by ICP-MS. For 
instance, it should show good ablation properties and should have low blanks for the 
elements of interest. Furthermore it should not cause additional spectral interferences. 
Therefore, both materials were investigated after separation and blotting of 40 pmol of β-
casein (Figure 3.5). From the accumulated 31P+ intensity it can be found that for the same 
laser energy the 31P+ intensity of the protein spot area is more than a factor of 13 higher 
for the NC in comparison to the PDVF material. This strong difference can only partially 
be explained by the different ablation behaviour of the membrane material. After the first 
laser scans the depths of the craters in NC and PVDF membranes were measured by a 
white light interferometer, they were found to be to be 65 µm and 31 µm, respectively 
(Figure 3.6a and b). For PVDF, a second scan on the same laser trace reached a depth of 
54 µm, while for NC the membrane was drilled through. From the crater profile for a 
laser trace of 10 mm length a volume of 0.19 mm3 for NC and only 0.074 mm3 for PVDF 
was calculated, thus 2.5 fold more material was ablated in case of an NC membrane. That 
shows that both materials behave quite differently as the chosen laser energy is more 
suitable for NC membranes. One reason for this different behaviour might be that NC 
decomposes easily after heating to temperatures above 185 °C whereas PVDF 
decomposes at around 425 °C. 
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Figure 3.5: 31P+ intensity distributions of 40 pmol of β-casein after blotting to an (a) NC and (b) 
PVDF membrane and subjected to LA-ICP-MS.86 
In a similar experiment the depth distributions of the protein spot were 
investigated by ablating every scan line a few times until the membrane material in the 
crater was completely ablated. This was done for both membrane materials, but because 
of the different ablation behaviours, the depth resolution was strongly different for both 
materials, because the same laser energy was used for both experiments. The resulting 
time profile is shown only for the PVDF material in Figure 3.7, because no protein 
related signal was detected for the NC material during the second scan. Considering the 
intensities of all the scans to be 100%, only 56% of the intensities could be obtained in 
the first scan (depth of 31 µm), whereas with the second scan – reaching a depth of 54 
µm – 30% was detected. With the third scan this value dropped to 9% only, but the depth 
was not measured in this case. In total five scans were needed to penetrate this material. 
From the results of this investigation it could be concluded that on both membrane 
materials the proteins were enriched within a depth of the upper 70 µm. 
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a) 
 
 
 
b) 
 
 
Figure 3.6: (a) Crater profile of a laser trace on an NC membrane measured by means of a white 
light interferometer, (b) Crater profile of a laser trace on PVDF membrane measured by means of a 
white light interferometer.86 
 
The value of 56% in the first scan was less than the value reported by Müller et 
al.,89 who had also used PVDF membranes and found recovery rates of gold-conjugated 
antibodies in the first scan line of 78.6%. However, the depth distribution of proteins can 
also depend on the applied protein and the amount. 
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Figure 3.7: Multiple line scans of a protein spot of 40 pmol β-casein on PVDF membrane.86 
From a pragmatic point of view the selection of the material is quite 
straightforward. Although both membranes enrich the protein in a thin surface layer, NC 
membranes are more suitable with the present lens system used so that for not too high 
amounts of protein loaded onto the membrane single scanning of the protein spot per 
sample is even sufficient and guarantees highest sensitivity, too. Additionally it was 
shown in Figure 3.2, that no additional spectral interferences are generated for NC 
membranes. This is the reason why this material was exclusively used further on. 
3.3.1.5 Comparison of Different Blotting Processes for LA detection 
There are different types of blotting processes available for the transfer of proteins 
from gels to membranes but contact and electro blotting methods were investigated and 
compared here to achieve better detection levels for phospho-proteins using LA-ICP-MS. 
Contact blotting is the simplest and it involves the diffusion principle. It is already known 
that contact blotting is less efficient than the electroblotting methods. However it was not 
clear how proteins are distributed in the upper layer of the membranes after using 
different blotting methods. As it was discussed in the previous section, this is important 
to optimise the laser ablation processes of membranes. Therefore an experiment was 
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performed, to check the distribution of the proteins in the membranes after different 
blotting methods and to find conditions of highest signal intensities.  
Two sets of protein samples, pepsin and β-casein, containing each about 50 pmol 
phosphorus were subjected to 1D separation. One set of samples was subjected to contact 
blotting and the other to semidry blotting. In order to avoid the interferences from the 
ICP-MS for 31P+ measurement at MR, membranes were not stained. After that LA was 
performed on the blots which were mounted on the same cylinder. The resulting 
phosphorus intensity plots are shown in Figure 3.8a and b for semidry and contact 
blotting, respectively. Trace 1 corresponds to β−casein and trace 2 to pepsin. From the 
intensity profile it is obvious that the semidry blotting procedure shows the highest signal 
intensity. From the integration data of these samples, it was found that the obtained 
intensity for β−casein using semidry blotting is ~1.01 ⋅ 106 cps which is 3 times higher 
than those of contact blotting (3.35 ⋅ 105 cps). It was also similar for pepsin where it was 
2.9 times higher for semidry blotting (1.16 ⋅ 106 cps) than those of contact blotting (3.9 ⋅ 
105 cps). Therefore semidry blotting was selected here for all further investigations. 
3.3.1.6 Sensitivity and Limits of Detection 
Sensitivity is the ratio of the net signal obtained to the concentration of a specific 
element. The detection limit of any method is indirectly proportional to its sensitivity. 
Thus for getting better detection limits, sensitivity has to be optimised. Sensitivity of a 
method is controlled by factors such as the instrument design and the various 
optimisation conditions used for the analysis such as the settings on the ion optics, 
alignment of torch positions etc. For any quantitative analysis, sensitivity is one of the 
significant parameters to be considered. The benefit of using HR-ICP-MS is that it is 
highly sensitive but the consistency of the resulting sensitivity should be checked with 
respect to the analysed samples, here different phospho-proteins. So far, only pepsin and 
β-casein were applied and therefore in the next experiments other phospho-proteins have 
to be investigated with respect to sensitivity. Since the molecular weight and structure of 
the phospho-proteins vary, this study was needed to develop quantification schemes for 
as many phospho-proteins as possible. The following experiment was designed keeping 
in mind all the optimisation procedures discussed in the above topics. As previously 
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discussed a nitrocellulose membrane was chosen and for the blotting the semi dry 
blotting method was adopted. 
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Figure 3.8: (a) 31P+ image of semidry blotting experiments with different proteins (1) β-casein and (2) 
pepsin, but with same amount of phosphorus, 50 pmol and (b) the same samples with contact blotting 
experiment. 
The phospho-proteins pepsin, α-casein and ovalbumin with a final phosphorus 
content of 45, 451 and 88 pmol were SDS-PAGE separated and blotted. The 2 
dimensional plot of the 31P+ intensities at MR were obtained after LA-ICP-MS 
measurement. 8 scans were performed for each protein spot in 1 mm distance. From 
Figure 3.9 different intensity spots can be seen dependent on the phosphorus content. For 
example α-casein which has 8 theoretical phosphorus residues shows a more intense spot 
and the signal intensity obtained is higher compared to the other 2 proteins. For 
ovalbumin, the spot is broader which is also true for pepsin. Apart from these spots some 
impurities were still detected which can be neglected. Additionally some spikes (denoted 
by arrows in Figure 3.9) could be seen coming from the minute particles present inside 
the cell during the laser ablation process.  
Each of these spots was cumulatively integrated. The integrated intensity value 
was calculated from the cumulative line scan obtained from the Matlab routine. This is 
shown in Figure 3.10. The integrated values are mentioned in the figure with the 
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respective phosphorus amount loaded. The integrated intensity for α-casein was 
obviously higher when compared with those of the other 2 proteins which have similar 
intensity distributions. The sensitivity of the method with respect to each protein was 
estimated using the peak area and found to be consistent (ovalbumin-2.16 ⋅ 104 cps/pmol, 
pepsin-2.67 ⋅ 104 cps/pmol and α-casein-2.44 ⋅ 104 cps/pmol) with a relative standard 
deviation of 11.6%. Each protein exhibits different distribution on the membrane, thus for 
calibration and quantification the whole peak area was taken into consideration for 
integration. The LOD of the method calculated using the 3σ definition for α-casein was 
1.4 pmol whereas for pepsin and ovalbumin it was 4.4 and 6.8 pmol, respectively. 
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Figure 3.9: 31P+ images of the blot obtained after LA-ICP-MS. Prior proteins were separated using 
SDS-PAGE and semi dry blotted. Amount of protein loaded: 1 µg with a final phosphorus amount of 
45, 451 and 88 pmol of pepsin, α-casein and ovalbumin. Arrow represents the spikes obtained during 
the laser ablation process. 
This method was also suitable for proteins which are present in the same lane on 
the membrane rather than in 3 lanes, which was shown above. The 2 different phospho-
proteins, ovalbumin and α-casein, were mixed together (with final phosphorus amounts 
of 75 and 92 pmol, respectively) and separated by SDS-PAGE separation and blotted. 
The 31P+ image of the blot after LA-ICP-MS is shown in Figure 3.11. The integration of 
the spot area was performed and the sensitivities achieved for the method were consistent 
with a relative standard deviation of 4.4% for the phosphorus amounts of different 
phospho-proteins measured (α-casein: 6529 cps/pmol, ovalbumin: 7373 cps/pmol). Peak 
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area was considered for the calculation of sensitivity. The LOD of the method calculated 
using the 3σ definition for α-casein was 0.43 pmol whereas for ovalbumin it was 1.86 
pmol which was better than the experiment where electrophoretic separation of three 
proteins were done in different lanes. 
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Figure 3.10: Integrated phosphorus intensities as a function of migration distance for the 3 proteins 
shown in Figure 3.9. 
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Figure 3.11: 31P+ images of the blot obtained after LA-ICP-MS. Samples: Mixture of protein 
ovalbumin and α-casein loaded with a final phosphorus amount of 75 and 92 pmol, respectively. 
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3.3.2 Calibration and Quantification Strategy 
For calibration different concepts are described in literature. For instance, Becker 
et al. have used an ultrasonically generated aerosol simultaneously introduced with the 
ablated aerosol for quantification.72 For application of this approach it is a prerequisite 
that the laser aerosol size distribution is very well represented by the pneumatically 
generated aerosol as well as it does not change during ablation. Additionally transport, 
vaporization and ionisation must be identical for both types of aerosols, which is hard to 
achieve. From this point of view all those concepts are preferred in this work where the 
signal of the standard and of the target protein is coming from a laser ablation process of 
the same matrix.  
For gel applications a couple of papers have already shown the suitability of a 
calibration by matrix matched standards. For instance, Becker et al. have recently also 
used an alternative calibration approach for phosphorus determinations in proteins.34 In 
this purpose the 31P+ intensity of the standard protein, in this case ovalbumin was dotted 
with total amounts ranging from 0.1 ng up to 500 ng on a gel after separation of the 
proteins. From the slope of the linear calibration graph and the gel blank they calculated a 
LOD for phosphorus of 0.18 µg/g. 
Marshall et al. have used the phosphorus containing protein β-casein for 
calibration and a limit of detection of 16 pmol has been estimated.71 The direct ablation 
of the gel was limited by a too high blank value of phosphorus in the gel. Bandura et al.69 
have used the protein phosvitin in 1D separation for a calibration calculating limits of 
detection at 50 – 100 pmol level.  
Alternatively, Chéry et al. have used hydrated gels with multielement standard 
solutions for a calibration and calculation of limits of detection under multielement 
conditions.31 This technique using metal standards hydrated in a gel cannot be used here, 
because metals are lost during the blot procedure due to the fact that they are moving to 
the cathode, whereas SDS treated proteins move to the anode. A calibration and 
quantification approach was chosen where the signal of the standard and of the target 
protein was coming from a laser ablation process of the same matrix.  
Therefore two different calibration procedures, 1) dotting and 2) blotting were 
investigated here for comparison. The first procedure was based on the use of standards 
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directly dotted by a pipette onto the surface of the membrane and in the second procedure 
a protein with well known phosphorus content was PAGE separated, blotted and then 
used to calibrate the samples which were present on the same blot membrane.  
 For the dotting experiment, 5 µl of three solutions in 5 series, ranging from 19 to 
152 pmol phosphorus in β-casein, 17.5 to 140 pmol phosphorus in pepsin and 25 to 200 
pmol phosphorus in an inorganic phosphorus solution, were dotted directly onto an NC 
membrane and were ablated after drying.  
Images of the phosphorus intensity distribution measured are shown in Figure 
3.12 for the dotting experiment. It can be seen from the dots that each protein is 
inhomogeneously distributed in the protein spots. Nevertheless, after integration of the 
spot area the calibration graphs are linear and the sensitivities for β-casein, pepsin as well 
as inorganic phosphorus fit well with not more than 20% deviation (Figure 3.13). 
Coefficients of determination (R2) of 0.9915, 0.9823 and 0.9898 could be obtained for 
PO43-, β-casein and pepsin, respectively. As a test analysis a SDS-PAGE separated α-
casein (Figure 3.14) with a total phosphorus amount of 93 pmol was used as unknown 
sample and quantified after blotting and laser ablation using the calibration curves.  
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Figure 3.12: 31P+ images of dotting experiment with different phosphorus amount of (1) PO43-, [a-25, 
b-50, c-100, d-150, e-200 pmol] (2) pepsin [a-17.5, b-35, c-70, d-105 and e-140 pmol] and (3) β-casein 
[a-19, b-38, c-76, d-114, e-152 pmol].86 
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Figure 3.13: Calibration graph obtained after integrating spot areas from Figure 3.12. 
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Figure 3.14: 31P+ images of an α-casein spot with phosphorus amount of 93 pmol on an NC 
membrane. 
Using the calibration of PO43-, pepsin and β-casein 47, 44 and 47 pmol 
phosphorus amounts of α-casein were calculated, respectively. All results show that by 
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dotting, the amount of phosphorus in the protein is underestimated and only a fraction 
can be found (around 55%). 
As an alternative approach, the standards were separated and blotted together with 
the test sample to compensate for the incomplete protein transfer. For this purpose β-
casein with increasing total amounts of phosphorus ranging from 38 to 304 pmol were 
blotted together with α-casein with a total phosphorus amount of 139 pmol. The 
phosphorus intensity distribution is shown in Figure 3.15 for different protein spots on an 
NC membrane after 1D SDS-PAGE separations. Using the calibration (R2 = 0.985) a 
total amount of 126 pmol of phosphorus was determined for the α-casein sample. Even 
though the sensitivity (Figure 3.16) in this calibration was lower compared to the dotting 
experiment, the quantified α-casein amount was in better agreement with the amount 
chosen for this experiment. A linear dynamic range was observed using this method for 
proteins containing phosphorus amounts of up to 300 pmol. The number of phosphate 
residues was calculated for α-casein using the two calibration strategies. The β-casein 
PAGE separated calibration strategy shows 7.4 phosphate residues in α-casein which is 
in good agreement with the theoretical value of 8, whereas by external dot calibration this 
value would be only 4.4. 
 From the much better accuracy which was achieved using SDS-PAGE and 
blotting of standards compared to the experiments where dotting was applied for 
calibration it can be concluded that not only the standards are ablated and transported in 
the same way as the test sample, but also that possible blotting losses are compensated if 
proteins are chosen as standards. This is the reason why this quantification strategy was 
preferred in this work. So far it is not clear yet, if this calibration strategy is valid only for 
proteins with a similar molecular weight, because the proteins selected here covered only 
a small range of the molecular weight scale of 23 to 35 kDa and thus it needed to be 
investigated for each set of target proteins. 
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Figure 3.15: 31P+ images of α- and β-casein spots on an NC membrane (1) 38, (2) 76, (3) 152, (4) 228, 
(5) 304 pmol phosphorus in β-casein and (6) 139 pmol phosphorus in α-casein.86 
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Figure 3.16: Calibration graph obtained after integrating β-casein spot areas from Figure 3.15. 
3.3.3 Linear dynamic range 
It was already discussed in the previous experiment that a linear dynamic range 
was observed for proteins containing up to 300 pmol phosphorus amounts. Therefore, the 
next experiment was performed to see at which point the membrane becomes overloaded. 
For this purpose β-casein with amounts of 1, 10, 100, 1,000 and 10,000 pmol (3.8 to 
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38000 pmol phosphorus amounts) was separated and blotted onto 2 NC membranes, one 
behind the other. The 31P+ intensity distributions are shown in Figure 3.17a and b. The 
integrated intensities for phosphorus of the protein spots are shown in a graph in Figure 
3.17c. From this figure it can be seen that the graph deviates from linearity already for 
total protein amounts of more than 100 pmol (380 pmol phosphorus amount). In addition 
to that quite significant intensities could also be observed in the second membrane. The 
main spot area of spot numbers 4 and 5 are about 0.3 and 0.8 cm2 and they contain 1,000 
and 10,000 pmol of the protein, respectively (Figure 3.17a). Thus, a protein loading of 
around 80 µg/cm and 300 µg/cm can be estimated where the latter is beyond the upper 
limits of the NC membranes capacity. For too high amounts of proteins they are 
penetrating deeper and at least pass through the membrane into the second membrane and 
possibly also to the anode filter causing a severe loss. This means that one has to 
determine always the linear dynamic range for a specific membrane material, a given 
amount of protein and blotting conditions, if quantitative results are needed.  
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Figure 3.17: 31P+ intensity distributions of increasing amounts of β-casein in the (a) first membrane 
and (b) second membrane. (c) Integrated intensities of the spot in the first and the second 
membrane.86 
3.3.4 Application 
3.3.4.1 Effects of Hydrogen Peroxide on the Total Protein Phosphorylation 
State in Urothelial Cells 
 In an initial experiment the time-dependent effect on the phosphoproteome of 
urothelial cells upon exposure to hydrogen peroxide was investigated. The aim of the 
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experiment was to define a suitable time window in which clear effects of H2O2 on 
protein phosphorylation can be measured by LA-ICP-MS. As has been mentioned 
previously, protein phosphorylation events usually occur within a few minutes upon 
stimulation of cells with oxydizing compounds. Therefore, the human urothelial 5637 
cells were treated with 100 µM H2O2 for 2, 4 and 7.5 min. The cells were lysed 
immediately after exposure in SDS-containing electrophoresis buffer. The cell lysates 
were subjected to SDS-PAGE, electro-blotting and subsequent laser ablation ICP-MS 
for phosphorus detection. The scanned Coomassie stained gel and the resulting 31P+ 
intensity distribution of the whole cell proteins after treatment with H2O2 are shown 
in Figure 3.18a and b. The white spots seen at the end of the low molecular weight 
range belong to phosphorus contaminations in the running front. Comparing both 
figures it is hard to see any direct correlation between phosphorus signals (Figure 
3.18b) and protein bands (Figure 3.18a), but this demonstrates already that the most 
abundant proteins are not carrying most of the phosphorus. Another feature of the 1D 
separations can also be seen in Figure 3.18a. Although similar total protein amounts 
were used and loaded into each well of the gel, the individual electrophoretic lanes 
show slight differences in protein content and mobility, and the latter complicates the 
calibration of the molecular weight scale and also has an implication for Figure 3.18b. 
Although there were no changes in the protein expression pattern visible in the 
Coomassie stained gel (Figure 3.18a), significant differences could be seen for the 
corresponding 31P+ distribution (Figure 3.18b). In comparison to the control, all 31P+ 
intensities in lane 1 to 3 were increasing which can be attributed to an increase of the 
whole phosphoproteome.  
 Concerning the question how much the phosphoproteome of the stressed cell 
line is increasing, the 31P+ intensities of each electrophoretic lane were integrated and 
normalized by the integrated protein content of each lysate using the stained gel 
(Figure 3.18a) and to the most intense protein band. Due to a high 31P+ background 
and a too low amount chosen the recalibration standard could not be used here for 
quantification. Therefore, Figure 3.19 shows a plot of the integrated measured 
intensities (normalized to 1 with reference to lane 4) in each lane, i.e. in the untreated 
cells (control) and the cells treated for 2, 4 and 7.5 min with H2O2. From this figure it 
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becomes obvious that during 7.5 min the phosphorus intensity increases by a factor of 
about 1.3 and is highest already after 4 min. In Figure 3.19 a fast response of the cells 
to H2O2-dependent oxidative stress is observed and this demonstrates that the 
sensitivity of the method described here is already sufficient to measure differences 
time resolved and the selected time window of H2O2-induced effects appears to be 
suitable for further investigations. 
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Figure 3.18: (a) Proteins from cell lysates of human 5637 urothelial cells were separated by SDS-
PAGE and stained with Coomassie Blue and scanned with a gel scanner (1) control, treated with 
H2O2 for (2) 4, (3) 7.5 and (4) 2 min (MW) dual colour marker. (b) 31P+ distribution of whole cell 
proteins separated by SDS-PAGE and subsequently blotted onto NC membranes. 31P+ was detected 
by ICP-MS after laser ablation. 
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Figure 3.19: Integrated total phosphorus intensity (normalised to 1) of all proteins after H2O2 
treatment of 5637 urothelial cells for 2, 4 and 7.5 min. 
 So far, the first data shown in Figure 3.18b also provides molecular weight 
resolved information. For this purpose, not the whole electrophoretic lane but some 
selected molecular weight ranges were integrated.  
 Figure 3.20 shows how the extent of phosphorylation differs between protein 
fractions in different molecular weight ranges. The low molecular weight fraction 
below 25 kDa is not shown in this figure, because this fraction was coming too close 
to the running front and therefore contained many different charged low molecular 
weight bio-molecules and not only proteins. 
 Again as mentioned before, we do not know if all phospho-proteins in the 
range from 25 to 250 kDa have the same blotting efficiency, therefore an absolute 
comparison is not possible yet. Thus relative changes in the 5 different fractions will 
only be discussed here. The largest increase of the normalised phosphorus intensity 
was seen in the high molecular weight range in the fractions 55 to 90 and 90 to 250 
kDa. In the fraction from 43 to 55 kDa a very well pronounced band was visible 
around 50 kDa in all 4 samples, which showed a fast increase in the first 4 min and 
remained more or less constant for the rest of the time. Overall, a treatment time of 
7.5 min was selected for the next experiment just as to work under more or less static 
conditions. 
 In the next experiment this method was applied to evaluate changes in the 
phosphoproteome by treatment of the urothelial cell by two different stimuli. 
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Figure 3.20: Integrated total phosphorus intensity (normalised to 1) of different protein fractions 
obtained by SDS-PAGE of whole cellular proteins from untreated and H2O2 treated 5637 urothelial 
cells at 2, 4 and 7.5 min.  
3.3.4.2 Modulation of the Protein Phosphorylation Status of Cells by 
Treatment with Epidermal Growth Factor and H2O2 
 As already mentioned, cells can respond specifically to different external 
stimuli. Following exposure, xenobiotics may cross the plasma membrane and exert 
their effects inside the cells. Compounds mediating their effects via membrane bound 
receptors switch on respective signalling pathways which mostly include multiple 
protein phosphorylations. The peptide hormone EGF was used for cell stimulation as 
a reference system. EGF binds to receptors of the ErbB-family, including EGFR 
(=ErbB1), which are coupled to different signalling pathways.83,90 The aim of the next 
experiment was to show alterations in the phospho-protein pattern of EGF-treated 
5637 urothelial cells and to compare them with changes observed upon H2O2-
treatment. Because distinct pathways are affected by EGF and H2O2, a differential 
phospho-protein profile can be expected upon exposure to the two compounds. 
 For the experiment cells were grown again in 3 different cell culture flasks. 
One was used as control and the other 2 were treated with either EGF (8.1 nM) or 
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H2O2 (100 µM) for 7.5 min. After treatment the cells of the cultures were lysed and 
the proteins were separated by SDS-PAGE. Protein and phospho-protein patterns 
were visualized by Coomassie staining of the gels and by 31P+ detection after protein 
transfer to an NC membrane by electro-blotting, respectively. The results are shown 
in Figure 3.21a and b. It should be mentioned that due to the previous experiment, 
two conditions were improved here. First, a higher amount was taken for the 
recalibration standard. Additionally, the PAGE separation was slightly modified to 
better resolve the low molecular weight range.  
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Figure 3.21: Analysis of the protein and phospho-protein pattern of 5637 urothelial cells, either 
untreated (2) or treated with EGF (3) and H2O2 (4). (a) Proteins separated by SDS-PAGE and 
stained with Coomassie Blue. M is the dual colour marker loaded on to the gel. (b) 31P+ map of the 
same samples after laser ablation of the proteins blotted onto NC membranes. 40 pmol of β-casein 
corresponding to a phosphorus content of 152 pmol was used as standard (1).  
 As can be seen from the Coomassie stained gel (Figure 3.21a), again there are 
no noteworthy alterations in the general protein expression pattern by the short time 
treatments with EGF or H2O2 compared to the control cells (Figure 3.21a). Again this 
measurement was used for calibration of the weight scale as well as for normalization 
of the total protein content in the sample. At a first glance, it is obvious, that both 
compounds lead to a general increase in phosphorylated proteins (Figure 3.21b). 
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 A more detailed analysis showed that EGF and H2O2 act differentially on the 
phosphoproteome. Based on proteins of different molecular weight ranges different 
types of response patterns elicited by EGF and hydrogen peroxide can be delineated 
as shown in Figure 3.22. The data shown was normalized to the total amount of 
proteins in the EGF sample used (lane 2 from Figure 3.21) to overcome the changes 
in cell culture experiments. For the low molecular weight range (15 to 18 kDa) a 
change was observed only for EGF but not for H2O2 compared to the control, whereas 
an increase of the phosphoproteome was seen for H2O2 in all different molecular 
weight ranges above 35 kDa, with the highest response in the highest range.  
 A decrease (dephosphorylation) of the phosphoproteome is observed for both 
stimuli mainly in the low molecular weight range from 18 to 25 kDa. Effects which 
are specific for either EGF or H2O2 were particularly clear in the two different 
molecular weight ranges of 40 to 50 and 95 to 300 kDa. In the high molecular weight 
range H2O2 caused a higher increase in the phosphoproteome compared to EGF. 
Although the total amounts of phosphorus did not show significant differences, which 
would lead to the misinterpretation that EGF is not causing any effect, the size 
fractioned representation showed a quite different phosphoproteome pattern for both 
samples. Additionally, if the same amount of stimuli was taken into account, the 
epidermal growth factor showed a much higher response by many orders of 
magnitude because only 8.1 nM were applied, which showed that this signalling 
cascade was causing a more severe effect on phosphorylation and de-phosphorylation 
processes.  
 Differential effects of H2O2 and EGF on the cellular phosphoproteome were 
seen with the LA-ICP-MS-method. Pathways which are influenced by H2O2 have 
already been discussed in section 3.1.2. However, although H2O2 and EGF showed 
distinct effects and acted on different processes there were also many common 
proteins which got phosphorylated in same levels by influence of both as can be seen 
from the results presented in Figure 3.22 in the molecular weight range from 25 to 40 
kDa. 
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Figure 3.22: Phosphorus content of different protein fractions obtained by SDS-PAGE of whole 
cellular proteins from untreated and EGF or H2O2-treated 5637 urothelial cells. Separated proteins 
were blotted onto NC membranes. 31P+ was detected by ICP-MS after laser ablation and quantified 
via one point calibration. 
 Overall, the results of the first preliminary experiments did not allow 
identifying specific proteins yet which are involved in signalling effects. On the other 
hand, all examples from literature mentioned in section 3.1.2 were concentrated on 
specific proteins, which most often were isolated and identified using a labelled 
antibody, without knowing if this target protein was the most relevant one. The data 
here allowed identifying in which molecular weight range effects are visible at which 
time scale and to which extent. This information could be used in a next step to select 
the most relevant proteins in a signalling pathway of phospho-proteins for further 
analysis.  
 Summarizing, these first investigations demonstrate already that the detection 
power achieved by using LA of blot membranes in combination with ICP-MS is a 
promising tool to study chemical stress induced in cancer cell lines time and 
molecular weight resolved. The specific alterations of the cellular phosphoproteome 
could be detected by LA-ICP-MS after a simple 1D-electrophoretic separation of the 
whole unfractionated cellular protein mixture. Keeping in mind that only 8 µl of cell 
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lysate was applied, the results shown here correspond to about 30,000 cells per 
sample only, assuming doubling of the cell number within the time range of exposure. 
Thus, the procedure is fast and requires low amounts of cell material, but still 
improvements are needed for biological studies. The sensitivity achieved is quite 
sufficient to observe changes in protein groups even after a few minutes treatment. A 
higher time resolution, in levels of a few seconds, is still a future goal, but this was 
limited in this investigation mainly by the speed and reproducibility of sample 
preparation. For instance, although we tried to load the same amount of protein to 
each well of the separating gel, differences of up to 30% were measured in the stained 
gel (calculated from the integrated intensities using gel scanner software) which could 
be attributed to differences in the cell cultures. Additionally reproducibility of the 
electrophoresis and the blotting experiments showed a relative standard deviation of 
11%. Another problem was related to the separation and can be seen in Figure 3.21. 
Due to the high amount of protein loaded to the wells, the running front and all bands 
are curved, which can be compensated by software tools to a certain extent only and 
therefore complicates the evaluation of the data. A faster method to stop the kinase 
and phosphatase activity instantaneously during sample preparation would also be 
needed for this purpose. 
 In the work presented here, the integrated net phosphorylation status of a 
group of proteins can only be seen and not of single well defined protein as a result of 
phosphorylation and dephosphorylation reactions within this group. However, this is 
already an important improvement compared to the work of Bandura et al., where 
only the total phosphorylation after digestion of a tyrosine kinase assay was 
measured.69 Nevertheless, by this technique it was already possible by Bandura et al. 
to provide a distinguishable difference between malignant cell lines and primary cell 
cultures.91 
 In principle, laser ablation ICP-MS is sensitive enough to measure protein 
phosphorylation in single protein spots. This was demonstrated already in the work of 
Becker and coworkers, who investigated LA of single protein spots of the human tau 
protein directly in the gel after 2D separation.72 This protein contained 17 
phosphorylation sites, which was identified by Fourier transform ion cyclotron 
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resonance mass spectrometry. In a more recent work, Becker et al. detected more than 
17 phosphorus containing proteins in a set of 176 protein spots from a human brain 
sample,92 but comparison with this work is not possible, because the amount of 
sample taken into account was not defined. 
 Concerning improvements of LOD, here it was limited by phosphorus blanks 
coming from the membrane material and from the unfractionated cell lysate. So far, 
phosphorus free membrane material is not yet commercially available, and the 
development of additional sample treatment could avoid the impurities. Alternatively, 
improvements in terms of sensitivity seem also to be promising. For instance, Elliot et 
al. showed that an increase of the laser beam diameter from 100 µm to 780 µm 
resulted in an improvement of the limits of detection by one order of magnitude. In 
our case further increase in the laser beam, which was already 500 µm wide, was not 
possible due to the limited laser output energy. Another approach to improve limits of 
detection looks promising and was described by Elliot et al.,93 who used whole gel 
elution. In this technique a whole protein spots was electroeluted from the gel into 
small volume containers and improvements were then possible if high efficiency 
pneumatic nebulisers were applied as this was discussed for instance by Pröfrock et 
al.70 
 For future work, also the assignment of alterations of the phosphorylation 
status to individual proteins is of major interest but this requires a higher resolution of 
the PAGE separations. Concerning resolution, usually 2D-gel electrophoresis is 
applied to achieve this goal, but this would give the risk that the amount of 
phosphorus now measured in a band is then distributed over several protein spots thus 
coming closer to the limit of detection. From this point of view, also improvements of 
detection power are required. Concerning this problem, both reductions of phosphorus 
blanks as well as improvements in terms of sensitivity are needed to measure single 
protein phosphorylation. Apart from improving the LOD, significant improvements 
seem to be possible mainly during the sample preparation step itself. For instance, the 
enrichment of phospho-proteins looks most promising. Various different techniques 
are available for this purpose, among which affinity based purification is the most 
promising approach.81,94,95 
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3.4 Concluding Remarks 
 LA-ICP-MS was investigated here for imaging of the intensity distribution of 
31P+ in electrophoretic spots of phospho-proteins after 1D PAGE separation and 
electroblotting onto commercial available blot membranes. 
 The parameters such as He gas flow rates and torch positions were optimised 
with the Aridus system before laser ablation and the sample preparation steps such as 
blotting and membrane materials were chosen to be suitable for better laser ablation 
conditions. In addition the power chosen for the method was also suited for better 
detection levels. The LA line-scan speed used was 1 mm/s which was much better in 
comparison to the previous investigations.71 The detection of phosphorus containing 
proteins by LA-ICP-MS was nearly not disturbed by molecular interferences when 
measured at medium mass resolution.  
 With the laser setup used throughout this investigation NC membranes were 
found to be advantageous compared to PVDF membranes and semidry blotting 
method was beneficial. The laser ablated areas on the membranes were studied and 
compared using white light interferometer. With the above mentioned optimised 
conditions, similar sensitivities of different phospho-proteins were achieved for all 
the proteins investigated if normalized to P. The sensitivity achieved for phosphorus 
in pepsin was calculated and found to be about 2.67 ⋅ 104 cps/pmol. 
 A limit of detection of about 1.5 pmol for β-casein was calculated using the 3σ 
definition. Reproducibility of the whole method - including electrophoretic 
separation, blotting and laser ablation – showed relative standard deviation between 
6% and 10% if the whole protein spot area was taken into account. Linearity could be 
achieved for a range of about 20 to 380 pmol phosphorus in proteins.  
Two calibration procedures, dotting and blotting for quantification of unknown 
amounts of phosphorus containing proteins, were compared. If β-casein was PAGE 
separated and used as calibration protein the blotting calibration strategy showed 7.4 
phosphate residues in the test protein α-casein which is in good agreement with the 
theoretical value of 8, whereas by external dot calibration this value was only 4.4.  
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 After elaboration of the calibration method it was already applied for a first 
application to study the change in the phosphoproteome of a single cancer cell line after 
EGF hormone and oxidative stress stimuli by H2O2 quantitatively using a protein 
standard for calibration. Although both stimuli have already been investigated in the 
literature, this was never done before with one and the same cell line, but this is a 
prerequisite to identify similarities and differences in the signalling pathways. H2O2 (100 
µM) induced an increase in total phosphorylation by a factor of 1.3 after treatment of 
cells for 7.5 min and in the fraction from 43 to 55 kDa a very well pronounced band was 
visible around 50 kDa in all the samples investigated. H2O2 caused more phosphorylation 
than EGF (8.1 nM) in the high molecular weight range above 90 kDa. It was shown that 
to a certain extent a calibration procedure using a protein standard during the same 
electrophoretic run compensates blot losses and incomplete ablations. In the results 
presented here, the measurement performed to study the hormone and oxidative stress 
stimuli allowed a time resolution at the scale of a few minutes and of course molecular 
size fractionation. At the moment the quantification methods investigated can be applied 
only for one dimensional SDS-PAGE, but for this study a much higher separation power 
for instance by application of 2 D PAGE is required in future. 
 But finally, as to give a more realistic assessment, the application chosen here was 
only a proof of principle experiment and it was only used to see relative changes of 
phospho-protein bands. Validation by conventional methods is needed to verify our 
findings.  
 Further improvements are still needed to further reduce the limit of detection of 
phosphorus by LA-ICP-MS, for instance by applying improved sample preparation 
techniques in cell culture experiments in order to reduce the phosphate blanks. 
Additionally phospho-protein purification and enrichment methods can be applied for 
prefractionating the total cellular proteins. 
So far, this new method was applied only for cell cultures. More complex samples 
such as tissues or body fluids need to be investigated to show that the quantification 
concept elaborated in this work can really be applied for studies in phosphoproteomics.  
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Chapter 4 
Method Development for Application of LA-ICP-MS in 
Screening and quantification of Labelled Proteins and 
Antibodies 
In the previous chapter the hetero-element phosphorus present in the protein was 
utilized to detect and quantify proteins. But for proteins with no or too low number of 
hetero-elements, labelling methods can be applied for detection of bio-molecules by LA-
ICP-MS in combination with separation methods. The main drawback of most of the 
recent labelling approaches discussed in literature is that the chemicals are not 
commercially available or only a very limited number of labelled antibodies can be 
bought from stock.96 The controlled labelling of proteins is a prerequisite for its 
quantification. The aim is therefore to elaborate different labelling methods in order to 
simultaneously detect and quantify proteins from a mixture using ICP-MS. For this 
reason, it is necessary to investigate different labelling procedures using chelating 
complexes such as DTPA or DOTA and Indian ink staining. The procedures for labelling 
of proteins via DOTA for e.g. molar ratios, reaction time, temperature and buffer were 
optimised in this work for application of LA-ICP-MS. 
On the one hand this study is of special interest for Western blotting where a 
protein is detected via a labelled antibody (Ab). On the other hand, the quantitative 
determination of different proteins in an organism, tissue or cell culture can be obtained 
i.e., differentially labelled proteins allow simultaneous detection using ICP-MS, thereby 
up and down regulation of different proteins can be studied at a given point of time.  
4.1 Introduction 
4.1.1 Indian Ink Staining  
For the quantification of proteins on membranes in the subnanogram and 
nanogram range sensitive dyes like aurodye, ferridye and Indian ink are commonly used 
among which Indian ink staining is a very sensitive and cheap staining method.97  
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Indian ink is made of carbon black which is believed to bind with proteins 
through its functional quinone groups.98 These activated carbon nanoparticles play a 
major role in purification of water, food, pharmaceuticals and fine chemicals because of 
their high surface area and porosity. Apart from binding with proteins it also contains 
other elements in high concentrations. Although these elements are not so abundant they 
are present in stable amounts. A screening of these elements by ICP-MS can help to find 
the abundant and stable element in the carbon black. Carbon black is essentially 
elemental carbon in the form of fine particles having a semi-graphitic structure in the 
form of randomly oriented condensed rings loosely held and with open edges having 
unsatisfied carbon bonds providing sites for chemical activity. Along with these sites 
there are also hydroxyl and carboxyl ions and sulphur in functional groups and small 
quantities of condensed hydrocarbons are adsorbed on the surface of the carbon black.99 
Its use is explored by Lönnberg et al.100 who estimated the antibody concentration in the 
attomole range. They used the combination of carbon black as the label with flatbed 
scanner as the quantitative test system. Originally Indian ink was used in our work for 
visualisation of protein spots but then it was found that, it contains lithium as a catalyst in 
high amounts which can be used for LA-ICP-MS detection as well.  
4.1.2 Labelling of Proteins and Antibodies 
Labelling of proteins is used in proteomics and in metallomics for quantitative 
detection of proteins. It is the joining of bio-molecules to proteins or peptides by 
chemical, metabolic or enzymatic means. It is also termed as heteroatom-tagged 
proteomics. In recent times this was discussed in various articles, e.g. of Prange et al.,9 
Sanz-Medel,101 Baranov et al.102 etc.  
Until recent times MALDI-TOF and ESI-MS methods are the only methods used 
extensively in quantitative proteomics research and their role in this field is 
unquestionable. Methods such as SILAC103 and isotopic104 coded tags are used for 
quantitative proteomics in combination with organic MS. The stable isotopes 13C, 15N, 2H 
or 18O are used as internal standards for the above methods either before or after 
enzymatic digestion. After separation by liquid chromatography methods, quantification 
of proteins can be obtained from MS via the mass differences between the heavy and 
 110
Chapter 4 
 
light samples. As an alternative method for quantification, element coding tags105 are 
used together with organic MS. Since there are many monoisotopic lanthanides 
multiplexing of samples is highly possible which results in simultaneous detection of 
proteins. They are highly stable and show all a similar chemistry, so that a method once 
developed for one lanthanide element might be applicable for the others as well. 
As a complementary tool, ICP-MS has already been used for quantitative 
detection of proteins via the bi-functional chelating agents. The advantage of using ICP-
MS is that compound independent calibration methods can be performed for 
quantification of proteins because of its matrix independency. The sensitivity of the 
method can be improved when lanthanides are used because there are no interferences 
which is not the case for the naturally tagged proteins. For analytical detection of proteins 
the most common use of chelating compounds was the combination with radioactive 
tracers. Among the large variety of chelating compounds, McDevitt et al.45 had compared 
the yield of binding 225Ac in chelates based on DTPA, 1,4,8,11-tetraazacyclotetradecane-
1,4,8,11-tetraacetic acid (TETA), 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic 
acid, 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrapropionic acid (DOTPA), 1,4,8,11-
tetraazacyclotetradecane-1,4,8,11-tetrapropionic acid (TETPA), 1,4,7,10-
tetraazacyclododecane-1,4,7,10-tetramethylene-phosphonic acid (DOTMP), α-(5-
isothiocyanato-2-methoxyphenyl)-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic 
acid (MeO-DOTA-NCS) and p-SCN-Bn-DOTA. In a second step they assessed also the 
yield in binding the chelate to an Immunoglobulin G antibody (IgG). Among the chelates 
investigated, only the compounds based on 1,4,7,10-tetraazacyclododecane-1,4,7,10-
tetraacetic acid showed the highest labelling yield of the antibody and the best recovery 
during sample preparation. The use of N-hydroxysulfosuccinimide as linker attached to 
this compound was described by Lewis et al.106 This group used an excess of 100 molar 
volumes relative to the protein of interest and performed labelling with radioactive 
isotopes (111In and 90Y). After optimisation of the labelling procedure the maximal 
number of labels detected per protein molecule was not more than 3.8 for an antibody and 
about 9 for c-cytochrome, demonstrating that this value strongly depends on the protein 
of interest. In all cases this value was much below the theoretical number of binding sites. 
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The lanthanide ions can be replaced for radioactive metals for conjugation with 
the DOTA-protein complex so that the proteins can be detected via ICP-MS. Labelling 
using chelating compound based on 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic 
acid has recently been studied by Linscheid and co-workers. They demonstrated that they 
can reach attomol limits of detection using ICP-MS in a flow injection mode.107  
4.2 Experimental 
4.2.1 Gel Electrophoresis 
 Vertical electrophoresis was performed as explained in section 2.2.3.1 using a 
discontinuous buffer system with 10% separating and 6% stacking gels. 1 to 2 µg of 
protein (unless and otherwise mentioned) from the stock with a final volume of 20 µl 
(10 µl sample + 10 µl sample buffer) was applied for vertical separation 
experiements. For the multielemental labelling experiment, horizontal electrophoresis 
with 10% precast gels was used for separating 1-2 µg of proteins (as explained in 
section 2.2.3.2). Nitrocellulose membrane was used for the transfer of proteins from 
gels for all experiment and the semidry blotting procedures was performed as 
explained in section 2.2.5. 
 Proteins, Bovine Serum Albumin (66 kDa), CYP1A1 and CYP2C11 antibody 
(150 kDa) were labelled and the stock solutions with a final concentration of 1 mg/ml 
were prepared in carbonate-bicarbonate buffer. The final molar amounts of BSA and 
antibody were 15.1 and 6.6 nmol/ml respectively. 
4.2.2 Labelling Protocol for DOTA and DTPA 
The protocol was explained in the section 2.2.9.1 for labelling of BSA and 
antibody and section 2.2.9.2 for labelling of BSA.  
4.2.3 Laser Ablation ICP-MS Optimisation 
The optimisation of LA-ICP-MS and experiments were carried out as explained in 
sections 2.2.12 and 3.2.4. For the laser ablation and the ICP-MS measurements, the 
instrumental parameters were optimised and are shown in Table 4-1. The absolute 
intensities obtained for different blot membranes could only be compared when they were 
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measured with similar optimisation conditions or with the help of internal standard. 13C+ 
measured at medium mass resolution was used for control of experimental conditions. 
For this purpose, single line scans were performed at the edges of the blot membranes 
where there was no electrophoretic spot. Unlike most of the experiments in the chapter 3, 
a microprocessor control unit was used here for positioning the laser cell and the whole 
procedure of ablating a full membrane was automated including the triggering of laser.  
Table 4-1: Instrumental parameters. 
Laser ablation system  
Laser energy  
Make-up gas flow rate (Ar)  
Carrier gas flow rate (He)  
Repetition rate, shots per second 
Translation velocity  
Distance between line scans  
Crater diameter 
3 mJ 
1 l/min 
1.6 l/min 
15 Hz 
1 mm/s 
1 mm 
~500 µm 
ICP-MS system ELEMENT 2 
Incident power  
Cooling gas flow rate  
Auxiliary gas flow rate  
Ni skimmer cone diameter  
Ni sampler cone diameter  
Isotopes measured  
Resolution setting 
1025 W 
16 l/min 
1.3 l/min 
1 mm 
0.7 mm 
153Eu+, 165Ho+, 159Tb+, 13C+ 
400 (LR) 
4,000 (MR) 
4.3 Results and Discussions 
4.3.1 Indian Ink Staining 
Different ways of screening of proteins using LA-ICP-MS and gel electrophoresis 
had been explored. The common method used in biochemistry for detecting and 
quantifying proteins in membranes is staining. Indian ink is one of the sensitive staining 
methods and can be used as alternative method for detection of proteins after separation 
 113
Chapter 4 
 
whereas labelling can be applied even before protein separation step. Here it was tried for 
the first time in combination with the LA-ICP-MS to determine the total protein 
quantification from the blot membranes. In order to be able to detect them with the ICP-
MS initially they needed to be screened for elements present in the protein spots after 
Indian ink staining. For that 7 µl of dual colour marker was used and subjected to SDS-
PAGE separations and blotting. After that it was Indian ink stained as explained in the 
experimental section. The electrophoretic spots were line scanned initially with the 
following elements at low resolution: 60Ni+, 63Cu+, 64Zn+ and 7Li+. Only lithium could be 
found at higher levels and each single band of the marker can clearly be seen from Figure 
4.1. In the production process of carbon black (and subsequently Indian ink) the element 
might have been used which binds to carbon black. 
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Figure 4.1: LA-ICP-MS surface plot showing the 7Li+ intensities. Sample: Dual colour marker Indian 
ink stained, subjected to SDS-PAGE, blotting and measured by LA-ICP-MS.  
In order to determine the working linear range for lithium detection by LA-ICP-
MS, in the next experiment a blot was prepared with the standard phosphorus proteins β-
casein and ovalbumin. Figure 4.2a shows the Indian ink stained blot before laser ablation 
and Figure 4.2b shows the corresponding lithium intensities after laser ablation of the 
same blot. The concentrations of proteins used (Figure 4.2a and b) were 1) 500 pmol β-
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casein, 2) 50 pmol β-casein, 3) 5 pmol β-casein and 4) 22 pmol ovalbumin. The resulted 
intensities showed a similar pattern for both the stained blot and the laser ablated lithium 
intensity blot. For two different proteins the obtained lithium intensities correspond to 
their binding capacity to the carbon black. In the next step all 3 spots of the protein β-
casein were integrated to obtain the calibration blot which is shown in Figure 4.3. A good 
linear relationship (R2 = 0.9994) was obtained with the applied amount of protein. The 
integrated intensity was also obtained for the ovalbumin sample and with the help of the 
above relation the calculated amount was about 25 pmol which is closer to the applied 
amount. This method is thus suited as one of the methods for the total protein 
quantification using LA-ICP-MS. Nevertheless more proteins have to be used in order to 
validate this method of detection. Multiplexing with simultaneous different protein 
detection is not possible with this staining method; alternatively with the help of the 
calibration graph an unknown protein can be estimated. From the ovalbumin spot in 
Figure 4.2b the detection limit of this method was calculated and it was estimated to be 
approximately 95 fmol. 
                                       a) 
1     2    3   4
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Figure 4.2: (a) Indian ink stained blot after SDS-PAGE and blotting. (b) 7Li+ intensity distribution 
measured by LA-ICP-MS of the same blot. Samples β-casein: (1) 500 pmol, (2) 50 pmol, (3) 5 pmol β-
casein and (4) 22 pmol ovalbumin. 
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Figure 4.3: Calibration graph obtained after integrating the lanes 1, 2, 3 (β-casein (1) 500 pmol, (2) 
50 pmol, and (3) 5 pmol) from Figure 4.2. 
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Figure 4.4: (a) 7Li+ images of dotting experiment measured by LA-ICP-MS after Indian ink staining. 
Samples: BSA with different concentrations (1) 15.15 pmol, (2) 7.58 pmol, (3) 3.79 pmol, (4) 1.52 
pmol, (5) 0.76 pmol, (b) corresponding calibration graph. 
 
As an alternative to the calibration using PAGE separations, dot blotting was used 
to compare and quantify the protein separated using electrophoresis. For the dotting 
experiment 2 µl of different concentrations of BSA ranging from 0.76 to 15.15 pmol 
were dotted directly onto the NC membranes and Indian ink stained overnight. They were 
then laser ablated after drying. Images of the lithium intensity distribution measured are 
shown in Figure 4.4a. It can be seen that protein spots are inhomogeneously distributed 
on the membrane as was also seen in the dotting experiment in chapter 3. The integration 
of the whole spot was performed and it showed good linearity (R2 = 0.9955). The SDS-
PAGE separated protein ovalbumin from lane 4 of Figure 4.2a was taken as the test 
protein and it was quantified using the calibration function. About 17 pmol of protein was 
quantified which was slightly lower than the applied amount (22 pmol). This is 
comparable to the dotting experiment explained for the phosphorus quantification in 
section 3.3.2, where higher amounts of protein were used. There the sensitivities for the 
dotting experiments were higher. Here it was also higher, in spite of lower amounts and 
different proteins used for the calibration. But here it was also observed that the estimated 
amount was closer to the applied amount for the PAGE separated calibration method 
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where protein was loaded together with the sample. Hence both methods are applicable 
for quantifying total proteins in a given sample.  
4.3.2 Labelling of Proteins Using DOTA 
The optimisation of labelling conditions using chelating compounds based on 
1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid with SCN as linker was already 
described in the literature but are by far not optimised for ICP-MS detection.45,106 All the 
parameters like pH, reaction time, temperature etc. were taken into consideration for the 
optimisation procedure except the sequence of the reaction steps. Additionally stable 
isotopes were used for labelling rather than radioactive, proteins were first reacted with 
the chelate and then the element was introduced to the complex. Initially, molar ratios of 
protein to the DOTA compound and the resulting complex with the element were 
optimised using LA-ICP-MS followed by temperature, reaction time and pH of the 
reactions. The integrated intensities of labelled proteins were used to compare and draw 
the conclusions and it was not possible to quantify the intermediate product between the 
DOTA and the protein. The experiments involving the optimisation of molar ratios 
between DOTA, protein and lanthanides were also compared by in-solution 
measurements using ICP-MS.  
4.3.2.1 Optimisation of BSA to DOTA Ratio (Step 1) 
The initial concentration of the protein amount used was 6 nmol/ml. In addition 
different amounts of DOTA were mixed. The reaction was accomplished in the 
carbonate-bicarbonate buffer (pH = 9.0). Initial experiment was done at RT for 24 h. As 
lanthanide europium (Eu) was selected and the mixture was incubated for 30 min at 37 
°C in the acetate buffer (pH = 7.0 - 7.5). The molar ratio of DOTA to europium was 
maintained at 1:10. Figure 4.5 shows the results from the ICP-MS in-solution 
measurement. From the results it could be observed that with 20 fold molar excess of 
DOTA, not even a single label of europium to BSA could be achieved. For 1:30 and 1:80 
molar ratios of DOTA to BSA, the approximate europium label to BSA achieved was 1. 
Only with a surplus of the DOTA to the protein from 1 to 100 a drastic rise of the 
relationship was observed. This high value of 7.6 can however possibly be attributed to 
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the free europium that was still present in the mixture. A very high quantity of europium 
solution had to be used, in order to receive the desired tenfold surplus of europium. It is 
possible that the surplus free europium with the cleaning steps cannot be removed again.  
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Figure 4.5: Influence of DOTA concentration on the stoichiometric relationship between BSA and 
europium.  
LA-ICP-MS was performed with the samples having different molar ratios 
between protein and DOTA (n(BSA):n(DOTA) = 1:20 to 1:100). From the in-solution 
measurement it was observed that there was high amount of europium labels present in 
the mixture where a molar ratio of 1:100 of BSA to DOTA was present. A similar 
phenomenon was observed from the surface plot of the LA-ICP-MS results as it is shown 
in Figure 4.6. In lane 3 in the figure there is a high background of europium ions which 
comes from the sample and at the end of the migration very intense signals could be 
spotted. These are the free charged europium ions which migrated together with the 
sample buffer and could not be removed by the purification steps. At the same time in 
lane 2 with lower molar ratio used (n(BSA):n(DOTA)-1:40) there is also background but 
at levels of about one magnitude lower than lane 3. From the integrated intensities, it 
could be seen that with increasing molar ratios of DOTA to BSA from 20 to 40 the 
resulted intensities showed a linear increase and it was almost increased twice for 1:100 
molar ratio than 1:40. From the experiment it is clear that the intensity is directly related 
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to excess of DOTA used, but has to be paid by higher background levels. Thus high 
DOTA amount is desirable to get more intensity and labels but for that more purification 
steps must be used. In the lane 1 and 2 signals could be detected for samples where there 
was actually no europium used. There was much of free europium ions present in the 
wells of the neighbour lane which probably entered into this lane. Another unexplainable 
result is that for 1:80 molar ratio of BSA to DOTA less signals could be seen which 
possibly occurred erroneously. The LOD of the method was 0.2 pmol calculated from 
sample at lane 3 which had a sensitivity of 2.09 ⋅ 105 cps/pmol for the 1 µg of protein that 
was applied.  
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Figure 4.6: LA-ICP-MS surface plot showing the 153Eu+ intensities with lanes corresponding to 
(n(BSA):n(DOTA):n(Eu)): (1) 1:40:0, (2) 1:20:0, (3) 1:100:1,000, (4) 1:80:800 (5) 1:40:400 (6) 
1:30:300 and (7) 1:20:200.  
4.3.2.2 Optimisation of DOTA to Europium Ratio (Step 2) 
The molar ratio of BSA to DOTA was maintained at 1:40 which showed the best 
signal to background ratio. All the other experimental conditions for the first reaction step 
between BSA and DOTA were followed as explained in the previous section. In the next 
step 3 samples were prepared with the chelated product with three different quantities of 
europium. The molar ratios of DOTA to europium were maintained at 1:2, 1:5 and 1:10. 
The reaction time for the lanthanide conjugation was 30 min at 37 °C in acetate buffer 
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(pH = 7.0 - 7.5). The purified samples were measured by means of ICP-MS. From Figure 
4.7 it can be seen that for a complete reaction of europium with DOTA in order to 
achieve a single label, at least a five fold surplus of europium was necessary. A higher 
amount of europium is recommended in order to achieve more labels which also depend 
on the protein used and the DOTA label in the step 1. A label of approximately 1.8 could 
be achieved for a DOTA to europium molar ratio of 1:10. It should also be noted that 
there was surplus of europium in the final solution which affected mainly the in-solution 
measurement and it could be removed although not completely by using PD10 columns.  
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Figure 4.7: Influence of the lanthanide concentration on the stoichiometric relationship between 
europium and BSA.  
LA-ICP-MS experiments were done by changing only the molar ratios of 
europium to DOTA in the second step. The resulting surface plot is shown in Figure 4.8 
and the protein spots were integrated to arrive at the cumulative intensities (lane 1: 5.48 ⋅ 
106 cps, lane 2: 9.51 ⋅ 106 cps, lane 3: 7.77 ⋅ 106 cps). The spikes in lane 1 were neglected 
for calculation. As it was shown with the in-solution experiments, a similar effect on the 
resulting labelling efficiency was confirmed with the LA-ICP-MS measurement. From 
the integrated data almost similar intensities could be achieved for the 3 samples 
according to the europium amount except the sample with DOTA to europium molar 
ratio of 1:2 which is slightly lower. Here it is confirmed that the added quantity of 
lanthanide ions was not the crucial factor for the success of the labelling procedure. The 
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strongest signal intensity under the conditions specified in Figure 4.8 was achieved for 
lane 2 where a DOTA to europium molar ratio of 1:5 was used although only little higher 
than 1:10. The reaction time used in the step 1 reaction was longer to achieve this 
labelling degree. This step was finally dependent on the first reaction between the protein 
and DOTA and the number of lysine and arginine residues of the protein (BSA has 59 
lysine and 23 arginine residues). A molar excess of 10 times of europium to DOTA was 
further used to achieve the required saturation of DOTA. 
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Figure 4.8: LA-ICP-MS surface plot showing the 153Eu+ intensities from the labelled BSA according 
to the molar ratios n(BSA):n(DOTA):n(Eu) (1) 1:40:80, (2) 1:40:200 and (3) 1:40:400 with europium 
reaction at 37°C, 30 min, pH 7-7.5. 
4.3.2.3 Optimisation of Temperature and Time  
Usually 1 or 2 h of reaction time between the protein and the chelating agent and 
a very short time of 30 min for the lanthanide labelling are adequate for the complete 
conjugation. As the labelling efficiency depends mainly on the molar ratio of the protein 
and chelating agent, longer reaction times are acceptable and need to be proved whether 
they improve the result. Also temperature needs to be optimised which can influence the 
reactions in accomplishing the required labels. 
A molar ratio of 1:40:400 corresponding to n(BSA):n(DOTA):n(Eu) was used. 
The reaction was accomplished in the carbonate-bicarbonate buffer (pH = 9.0). Initial 
experiments were done at RT and the reaction time chosen were varied between 80 min 
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to 24 h. The step 2 reaction was performed for 30 min at 37 °C in the acetate buffer (pH = 
7.0 - 7.5). From the results of the ICP-MS in-solution experiments, for an 80 min reaction 
time only a small fraction of the BSA was labelled and only after 16 h a clear rise of the 
europium-labelled to BSA was recognized. After 24 h signals were declining which led to 
the conclusion that the protein was not only denatured after 24 h, but also already partly 
destroyed, or that the isothiocyanate group of DOTA was separated again from the 
protein. In addition to the above experiment a temperature of 4 °C was also examined for 
the step 1 reaction. But the labelling efficiency was below 1, possibly because at 4 °C 
reaction between DOTA and the amino groups of the protein hardly took place. 
 LA-ICP-MS experiment was performed on the samples where the reaction time 
used was between 1 and 24 h for the step 1 reaction. Figure 4.9 shows the fact that signals 
could be recognizable for all the reaction times but the highest for 16 h. Although fewer 
labels shown for the other reaction times used with the in-solution measurements, it was 
still recognizable with LA-ICP-MS. The spots were integrated and the intensities for 24, 
16, 4, 3, 2 and 1 h were found to be 6.22 ⋅ 106 cps, 7.13 ⋅ 106 cps, 5.9 ⋅ 106 cps, 4.55 ⋅ 106 
cps, 3.89 ⋅ 106 cps and 3.76 ⋅ 106 cps respectively. It shows an increase from 2 to 16 h 
reaction time with a little difference between 1 and 2 h. The difference between 1 and 16 
h reaction time was about 2 times, but for the in-solution experiments high amounts of 
labels could be seen which also might have arrived from the free europium ions which 
were still present after washing steps. With the TXRF measurements also lower labels 
were obtained when lower reaction times were used.108 The highest label of 4.1 was 
obtained for the 16 h reaction time for step 1. From the experiment it could be concluded 
that reaction time for BSA for which maximum labelling efficiency could be achieved 
should be around 16 h. This can be different for other proteins considering the binding 
sites of the DOTA to the protein i.e. the number of accessible amino groups. In case of 
antibodies discussed in the later section 4.3.2.5 and chapter 5 less reaction time was used, 
as reaction times can hinder their specificity with their respective antigen.  
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Figure 4.9: LA-ICP-MS surface plot showing the 153Eu+ intensities with the molar ratio of 
n(BSA):n(DOTA):n(Eu) maintained at 1:40:400. Reaction time used for samples in lane 1 at 16 h (2) 
4 h, (3) 3 h, (4) 2 h and (5) 1 h. Integrated intensities obtained from the respective spots: (1) 6.22 ⋅ 106 
cps, (2) 7.13 ⋅ 106 cps, (3) 5.9 ⋅ 106 cps, (4) 4.55 ⋅ 106 cps, (5) 3.89 ⋅ 106 cps and (6) 3.76 ⋅ 106 cps. 
 
The reaction times of 15, 30, 45 and 60 min were tested for the step 2 reaction 
between the BSA-DOTA complex and europium. The molar ratio of BSA to DOTA to 
europium was maintained at 1:40:400. The temperature used for the step 2 reaction was 
maintained at 37 °C and 58 °C (15 and 30 min reaction time only). It can be seen from 
the surface plot and the corresponding integrated intensities (Figure 4.10a and b) that 
there was an increase in the final labels achieved for the protein at reaction time of 60 
min at 37 °C. But at the same time background increased and high intense signals could 
be seen at the end of the migration distance. There was an increase in the counts from 15 
to 30 min reaction time and an unexpected decrease in integrated counts at 45 min. When 
the temperature of the reaction increased to 58 °C there was a decrease in the obtained 
intensities by about half for 15 min reaction time. But for 30 min reaction time at 58 °C it 
increased but with higher background and intense signals at the end of the migration spot. 
The reaction between the lanthanide and the DOTA was faster and lower reaction times 
were sufficient for conjugation reactions to go to completion. Longer reaction times were 
suitable but with higher background and the degree of labelling was affected by higher 
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temperatures. The more reactive the DOTA, the shorter the reaction time and a reaction 
time of 30 min at 37 °C was suitable for the reaction between lanthanide and protein 
chelate complex. 
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Figure 4.10: (a) LA-ICP-MS surface plot showing the 153Eu+ intensities with the molar ratio of 
n(BSA):n(DOTA):n(Eu) maintained at 1:40:400. Europium reaction time used for samples in lane 1 
at 60 min (2) 45 min, (3) 30 min and (4) 15 min performed at 37 °C, (5) 15 min and (6) 30 min at 58 
°C. (b) Integrated intensities obtained from the respective spots as a function of europium reaction 
time. 
 125
Chapter 4 
 
4.3.2.4 Buffer Conditions 
In the literature many different buffer systems are used for labelling of antibodies 
and proteins.45 But it depends on the type of chelating agent used. The manufacturer of 
DOTA recommends carbonate-bicarbonate buffer for the reaction between proteins and 
the chelating agent. All the experiments explained in the above sections were performed 
with this buffer. There was no problem in using this buffer for the LA-ICP-MS 
measurements. In addition other buffers were also investigated to see if they are suitable. 
It should be noted that the amino group of the commonly used buffer can likewise react 
with the active group of the DOTA. Therefore trichloroethylene HCl is used for stopping 
the reaction. For the step 1 reaction different buffers are applicable, depending mainly on 
the type of chelating agent. Theoretically only the terminal amino group of the protein 
should react with the DOTA at a pH value of 7.5. In this range at the best phosphate 
buffers are used. Citrate buffers are less suitable since they are complexing agents and 
also could bind to the lanthanide, if the intermediate product is not properly buffer 
exchanged. This can again lead to a high background in the LA-ICP-MS. At a pH value 
of 9 and more highly above all the lysine groups of the protein are labelled since at this 
pH lysine amines are good nucleophiles. Ammonium acetate was used at pH 7.0 to 7.5 as 
buffer during the step 2 reaction. Different buffer systems were tested for the first step. 
HEPES buffer showed no signal, Citrate phosphate buffer was tested at pH 7.7 and 8.6 
and carbonate-bicarbonate buffer at pH 9.0. A molar ratio of 1:40:400 corresponding to 
n(BSA):n(DOTA):n(Eu) was used. The surface plots of the europium intensities from 
europium-labelled BSA for both carbonate-bicarbonate and citrate phosphate buffers are 
shown in Figure 4.11a and b, respectively. It can be seen from lane 1 of Figure 4.11b, that 
there was a high background possibly due to the complex building of the citrate buffer. 
Additionally in step 2 it could react with the lanthanide. Therefore more purification and 
buffer changing steps between step 1 and step 2 were needed in this case. From Figure 
4.11b it also can be seen that when the pH decreased there was loss in the signal intensity 
and therefore in the labelling efficiency. But with carbonate-bicarbonate buffer there was 
lower background and comparable intensities could be obtained. So as previously 
performed it was further used for the step 1 reaction at pH 9. 
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Figure 4.11: 153Eu+ signals measured by LA-ICP-MS on a blot membrane; a) carbonate-bicarbonate 
buffer at pH 9 and b) citrate phosphate buffer used for the reaction between DOTA and the BSA, 
lane 1: pH 8.6 and lane 2: pH 7.7. (n(BSA):n(DOTA):n(Eu)-1:40:400). 
4.3.2.5 Labelling of Antibody CYP1A1  
In the next step it was investigated if the conditions optimised for proteins can 
also be applied for antibodies. Such an approach can be used as basis for multielemental 
labelling of antibody for detection of multiple antigen samples which will be explained in 
detail in chapter 5. Since an antibody should maintain its antigen specificity, a lower 
molar ratio of DOTA to antibody was initially used and checked whether this was enough 
to get a similar sensitivity achieved for experiments involving BSA. CYP1A1 was used 
as the antibody and it will be explained in detail in chapter 5. The reaction conditions 
such as buffer and pH from the above mentioned steps were used; the reaction time for 
the step 1 reaction was maintained for 80 min as longer reaction times could influence the 
antigen specificity and step 2 reaction was performed similar to section 4.3.2.2; the molar 
ratio of n(Ab):n(DOTA):n(Eu) was maintained at 1:20:200. The resulting LA-ICP-MS 
surface plot for the 8 pmol antibody sample is shown in Figure 4.12. Two bands 
corresponding to heavy and light chains were visible because of the denaturing conditions 
used during the SDS-PAGE. The sensitivity was higher in the heavy chain (around 50 
kDa) when compared to the light chain (around 20 kDa) which relied on the amount of 
protein at each spot. The sensitivity of the method with respect to the heavy chain of the 
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antibody was found to be 2.9 ⋅ 106 cps/pmol which was higher than those of the 
respective BSA sample used in section 4.3.2.1. Thus a molar ratio of 1:20 for antibody to 
DOTA was enough to achieve better sensitivity and loading more of chelating agent 
could lead to the antigen unspecificity. In addition a LOD of about 30 fmol could be 
achieved for the antibody which was better than BSA prepared with similar reaction 
conditions. 
For the quantification of antigen samples (which will be explained in detail in 
chapter 5) using these antibodies, a calibration was needed with the labelled antibody. 
Therefore an experiment was performed by labelling antibody CYP2C11 with holmium 
using the conditions explained in section 4.2.2. Holmium was chosen to compare the 
sensitivity of the method with other lanthanides. A calibration was performed with four 
different amounts of one and the same labelled antibody. 4-10 pmol of antibody were 
loaded for separation onto the gel and the resulting LA-ICP-MS surface plot is shown in 
Figure 4.13. The observed intensities were proportional to the loaded amounts. Here 
approximately 8 to 9 line scans representing each electrophoretic lane for each amount 
were added to obtain a single electropherogram. Two peaks were seen, one high and 
another low molecular weight as it was the case also for the europium-labelled antibody. 
The protein spots were integrated, and is shown in Figure 4.14 as a function of scanning 
distance. Even a low amount of 4 pmol of antibody gave a signal above the blank value. 
A sensitivity of 9.65 ⋅ 104 cps/pmol could be obtained with respect to the heavy chain 
which was lower but after normalization with the signals obtained for the internal 
standard 13C+ in comparison to measurements measured during the same time, the 
resulted sensitivity should be almost two orders of magnitudes higher which is 
comparable to europium-labelled antibody. 
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Figure 4.12: 153Eu+ signals measured by LA-ICP-MS on a blot membrane; samples: 8 pmol 
europium-labelled antibody CYP1A1 with DOTA reaction at 80 min, RT, pH 9.0 and europium 
reaction at 37 °C, 30 min, pH 7-7.5.  
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Figure 4.13: 165Ho+ signals measured by LA-ICP-MS on a blot membrane; Samples: holmium-
labelled antibody CYP2C11 with DOTA reaction at 80 min, RT, pH 9.0 and europium reaction at 37 
°C, 30 min, pH 7-7.5. 
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Figure 4.14: Sum of intensities of single laser line scans per each electrophoretic lane; black line: 10 
pmol; red line: 8 pmol; blue line: 6 pmol; green line: 4 pmol were loaded onto a gel. Labelling 
conditions: 80 min at RT with a molar ratio of 1:20:200 (n(Ab):n(DOTA):n(Ho)).  
4.3.3 Comparison of DTPA with DOTA 
The SCN-DOTA is quite expensive and therefore a much cheaper alternative 
using chelating complex DTPA was also investigated. A detailed study of the optimising 
procedures is already available in literature55 but not with respect to ICP-MS based 
detection. In most cases it has been used for experiments with radioactive measurements. 
For both, DTPA and DOTA experiments, BSA was chosen as the model protein for 
comparison. Two types of molar ratios between BSA and chelating agents, DTPA and 
DOTA were used. The molar ratio for BSA to DTPA was chosen to be 1:2 and 1:4 but 
for DOTA it was 1:10 and 1:20. In case of DTPA the molar excess europium used was 
only 4 times higher than the BSA molar amount. But for DOTA it was used 100 and 200 
times higher as explained before in the section 4.3.2. After that 1 µg of protein with 2 
different ratios from each set of samples was used for separation and the surface plot is 
shown in Figure 4.15 and Figure 4.16 for DTPA and DOTA experiments, respectively.  
When DTPA was used as the chelating agent 2 bands were visible where it was 
expected to have only one around 66 kDa. In all previous experiments with BSA and 
DOTA and also as shown here in Figure 4.16 only one protein band is visible when 
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DOTA was used. As the two experiments were done on the same blot the intensities can 
be compared. And that the integrated intensities were approximately one order of 
magnitude higher in case of DTPA labelled protein than DOTA when taken into 
consideration only one band at 66 kDa (Table 4-2). Also the sensitivity was one order of 
magnitude higher and LODs were better in case of DTPA. The LODs for labelling 
experiments using DOTA were higher probably due to the lower ratios of the chelating 
agent to protein used and that they are not sufficiently linked. Despite the better 
sensitivity and detection limits, DTPA showed 2 bands possibly due to the dimer 
formation by linking 2 protein molecules. This chelator needs to be further studied in 
detail as it showed good detection levels. 
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Figure 4.15: 153Eu+ intensities measured by LA-ICP-MS; samples: labelled BSA lane 1: molar ratio of 
n(BSA):n(DTPA) was maintained at 1:2 and in lane 2 at 1:4. For both samples in the step 2 reaction 
the ratio of europium to BSA was maintained at 1:4. 
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Figure 4.16: 153Eu+ intensities measured by LA-ICP-MS; samples: labelled BSA lane 1: molar ratio of 
n(BSA):n(DOTA) was maintained at 1:10 and in lane 2 at 1:20. For both samples in the step 2 
reaction the molar ratio of europium to DOTA was maintained at 1:10. 
 
Table 4-2: Sensitivity and LOD of the method with respect to europium-labelled BSA via DTPA and 
DOTA. 
 
 DTPA DOTA 
Parameters Lane 1 Lane 2 Lane 1 Lane 2 
Peak height (cps) 4.07 ⋅ 106 1.84 ⋅ 106 1.85 ⋅ 105 2.78 ⋅ 105 
Sensitivity (cps/pmol) 2.72 ⋅ 105 1.23 ⋅ 105 1.23 ⋅ 104 1.86 ⋅ 104 
Integrated intensity 
(cps) 
8.8 ⋅ 105 
(low mw) 
7.3 ⋅ 106 
3.37 ⋅ 105 
(low mw) 
2.96 ⋅ 106 2.1 ⋅ 105 3.1 ⋅ 105 
LOD (fmol) 15 37 300 150 
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4.4 Concluding Remarks 
In this chapter, 2 different labelling methods and one staining method were 
investigated for the quantification of proteins and antibodies.  
 Indian ink staining was performed overnight on blots. The screenings of different 
elements using LA-ICP-MS were performed and only lithium was detected at high levels. 
Two types of calibration methods were studied using dotting and PAGE separated protein 
standards and as test sample ovalbumin was quantified. The value obtained was close to 
the theoretical applied on the blots for PAGE separated quantification method and 
slightly lower when dot blotting was used. Indian ink stained blots can be used for the 
total protein quantification. The LOD of this method was estimated to be approximately 
95 fmol for lithium in proteins.  
 The next two methods were based on the bioconjugation chemistry. The one using 
DTPA dianhydride showed good sensitivities even with lower ratios between protein and 
the chelating agent. But in the experiments performed always more than one band was 
detected for a single protein possibly due to the dimer formation of the protein molecules. 
Nevertheless labelling based on this chelator should be investigated in detail in future. 
The other chelating agent p-SCN-Bn-DOTA was used which specifically target 
amino groups of the proteins. The labelling conditions using this chelating agent were 
optimised here for multielemental detection of proteins. The procedure consists of 2 
parts: binding of the protein to the chelate (step 1) and reaction of the first step product 
with lanthanides (step 2). The results obtained from in-solution and LA-ICP-MS 
experiments show that reaction times have to be optimised for each protein separately. 
For BSA higher labelling efficiency could be seen when a longer reaction time of 16 h 
and RT were chosen between protein and DOTA in step 1. BSA was stable after this long 
reaction time and could be detected by LA-ICP-MS. The molar amount of DOTA should 
be used 40 times higher than those of the BSA to achieve a final labelling degree of 2. 
For the step 1 reaction carbonate-bicarbonate buffer at pH 9.0 was ideal when compared 
with the other buffer systems where high background could be seen. 
For the step 2 reactions 10 times higher amounts of lanthanide in relation to 
DOTA was enough for the complete saturation. The ideal temperature to achieve this was 
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37 °C, the reaction time was 30 min and the reaction was carried out in acetate buffer at 
pH 7.0 to 7.5.  
With higher molar ratios between DOTA and BSA, higher background could be 
seen with LA-ICP-MS experiments. This was largely due to the free lanthanide ions 
present in the sample. Better purification steps will be needed to avoid this 
contamination. Beyond 16 h reaction time between DOTA and BSA signals were 
declining probably due to denaturation of proteins. Since BSA has more binding sites it is 
expected to have more labels. But it also depends on the quaternary structure of the 
protein and the available amino groups for the linking. 
The same set of experimental conditions was also applied for two antibodies 
(CYP1A1 and CYP2C11). Both were labelled with europium and holmium 
simultaneously. The ratio between DOTA and protein in the step 1 reaction differed for 
the antibody where even with a 20 fold molar excess of DOTA to antibody similar 
sensitivities could be achieved. A reaction time of 80 min between antibody and DOTA 
was enough to have better signals than with BSA. Two bands were visible for both 
denatured antibodies from the surface plot which shows that both the heavy and light 
chains were labelled. Nevertheless higher labelling degree was seen for the heavy chain. 
The sensitivity obtained was higher for the europium-labelled antibody with respect to 
the heavy chain and the LOD was estimated to about 30 fmol whereas for the holmium-
labelled antibody it was about 40 fmol.  
In conclusion, a simple and optimised method was described for covalently 
attaching the chelator DOTA to proteins and antibodies and for labelling of the coupled 
proteins with the lanthanides. The antibody labelling experiments showed that the 
antibodies can be labelled and detected by the LA-ICP-MS method but after labelling 
their specificity for antigen has to be checked which will be shown in the next chapter. 
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Chapter 5 
LA-ICP-MS based Detection of Multiple Cytochromes P450 by 
Element-Labelled Monoclonal Antibodies  
The ICP-MS is a multielement detector but has been applied as single element 
detector in most of the previous applications. In this chapter multielement capabilities 
should be explored at hand of a selected application. The example chosen here was based 
on Cytochromes P450 (CYP) detection. CYPs are groups of enzymes which are 
structurally very similar and difficult to study simultaneously with standard biochemical 
methods. But very specific monoclonal antibodies were available for some of the 
enzymes and provided by PD. Dr. Roos. It is the idea of this investigation to use 
antibodies differentially labelled with different elements so that different proteins can be 
detected concomitantly. Two differentially labelled antibodies one with iodination and 
the other using DOTA will be investigated for the immunoblotting step for detection of 
the respective CYP enzymes on the blots. From these blots the different CYP enzymes 
will be semi-quantitatively detected using LA-ICP-MS. 
5.1 Cytochromes P450 
Cytochromes P450 belonging to the group of heme proteins are enzymes which 
are involved in a variety of metabolic and biosynthetic processes. The 450 in this name is 
attributed to the position of the Soret maximum in the absorption spectrum of the reduced 
Fe2+-CYP carbon monoxide complex at 450 nm.109 The human genome encodes about 60 
Cytochrome P450 proteins, but the number of known CYP enzymes exceeds 1,000 
considering also invertebrate, plant and bacterial enzymes. All CYP enzymes exhibit 
similarity in their structure and general mechanism of action; however, there are 
significant differences in the detailed function of individual enzymes as well as in the 
structures and properties of their active sites. 
In mammalian species including man, CYPs are the most important class of 
enzymes involved in the metabolism of xenobiotics and are, thus, part of the 
detoxification machinery of an organism. There are over 200,000 chemicals which are 
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metabolized by these CYPs. Their primary task is to introduce new functional groups into 
a molecule, thereby facilitating the subsequent work of phase II-enzymes which attach 
hydrophilic groups such as glutathione or sulphate to the CYP-derivatized xenobiotics. 
This concerted action of enzymes aims to increase the water-solubility of compounds to 
achieve their efficient excretion. 
5.1.1 Cytochromes P450 Enzymes 
There are approximately 20 CYP isoforms among the CYP 1, 2, 3 and 4 
subfamilies present which metabolise drugs. In humans, CYPs comprise about 57 
different enzymes within this enzyme superfamily.110 Roughly, a half of them recognise 
xenobiotic substrates. These xenobiotics metabolizing CYPs are membrane bound 
enzymes which are predominantly localized in the endoplasmic reticulum. The different 
CYP enzymes are structurally and in some cases also with respect to substrate specificity 
very similar so that distinction by electrophoretic behaviour, enzymatic reactivity and 
spectroscopic properties can be a problem, but highly specific structural features of 
individual CYP enzymes can be recognized by antibodies, in particular by monoclonal 
antibodies.110 However, cross-reactivities of antibodies recognizing more than one CYP 
enzyme occur frequently.111 
It is a great challenge to identify and quantify the numerous different Cytochrome 
P450 proteins of microsomal fractions. CYP profiles differ between species, between 
individuals, between tissues and as a function of age. Furthermore, the profiles are 
adaptively modulated by xenobiotics which may induce or suppress a set of CYP 
enzymes dependent on the compound.  
5.1.2 Expressions of Cytochromes P450 Enzymes 
CYP1A1 (enzyme no. 1 in subfamily A of family 1) is not present or found at low 
levels only in several tissues under normal conditions. The enzyme can be induced, 
however, via a receptor dependent process by certain xenobiotics, such as polycyclic 
aromatic hydrocarbons (PAH), dioxin and coplanar polychlorinated biphenyls 
(PCB).112,113 Polycyclic aromatic hydrocarbons are a group of over 200 different 
chemicals formed when coal, wood, gasoline, oil, tobacco or other organic materials are 
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burned. And humans are exposed to these chemicals in their day to day activity. These 
chemicals are identified to cause mammary cancer in rats and mice. It was reported that 
the PAH benzo[a]pyrene causes breast cancer in rats when given in high doses for a 
longer period of time. These chemicals are metabolized in the human body through CYP 
isozymes. So once exposed to these chemicals CYP isozymes are induced. As these 
PAHs are involved in causing various diseases particularly tumours it is important to 
study their levels in our body. Their impact on animals could be studied through their 
metabolizing enzyme levels and their expressions. It was shown that CYP1A1 expression 
increases upon oral PAH exposure in many tissues including small intestine, liver, 
kidney, lung and spleen of rats and minipigs114,115 enabling the respective tissues to 
metabolize just the inducing PAH compounds. This CYP1A1-dependent PAH 
metabolism leads to chemically reactive intermediates116 and is considered as one of the 
initial steps in chemically induced carcinogenesis by PAH.117,118 Induction of CYP1A1 
and of some further CYP enzymes (CYP1A2, CYP1B1, CYP2S1) is controlled by the 
aryl hydrocarbon receptor, a ligand activated transcription factor.119,120 Cigarette 
smoking, barbecue food and omeprazole are the main inducers of CYP1A1 enzyme. In 
association with further proteins, the receptor is primarily located in the cytoplasm. Upon 
ligand binding (PAH, dioxin), some proteins dissociate from the receptor complex which 
is subsequently translocated to the nucleus. Here, the aryl hydrocarbon receptor becomes 
active as transcription factor in association with the ARNT protein thereby initiating the 
transcription of the aforementioned CYP genes and other genes.121 In contrast to 
CYP1A1, the CYP isoenzyme CYP2E1 metabolizes smaller and also hydrophilic 
molecules. Among these are industrial bulk materials such as benzene, toluene, vinyl 
chloride and trichloroethylene.122 Further CYP2E1 substrates are ethanol and 
nitrosamines. As in the case of CYP1A1-dependent PAH metabolism, the latter are 
converted to chemically reactive compounds by CYP2E1.123 It is only mentioned that 
DNA-methylation in the CYP2E1 promoter region, ligand dependent mRNA and protein 
stabilization as well as protein kinase A-dependent phosphorylation of the CYP2E1 
protein play a role besides transcriptional regulation via cis-acting 
elements.110,124,125,126,127 CYP2E1 is also mainly induced by ethanol, chloral hydrate and 
isoniazid.128,129,130  
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Isoniazid is one of the safe drugs used to treat tuberculosis.131 As it is more and 
more used in the post HIV era, it also increases the adverse drug-drug interactions. 
Isoniazid is known to be involved in various drug-drug interactions including with 
phenytoin which decreases its release from humans as well as from animals. So an 
optimum dose of isoniazid is required for the tuberculosis treatment which involves less 
or no side effects. Isoniazid is known to be involved in the inhibition of various CYP 
isozymes, thereby makes the process difficult for metabolizing various other drugs which 
are co-administered together with isoniazid. In contrary it is also involved in the 
induction of various enzymes including CYP2E1. It is known that isoniazid is a weak 
noncompetitive inhibitor of CYP2E1.132 The isoform CYP2E1 was studied in detail in 
human and animal models after isoniazid administration and the inhibition and induction 
effects of this enzyme were studied in rat liver microsomes.  
5.2 Experimental 
5.2.1 Antigen and Monoclonal Antibodies 
The purified monoclonal antibodies and microsomal samples were provided by 
PD Dr. P. H. Roos from IfADo, Dortmund. They were isolated and purified as explained 
in the literature.133 
5.2.2 Protein Quantification 
The concentrations of proteins and antibodies were determined according to the 
method of Lowry explained in section 2.2.2.3 with bovine serum albumin as a standard. 
For quantification of antibodies, a Nanodrop instrument was used and the experiment was 
performed as explained in section 2.2.2.2.  
5.2.3 Antibody Labelling with Europium and DOTA 
The protocol was explained in the section 2.2.9.1 for labelling of the monoclonal 
CYP1A1 antibody with europium using 2-(4-isothiocyanatobenzyl)-1,4,7,10-
tetraazacyclododecane-1,4,7,10-tetraacetic acid. The molar ratio of 
n(Ab):n(DOTA):n(Eu) was maintained at 1:20:200.  
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5.2.4 Antibody Labelling with Iodine 
The method for iodination was very well described in the papers of Markwell,46 
Jakubowski49 and by the manufacturer of the Iodo-beads and therefore only a brief 
description follows here focusing on practical aspects.  
 Buffer 1 consisted of 0.1 M Tris (12.11 g/l) and with HCl optimised for a pH 
range from 6.5 to 7. The iodination buffer (buffer 2) consisted of 100 ml buffer 1 to 
which 0.01 M NaI (Merck, Darmstadt, German) equivalent to 0.15 g was added and 
stored in the refrigerator. Aliquots of 250 µl were used for the iodination procedure only. 
 On the day of use, for cleaning, the bead(s) were washed for 30 s in 500 µl of the 
buffer solution 1 in Eppendorf tubes and dried on filter paper. After this the beads were 
loaded into a new Eppendorf tube together with 250 µl of the iodination buffer 2. The 
manufacturer recommends applying up to 6 beads in a single reaction vessel, but this 
depends on the total amount of protein and buffer used and the protein itself. Incubation 
took place for 5 min usually at room temperature. The production of free iodine was 
observed by the change of the colourless solution to brown in less than 15 s. This part of 
the experiment should be performed in a fume hood due the presence of volatile iodine. 
In the next step a fixed amount of antibody of 500 µg (30 µl dual colour marker in case 
of iodination of marker) was dissolved in 250 µl of buffer 1 and added to the reaction 
vessel. The total reaction volume of 0.5 ml was always kept constant. If not mentioned 
otherwise the reaction was stopped after 4 min. Antibodies were always iodinated for not 
longer than 4 min in order not to loose the binding capability by oxidation of the binding 
sites. For stopping the reaction the solution was removed from the Iodo-bead. Each bead 
was used only once. In case of the dual colour protein weight standard the complete loss 
of all colours was observed shortly after starting the iodination procedure due to 
oxidation. 
5.2.5 Gel Electrophoresis and Blotting 
 Horizontal SDS-PAGE with 10% precast gels was used for separating proteins 
as explained in section 2.2.3.2 as gels of large size can be used. Nitrocellulose 
membrane was used for the transfer of proteins from gels for all experiments and the 
semidry blotting procedure was performed as explained in section 2.2.5. This was 
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followed by immunoblotting method as explained in section 2.2.7. The membrane 
was air-dried and then used for laser ablation.  
5.2.6 Luminescence-based Antibody Detection 
After blotting, the nitrocellulose sheets were incubated over night in PBS (9.5 
mM sodium phosphate buffer, pH 6.9, 137 mM NaCl, 2.7 mM KCl), 0.1% Tween 20, 
10% milk powder followed by 3 washing steps with PBS/0.1% Tween 20 for 10 min 
each. The blot membrane was then exposed for 1 h to the first antibody (anti-CYP1A1 or 
anti-CYP2E1) diluted in PBS at a concentration of 1 μg/ml. After 5 washing steps with 
PBS/0.1% Tween 20, incubation with the peroxidase coupled secondary goat anti-mouse 
IgG was performed for 90 min. Non-bound antibodies were removed by 5 washing steps 
with PBS/0.1% Tween 20 (10 min each).  
5.2.7  Laser Ablation ICP-MS Optimisation 
The optimisation of LA-ICP-MS and measurements were carried out as explained 
in section 2.2.12 and 3.2.4. The isotopes 53Eu+ and 127I+ were measured at low resolution 
mode and 13C+ was measured at medium mass resolution. As before 13C+ measured at 
medium mass resolution was used for control of experimental conditions. For the laser 
ablation and the ICP-MS measurements, the instrumental parameters were optimised and 
are shown in Table 5-1. 
The antibody-treated nitrocellulose blot membranes were rastered and measured 
simultaneously in a single run using the updated high electric scan speed system as 
explained in section 4.2.3. 
Table 5-1: Instrumental parameters. 
Laser ablation system  
Laser energy  
Make-up gas flow rate (Ar)  
Carrier gas flow rate (He)  
Repetition rate, shots per second 
Translation velocity  
Distance between line scans  
3 mJ 
1 l/min 
1.05 l/min 
15 Hz 
1 mm/s 
1 mm 
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Crater diameter ~500 µm 
ICP-MS system  
Incident power  
Cooling gas flow rate  
Auxiliary gas flow rate  
Ni skimmer cone diameter  
Ni sampler cone diameter  
Isotopes measured  
Resolution setting 
1350 W 
16 l/min 
1.3 l/min 
1 mm 
0.7 mm 
153Eu+, 127I+, 13C+ 
400 (LR), 4000 (MR) 
5.3 Results and Discussion 
5.3.1 Analysis of Labelled Antibodies 
 The chelating agent DOTA specifically targets the amino groups present in the 
antibody. For instance IgG1 type of antibody has 64 lysine residues present in the 2 
heavy chains which are targeted by DOTA. To check the labelling procedure and also the 
binding capacity of the europium and iodine to the heavy and light chains, an experiment 
with denaturated conditions was performed and is explained as follows.  
For evaluating the success of labelling procedure and of maintenance of antibody 
integrity, the labelled antibodies anti-CYP1A1 and anti-CYP2E1 were analysed by SDS-
PAGE, blotting and subsequent LA-ICP-MS. Electrophoresis was performed for the 
europium labelled CYP1A1 antibody in presence or absence of disulfide reducing agents, 
DTT, resulting either in dissociation of the antibody molecule into heavy and light chains 
or in keeping the quaternary structure intact. The result is shown for the europium-
labelled anti-CYP1A1 antibody under non reducing conditions in Figure 5.1a. Only one 
153Eu+ band is seen just in the molecular weight range of an intact antibody molecule 
indicating that 1) the antibody was successfully labelled with europium, 2) that the 
antibody was pure and 3) that the antibody was not degraded by or during the labelling 
procedure. Application of different amounts of labelled antibodies showed that at least 
0.1 µg antibody corresponding to about 0.66 pmol antibody can be detected by LA-ICP-
MS. The areas of the antibody spot were integrated and plotted against the antibody 
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concentration. The resulting calibration is shown in Figure 5.1b and a linear dependence 
of applied antibody concentration with respect to the intensity was found.  
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Figure 5.1: (a) 153Eu+ intensity distribution of different amounts of the non denaturated europium-
labelled CYP1A1 antibody measured by LA-ICP-MS after SDS-PAGE and transfer to an NC 
membrane (1) 6.6 pmol, (2) 3.3 pmol, (3) 0.66 pmol. (b) Integrated total europium intensities of 3 
different concentrations of anti-CYP1A1 antibody obtained by SDS-PAGE. (c) 153Eu+ intensity 
distribution of 6.6 pmol amount of the denaturated europium-labelled CYP1A1 antibody measured 
by LA-ICP-MS after SDS-PAGE and transfer to an NC membrane. Left figure shows the 127I+ 
intensities from the iodinated Bio-Rad marker. 133 
In the presence of DTT for 6.6 pmol of antibody as shown in Figure 5.1c, two 
clear bands are visible which correspond to the heavy and light chains of the antibody 
due to the cleavage of the antibody into heavy and light chains. The molecular weight 
was checked by running the iodine labelled Bio-Rad marker simultaneously with the 
sample. Both spots were integrated and the resulted intensities were used for quantifying 
the CYP samples. The sensitivity was higher in the heavy chain which migrated at around 
50 kDa when compared to the light chain around 20 kDa. The obtained sensitivity 
reflected the binding sites (amino groups) available for the chelating compound, i.e. more 
chelating compound binding to the heavy chain and less to the light chain. But the light 
chain was more efficiently labelled than the heavy chain. While molecular weights of 
heavy and light chains differed by a factor of about 2 the 153Eu+ intensities differed only 
by 1.4. The intensities obtained with the present labelling conditions were enough for the 
LA-ICP-MS detection. The sensitivity with respect to the heavy chain and LOD of the 
method was estimated to be about 1.46 ⋅ 105 cps/pmol and 40 fmol respectively. It should 
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be noted that for the immunoblot preparations the europium labelled antibody was faced 
with milder conditions than for the electrophoretic separation in the presence of SDS. The 
same antibodies were used for the immunoblotting experiments for the detection of the 
respective CYP enzymes, thus quantification of the sample was possible.  
In order to make the quantification process comparable, the iodine labelled 
CYP2E1 antibody was also analysed by SDS-PAGE only in the presence of the reagent 
DTT. Six different concentrations of iodine-labelled antibodies were applied. The result 
presented in Figure 5.2a shows iodine-labelled bands corresponding to the separated 
heavy and light chains. An additional band above the heavy chain can be interpreted as 
un-cleaved dimers consisting of one heavy and one light chain. Nevertheless, the pattern 
shows that both chains were labelled with iodine which involved tyrosine and possibly 
histidine residues of the protein. The resulted intensities of both chains were integrated 
and plotted against the antibody amount applied. As shown in Figure 5.2b it is linear over 
the concentration investigated (R2=0.993). The LOD was calculated and found to be 10 
fmol which is better than that of the europium-labelled antibody detection. The sensitivity 
was higher and estimated to be 5.83 ⋅ 107 cps/pmol. 
There are many types of calibration and quantification approaches used in ICP-
MS. Some of them were already discussed in chapter 2 and 3. In chapter 3 standard 
phosphorus proteins, with known amount of phosphorus were used to quantify unknown 
phosphorus proteins either in the same blot after separation or after dot blotting. With the 
results shown in chapter 3, calibration using standard proteins subjected to PAGE 
separation similar to sample was worked well for quantification. One approach of 
quantifying CYP proteins from the different microsomal preparations is via purified CYP 
enzymes. But such purified standards are not available and therefore an alternative 
approach for CYP protein quantification has to be elaborated using LA-ICP-MS via 
absolute quantitation of the label elements, here europium and iodine from the 
calibrations using the labelled antibodies. This was tried here for the initial study. The 
same labelled antibodies which were used for the immunoblotting experiments were 
PAGE separated and blotted under similar conditions to the microsomal preparations and 
used as calibration for simultaneously quantifying multiple antigens, thus avoiding the 
knowledge of the labelling degree of antibody. Nevertheless a theoretical 1:1 
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stoichiometry between monoclonal antibodies and monomer CYPs was taken into 
account. Thus here only a preliminary semiquantitative detection of CYPs was possible 
which required additional methods for the validation. 
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Figure 5.2: (a) 127I+ intensity distribution of different amounts of the denaturated iodine-labelled 
CYP2E1 antibody analysed by LA-ICP-MS after SDS-PAGE and transfer to an NC membrane (1) 
13 pmol, (2) 10 pmol, (3) 6.6 pmol, (4) 5 pmol, (5) 3.3 pmol and (6) 1.66 pmol.  (b) 127I+ integrated 
signal intensities from Figure 5.2a as a function of applied antibody amounts.133 
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The calibration functions from the denaturated iodine from Figure 5.2b and 
corresponding intensities from the europium-labelled antibody from Figure 5.1c were 
used for quantification of the CYPs in this chapter. But before quantification of the CYPs 
could be done, it was required to first detect the CYPs and check whether the antibodies 
are still binding after labelling. Therefore 2 separate experiments were performed with 
the two labelled antibodies separately which will be explained in the following sections. 
5.3.2 Detection of CYP1A1 with a Europium-Labelled Antibody 
 For assessing the binding activity of the europium-labelled anti-CYP1A1 
antibody and its suitability for CYP1A1 quantitation by LA-ICP-MS, it was applied in an 
immunoblotting experiment. As a first application liver microsomes of rats which were 
treated with specific inducers for CYP enzymes, namely 3-methylcholanthrene for 
CYP1A1 were used.134 Their spectrophotometrically determined microsomal CYP 
content amounts to 2.08 nmol CYP per milligram of protein. Thus CYPs made up about 
10% of the total microsomal protein, calculated from an average CYP molecular mass of 
50 kDa. Specific monoclonal antibodies for both CYP enzymes were already 
developed.135 One of the affinity-purified antibodies for CYP1A1 was labelled with 
europium via the DOTA chelating agent by the procedure described in section 5.2.3.  
 0.1 µg to 5 µg of liver microsomal proteins raised in rats treated with CYP1A1-
inductor 3-MC were PAGE-separated. After blotting, the membrane was incubated in 
europium-labelled anti-CYP1A1-antibody. The CYP enzyme CYP1A1 in liver 
microsomes of 3MC treated rats was detected with the specific europium labelled 
monoclonal antibody by means of LA-ICP-MS. The 153Eu+ band pattern shows that the 
antibody specifically recognizes CYP1A1 in the relevant molecular weight range of 
around 50 kDa (Figure 5.3). 
 The intensity obtained corresponds to the amount of applied microsomal protein. 
The detection limit for CYP1A1 was close to 0.1 µg of applied microsomal protein. Thus 
it is estimated that about 140 fmol of CYP1A1 can be detected with this method taking 
into consideration that CYP1A1 can make up to about 70% of the total CYPs in liver 
microsomes of 3-MC treated rats.134 
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Figure 5.3: 153Eu+ intensity distribution of different amounts of the rat liver microsomal protein 
samples (isolated from rats after 3MC treatment): (1) 5 µg, (2) 1 µg, (3) 0.5 µg, (4) 0.1 µg, measured 
by LA-ICP-MS after SDS-PAGE, transfer to an NC membrane and immunoblotted with europium-
labelled CYP1A1 antibody.133   
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Figure 5.4: Detection of SDS PAGE separated and blotted CYP1A1 from rat liver microsomes of 3-
methylcholanthrene treated rats. Amount of microsomal protein applied: (1) 5, (2) 1, (3) 0.5 and (4) 
0.1 µg. Primary antibody: anti-CYP1A1. Secondary antibody: goat anti-mouse IgG, peroxidase 
coupled. Detection: luminescence.133 
 Parallel to detection by LA-ICP-MS, conventional luminescence detection was 
performed to compare the sensitivity with the LA-ICP-MS method and validate the 
results. In this method initially the microsomal samples from rats after 3-
methylcholanthrene treatment were subjected to SDS-PAGE and Western blotting. Then 
the membrane was treated with respective primary monoclonal antibody followed by a 
peroxidase-labelled secondary antibody directed against mouse immunoglobulin G. The 
result obtained from the method is shown in Figure 5.4. The sensitivity obtained through 
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luminescence based procedure was slightly higher than the LA-ICP-MS based method 
using DOTA-chelated europium. This method allowed the readout of a single CYP 
protein in a 1D separation. But concomitant detection of proteins was not possible when 
compared with the LA-ICP-MS method. 
5.3.3 Detection of Blotted CYP2E1 with an Iodine-Labelled Antibody 
An antibody corresponding to CYP2E1 was labelled by iodine using iodination. 
Liver microsomes of rats treated with isoniazid was used which is known to increase 
CYP2E1 levels.136 Liver microsomal protein of isoniazid treated rats was applied to SDS-
PAGE in amounts of 0.125 to 5.0 µg. LA-ICP-MS of the blotted samples for 127I+ 
revealed a clear band in the 50 kDa molecular weight range (Figure 5.5). The intensity 
obtained corresponds to the amount of applied microsomal protein. The estimated 
detection limit for CYP2E1 was close to 0.25 µg of applied microsomal protein which 
corresponds to about 70 fmol CYP2E1. The calculation was based on the specific CYP-
content of the microsomes which amounted to about 1 pmol total CYPs/µg microsomal 
protein and the fact that CYP2E1 constituted about 30% of total CYPs in liver 
microsomes of isoniazid-treated rats.134 A parallel analysis of the samples by means of a 
secondary antibody and luminescence detection showed that both methods have 
comparable sensitivity (Figure 5.6). 
The above 2 experiments (section 5.3.2 and 5.3.3) were performed on separate 
membranes with the liver microsomal samples of differentially treated rats. There was a 
difference in the maximum intensities achieved for the 2 different blots which was due to 
the different labelling procedures. Higher intensities and sensitivities could be seen for 
CYP2E1 detection via iodinated antibody. The difference in intensities was not important 
because for quantification the same labelled antibodies were taken into account which 
was PAGE separated and blotted. Until now only one antibody was applied during the 
immunoblotting procedure in the examples presented so far. In order to save time and 
reduce errors, a new method was tried to identify proteins in a single experiment.  
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Figure 5.5: 127I+ intensity distribution of different amounts of the rat liver microsomal protein 
samples (isolated from rats after isoniazid treatment): (1) 5 µg, (2) 3 µg, (3) 1 µg, (4) 0.5 µg, (5) 0.25 
µg and (6) 0.125 µg, measured by LA-ICP-MS after SDS-PAGE, transfer to an NC membrane and 
immunoblotted with iodine-labelled CYP2E1 antibody.133  
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Figure 5.6: Detection of CYP2E1 in liver microsomes of isoniazid-treated rats with luminescence 
based detection using monoclonal antibody specific for CYP2E1 and peroxidase coupled secondary 
antibody. Microsomal protein in the amounts of (1) 5, (2) 3, (3) 1, (4) 0.5, (5) 0.25 and (6) 0.125 μg 
were separated by SDS-PAGE and subsequently transferred to a nitrocellulose membrane by 
electro-blotting.133  
5.3.4 Simultaneous Detection of 2 CYPs in One Western Blot 
Experiment 
 In the next experiments, simultaneous detection of CYPs was investigated. In 
order to perform this experiment, 2 differentially labelled monoclonal antibodies (section 
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5.3.2 and 5.3.3) were mixed together during the immunoblotting procedure. The blots 
were then analysed by LA-ICP-MS to visualize the proteins from each sample on the 
same membrane. This way of simultaneous detection of various biological parameters at 
the same time can be seen as a proof of principle for future multiplexing experiments. 
Multiplexing of samples reduces the number of gels required for an experiment, 
minimizes quantitative and qualitative experimental errors from inter-gel or inter-
membrane comparisons. The same microsome samples were applied as before after 
treating rats with 3MC and isoniazid. A third microsomal sample used was obtained from 
minipigs which were subjected to oral intake of a PAH mixture. PAH was shown to 
induce CYP1A1-dependent enzymatic activity in cells of the minipig duodenum. Little is 
known on the presence and the level of CYP2E1 in these cells.115 Thus experiments to 
measure the levels of CYP1A1 and CYP2E1 in the microsomal protein samples will 
provide new insights in protein expression studies simultaneously.  
5.3.4.1 Liver Microsomes of 3-Methylcholanthrene-treated Rats 
 0.5 µg to 10 µg of microsomal proteins raised in rats treated with CYP1A1-
inductor 3-MC were PAGE-separated. After blotting, the membrane was concomitantly 
incubated with the europium-labelled CYP1A1 antibody and iodine-labelled CYP2E1-
antibody. The CYP enzyme CYP1A1 in liver microsomes of 3MC treated rats was 
detected with a specific monoclonal europium-labelled antibody CYP1A1 (Figure 5.7a). 
LA-ICP-MS of the blotted samples for 153Eu+ revealed a clear band in the 50 kDa 
molecular weight range. The acquired intensity is proportional to the amount of 
microsomal protein applied.  
 The 153Eu+ intensities were then used for quantifying the respective CYP1A1 
samples by using the corresponding europium-labelled intensities from Figure 5.1c. The 
respective CYP1A1 concentration is shown in Table 5-2. The antigen amount was 
calculated by taking into account the complete integrated signals belonging to CYP1A1. 
For a 10 µg total microsomal protein 281 ng CYP1A1 was calculated, and the CYP1A1 
expression increased with the microsomal sample after 3MC treatment.  
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Figure 5.7: Concomitant detection of (a) CYP1A1 and (b) CYP2E1 with a europium-labelled and 
iodine-labelled antibody, respectively. Blot membranes were scanned and analysed by LA-ICP-MS 
for 153Eu+ and 127I+. Samples: liver microsomes of 3-methylcholanthrene treated rats. The amounts of 
microsomal proteins applied for SDS-PAGE separation were (1) 10 µg, (2) 5 µg, (3) 1 µg and (4) 0.5 
µg.133 
 127I+ measurement of the same blots simultaneously shows specific signals for 
CYP2E1 in the same lane (Figure 5.7b). 127I+ intensities increased linearly with the 
amount of applied microsomal protein but could not be detected below 1 µg. In addition 
to the specific band around 50 kDa 3 more bands were visible. The origin of these bands 
was not clear but it could be assumed that they represented ubiquitous CYP2E1-protein 
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still recognized by the antibody. These bands were also detected by luminescence-based 
detection and confirmed that they were not artefacts of the LA-ICP-MS method. 
Table 5-2: Table shows the amounts of CYP1A1 present in the sample from the total microsomal 
proteins which were loaded on the gel and separated using SDS-PAGE. 
3MC microsomes (µg) CYP1A1 antigen (ng) 
10 281.0392996 
5 226.5154669 
1 49.36132296 
0.5 17.25437743 
 By using the calibration graph from Figure 5.2b, the estimated amount of 
CYP2E1 present in the 10 µg sample was calculated and estimated to be 70 ng. The 
amount obtained was very low when compared to those of the CYP1A1 which was 
induced upon stimulation by 3MC. This showed that the 3MC treatment did not or very 
mildly induce CYP2E1 expression. 
The protein spots of 10 µg microsomal protein for CYP1A1 and CYP2E1 were 
integrated and the line scan of both is shown in black and pink colour, respectively. It 
should be noted here that the molecular weight of rat CYP1A1 was 59393 Da and of rat 
CYP2E1 was 56627 Da.137 The small difference of less than about 3000 Da protein could 
be differentiated by the element labels and electrophoretic mobility which then was 
detected by LA-ICP-MS. In Figure 5.8 the obtained 127I+ intensities for CYP2E1 were 
background corrected in order to show them together with the 153Eu+ intensities. 
The increase in the CYP1A1 expression was also observed in literature from the 
Western blot analysis where the levels of this enzyme in addition to CYP1A2 increased 
in the liver microsomes of 3MC treated guinea pigs.138 This study was done to compare 
the induction of CYP1A1 and CYP1A2 in guinea pig liver after 3MC treatment. Only the 
levels of CYP1A1 were induced both in liver of the guinea pig after treatment. A similar 
result was also observed in a study conducted on transgenic rats with insufficient blood 
growth hormone.139 The expressions of CYP1A1 and CYP2B using the enzyme activity 
assays and immunohistochemistry were compared. 3MC administration induced 
CYP1A1 in both wistar and mini rats. But the induction was higher in the mini rat liver 
than in the wistar rat liver. Tani et al. investigated the induction of CYPs by their EROD 
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activity. The EROD activity (7-ethoxyresorufin O-deethylase activity) test showed that 
about 2458+/-1058 pmol/min/mg protein were found for the CYP1A1 enzyme after 3MC 
treatment. CYP1A1 associated enzyme activity could be studied by using 7-
ethoxyresorufin as substrate. This EROD activity is the most sensitive and reliable 
method for determining the induction of CYPs.  
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Figure 5.8: Superimposed line scans for 153Eu+ and 127I+ intensities of the 10 µg samples of Figure 5.7 
corresponding to CYP1A1 and CYP2E1, respectively. The main protein peaks were 
electrophoretically separated. A CYP2E1 rider peak overlaps with the CYP1A1 peak clearly 
distinguished by the different labels (3MC 3-methylcholanthrene).133 
5.3.4.2 Liver Microsomes of Isoniazid-treated Rats 
0.5 to 2 µg of microsomal protein samples after isoniazid treatment were SDS 
PAGE separated and immunoblotted. From Figure 5.9a, it can be inferred that a 
CYP1A1-associated 153Eu+ signal is not or is only slightly seen even at 2 µg microsomal 
sample. 
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Figure 5.9: Concomitant detection of (a) CYP1A1 and (b) CYP2E1 with a europium-labelled and 
iodine-labelled antibody. Blot membranes were scanned and analysed by LA-ICP-MS for 153Eu+ and 
127I+. The samples were liver microsomes from isoniazid-treated rats. The amounts of protein applied 
for SDS-PAGE separation were (1) 2 µg, (2) 1 µg and (3) 0.5 µg.133 
 But for the same concentration of the protein sample significant intensities could 
be obtained for CYP2E1 down to 1 µg using the iodine-labelled CYP2E1. CYP2E1 
expression was detectable in the liver microsomes of isoniazid-treated rats of around 0.5 
µg of microsomal proteins (Figure 5.9b) which corresponded to about 160 fmol of 
CYP2E1 taking into consideration that CYP2E1 made up about 1.6% of total liver 
microsomal protein in isoniazid-treated rats.134 The protein spots of 2 µg microsomal 
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protein for CYP1A1 and CYP2E1 were integrated and the line scan of both is shown in 
black and pink colour, respectively, in Figure 5.10. The background of the iodine 
intensities for CYP2E1 was subtracted in order to show them together with the europium 
intensities corresponding to CYP1A1. It is obvious from Figure 5.10 that CYP2E1 was 
present in higher amounts when compared to those of the CYP1A1 which was 
completely absent or present at low levels after treatment with isoniazid. In conclusion, 
the results confirmed what was known about the CYP expression profile in liver 
microsomes of isoniazid-treated rats.  
 After applying the same calibration function from Figure 5.2b, the amount of 
CYP2E1 was estimated to be 70 ng for a 2 µg rat liver microsome after isoniazid 
treatment. A very low amount of CYP2E1 could be observed here, but we are not sure 
whether it was a weak inhibition or induction of it by isoniazid in vitro. Some studies 
suggest that there are both effects of isoniazid.140 In fact some of the substrates could be 
cleared because of the binding of isoniazid to the active sites of CYP2E1 leading to its 
metabolic inactivity. To conclude it, a detailed study is needed with more concentration 
ranges and also studying in vivo will help in determining the drug-drug interactions 
involving isoniazid. 
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Figure 5.10: Superimposed line scans for 153Eu+ and 127I+ of the 2 µg samples of Figure 5.9 
corresponding to CYP1A1 and CYP2E1, respectively.133 
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5.3.4.3 Duodenal Microsomes of Minipigs Orally Exposed to Polycyclic 
Aromatic Hydrocarbons  
Two different concentrations of 10 and 20 µg of duodenal microsomes from 
minipigs after oral intake of a polycyclic aromatic hydrocarbon mixture were subjected to 
SDS PAGE and immunoblotting with 2 differentially labelled antibodies as explained 
before. The amounts of microsomal protein used were high because of low CYP P450 
levels in microsomes of the gastro-intestinal tract. After laser ablation, from the 
corresponding europium intensities (Figure 5.11a) it was found that microsomal CYP1A1 
was expressed in duodenal cells of minipigs after treatment with polycyclic aromatic 
hydrocarbon which was in contrast to liver microsomes of isoniazid-treated rats. With the 
corresponding intensities from the europium-labelled antibody from Figure 5.1c the 
respective amounts of CYP1A1 expression corresponding to the amount of total 
microsomal proteins were calculated and shown in Table 5-3. 40.5 ng of CYP1A1 was 
found for a 20 µg applied microsomal sample. A slightly higher amount than the half of 
the CYP1A1 was observed for the 10 µg microsomal sample. As no other specific bands 
were visible it was clear that only CYP1A1 was expressed which was also observed in 
the studies of Roos et al. who obtained the highest induction of CYP1A1 with a sample 
containing 274 mg 5- and 6- ring PAH/kg soil, resulting in a 360 fold increase in the 
EROD activity.141 These experiments showed that the labelled antibodies could very well 
be used for simultaneous detection and quantification of proteins.  
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Figure 5.11: Concomitant detection of (a) CYP1A1 and (b) CYP2E1 with a europium-labelled and an 
iodine-labelled antibody, respectively. The samples were duodenal microsomes of minipigs orally 
exposed to polycyclic aromatic hydrocarbons. Blot membranes were scanned and analysed by LA-
ICP-MS for 127I+ and 153Eu+. The amounts of microsomal proteins applied for SDS-PAGE separation 
were (1) 20 µg and (2) 10 µg.133 
The 127I+ distribution is shown in Figure 5.11b for the 10 and 20 µg samples. 
CYP2E1 was also detectable but at low levels. Again with the iodine-labelled CYP2E1 
antibody 2 bands were seen. A new band at lower molecular weight range in addition to 
the normal band at 50 kDa was detected and its identity is not clear. In addition higher 
background levels could be seen for 127I+. The superimposed line scans corresponding to 
the 20 µg microsomal sample are shown in Figure 5.12. After integration of the spot, 5.7 ⋅ 
105 cps could be achieved for a 10 µg CYP2E1 duodenal microsomal sample but the 
levels were lower than in liver microsomes of 3MC treated rats (Figure 5.7) (3.07 ⋅ 106 
cps – 10 µg). The total amount of CYP2E1 present was calculated from the calibration 
function (Figure 5.2b) and found to be 70 ng for the total of 20 µg microsomal protein, 
which was low compared to the CYP1A1 expression (Table 5-3). 
Two blot membranes developed by means of the primary antibodies and a 
peroxidase-coupled secondary antibody were used for separate detection of CYP1A1 and 
CYP2E1 by luminescence. In contrast to liver microsomes of isoniazid-treated rats, 
CYP1A1 was clearly expressed in duodenal minipig microsomes after PAH exposure 
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(Figure 5.13a). CYP2E1 was also detectable but only at low levels (Figure 5.13b). The 
results shown in Figure 5.13a and b are in accordance with the LA-ICP-MS data. 
The expression of the liver microsomal Cytochrome P450 enzymes CYP1A1 and 
CYP2E1 which were induced by PAH in exposed rats were studied. The presence of 
CYP2E1 protein in minipig duodenal cells is shown here for the first time. The 
expression of 2 CYP isozymes were shown in this study which can be further continued 
for more CYP enzymes once the improvement in the labelling procedure was done.  
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Figure 5.12: Superimposed line scans for 153Eu+ and 127I+ of the 20 µg samples of Figure 5.11 
corresponding to CYP1A1 and CYP2E1, respectively.  
 
Table 5-3: Amount of CYP1A1 with respect to the total microsomal protein after PAH exposure. 
Microsomal protein after exposure to PAH (µg) CYP1A1 (ng) 
20 40.51327821 
10 29.62231518 
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Figure 5.13: Detection of CYP1A1 and CYP2E1 with their specific antibodies. Samples: duodenal 
microsomes of minipigs orally exposed to polycyclic aromatic hydrocarbons (applied amounts of 
proteins (1) 20 and (2) 10 µg). A set of blots was treated with a primary anti-CYP1A1 antibody (a) or 
an anti-CYP2E1 antibody (b) and a secondary peroxidase coupled goat anti-mouse IgG antibody. 
The bands were visualized by chemiluminescence detection.133 
5.4 Concluding Remarks 
A novel approach to detect, identify and semi quantify different CYPs 
simultaneously in a single step by means of co-incubation with iodinated and lanthanide-
labelled antibodies using LA-ICP-MS was demonstrated. For this purpose, the CYP1A1 
antibody was labelled with europium via DOTA and CYP2E1 was iodinated. Under 
denaturating conditions 2 bands were visible for europium and iodine-labelled antibody 
whereas only one band was visible without denaturation. The LOD for iodine-labelled 
antibody with respect to the heavy chain was calculated and found to be 10 fmol whereas 
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for europium-labelled antibody it was 40 fmol. Initially these labelled antibodies were 
individually probed on Western blots with microsomal samples of rat liver and minipig 
duodenum to check their specificity for antigens. They recognised their respective CYP 
enzymes and by this method about 140 fmol of CYP1A1 and 70 fmol of CYP2E1 could 
be detected from their respective microsomal samples. 
In the next step, both the iodine and europium-labelled antibodies were mixed 
together during the immunoblot procedure and then the blot was subjected to LA-ICP-
MS. By this way 2 different CYPs, CYP1A1 and CYP2E1 in microsomal samples of 
differentially treated rats and minipigs, were simultaneously detected. In combination 
with the electrophoretic separation, a small difference of less than about 3000 Da protein 
could be differentiated using LA-ICP-MS method.   
The calibrations obtained from surface plot of different concentrations of labelled 
antibody were used to simultaneously quantify the CYPs. About 281 ng and 70 ng of 
CYP1A1 and CYP2E1 were quantified respectively for a 10 µg total microsomal protein 
sample from 3-MC treated rats. The CYP1A1 levels were completely absent in liver 
microsomal samples of isoniazid-treated rats compared to CYP2E1. The quantified 
amounts of CYP1A1 and CYP2E1 were about 30 ng and 70 ng respectively for a 10 µg 
microsomal sample obtained from duodenum of minipigs which were orally exposed to a 
PAH mixture.  
The LODs were better for iodine-labelled antibody compared to europium-
labelled antibody. At the same time higher background levels were observed for iodine-
labelled antibody. With the optimised laser ablation sampling conditions, the LOD for the 
europium-labelled antibody was improved. 
For the analysis, only ‘primary’ antibodies were necessary. For comparison and 
validation, chemiluminescence detection was applied which showed a comparable 
sensitivity. But for this method a peroxidase or otherwise labelled secondary antibody is 
required in addition to the primary antibody.  
The levels of CYP2E1 present in the microsomal samples obtained from 
duodenum of minipigs which were orally exposed to a PAH mixture were shown here for 
the first time. As shown here, the LA-ICP-MS method is useful to measure multiple 
CYPs simultaneously. In future, the number of enzymes and parameters to be analysed 
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can be extended further with the help of more than 2 differentially labelled antibodies. 
Labelling of antibody with more elements such as lanthanides or iodine will allow then to 
develop multiplexing approaches for the LA-ICP-MS method. Thus many proteins can be 
simultaneously detected and quantified which is not possible with methods such as 2-
dimensional difference gel electrophoresis (DIGE) where up to only 5 different protein 
samples can be compared and analysed simultaneously. 
Chapter 5 
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Chapter 6 
Conclusions and Future Work 
In this work 2 different strategies for detection and quantification of proteins 
using LA-ICP-MS in combination with SDS-PAGE and blotting were developed and 
presented. One is based upon direct detection of hetero-elements especially phosphorus 
and the second was done by using metal containing stains and through labelling of 
proteins and antibodies via chelating agents. All the approaches were optimised here for 
ICP-MS based applications. For this purpose a LA-ICP-MS cell was developed and 
optimised for sample introduction of blot membranes into an ICP-MS. The procedures 
developed were tested at hand of 2 applications; phosphoproteomics and cytochrome 
expressions. 
 The optimisation of LA parameters such as carrier and make-up gas flow rates, 
scan velocity and laser energy in addition to ICP-MS generator forward power, torch 
positions was performed to achieve better detection limits and sensitivity for the 
detection of phospho-proteins on blot membranes. With the laser setup used 
throughout this investigation NC membrane was found to be advantageous compared 
to PVDF membrane and semidry blotting method was suitable. With this method, 
good linearity could be achieved in the range from about 20 to 380 pmol phosphorus 
in proteins and a LOD of about 1.5 pmol of phosphorus in β-casein was calculated 
when measured at medium mass resolution. In addition comparable sensitivities could 
be achieved for different phospho-proteins. The experiments showed good 
reproducibility with relative standard deviation between 6% and 10% if the whole 
protein spot area was taken into account. 13C+ signals from the ablated membrane 
material was found out to be suited as internal standard for drift correction.  
 Two calibration procedures 1) Blotting and 2) Dotting calibration for 
quantification of unknown amounts of phosphorus containing proteins were investigated 
and compared. Better accuracy was achieved using the first method which led to the 
conclusion that not only the standards were ablated and transported in the same way as 
the test sample, but also that possible blotting losses were compensated if proteins were 
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chosen as standards. Therefore protein standards have always been used for internal 
calibration and quantification. 
 With the internal PAGE calibration approach the changes in the phosphoproteome 
of a single cancer cell line 5637 after application of hormone (EGF) and oxidative stress 
stimuli by H2O2 were measured quantitatively. It could be shown that H2O2 (100 µM) 
induced an increase in total phosphorylation by a factor of 1.3 after treatment of cells for 
7.5 min and caused more phosphorylation than EGF (8.1 nM) in the high molecular 
weight range above 90 kDa.  
 Indian ink staining was used to visualize the protein spots on membranes and a 
contaminating element (Li) was applied for ICP-MS detection as well resulting in 
moderate limits of detection. Significant improvements have been achieved with a 
method based on bioconjugation chemistry. For this purpose two different labelling 
strategies based on chelation of lanthanide elements with 1) DTPA dianhydride and 2) 
DOTA were investigated here for detection of proteins by use of LA-ICP-MS. The 
strategy based on chelation with DTPA dianhydride showed the best sensitivity but was 
hampered possibly due to dimer formation of the protein molecules. Nevertheless this 
method looks very promising for future applications with mono-valent DTPA with 
specific target linkers, e.g. targeting amino or sulphur groups of the proteins. 
 The other labelling strategy was based on the commercially available chelating 
agent DOTA and the reaction of the protein and Eu as one typical lanthanide element 
with this chelating agent was optimised for detection by LA-ICP-MS. The labelling 
procedure consisted of two steps: a slow reaction of DOTA with a protein (4 to 24 h 
reaction time) and a faster second one (30 min) where DOTA was binding the Eu(III) 
cation. The model protein BSA was analysed with ICP-MS in-solution and by means of 
LA-ICP-MS after SDS-PAGE separation and blotting onto membranes. Different 
reaction parameters were studied such as pH, temperature, reaction time and also molar 
excess ratios of DOTA which were varied for both reaction steps. The optimised labelling 
conditions were slightly different for proteins such as BSA and for antibodies. It could be 
shown that the labelling efficiency was strongly depend on the protein structure and the 
amino groups being available for labelling. LODs of about 30 fmol and 200 fmol for an 
europium-labelled antibody and for BSA were calculated, respectively. 
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The labelling procedure developed using DOTA in combination with Eu was 
applied to monoclonal antibodies. Additionally iodination of antibodies following 
standard protocols was applied for simultaneous detection and quantification of 2 
different CYPs (CYP1A1 and CYP2E1) using LA-ICP-MS and Western blotting in 
complex biological samples. For this purpose rats and minipigs have been exposed to 
several CYP P450 inducers and liver microsomes of the rats and duodendum of the 
minipigs have been used to study CYP P450 induction by different pharmaceutical and 
cancerogenic chemical compounds. 
First results for the 2 enzymes CYP1A1 and CYP2E1 show that the antibodies 
maintained their antigen binding properties after labelling as demonstrated by LA-ICP-
MS analysed immunoblots. In the animal studies, a strong CYP1A1 signal was found in 
liver microsomes of 3-methylcholanthrene treated rats while it was (nearly) absent in rats 
treated with isoniazid. The constitutively expressed CYP2E1 was found in microsomes of 
both treatment groups. Duodenal microsomes of minipigs orally exposed to polycyclic 
aromatic hydrocarbons showed a clear CYP1A1 signal with low levels of CYP2E1. From 
these results, it can be estimated that about 140 fmol of CYP1A1 and 70 fmol CYP2E1 
are still detectable with this method taking into consideration that CYP1A1 can make up 
to about 70% of the total CYPs in liver microsomes of 3-MC treated rats and CYP2E1 
constitutes about 30% of the total CYPs in liver microsomes of isoniazid-treated rats. 
From all these results it can be concluded that detection of proteins and antibodies 
by use of natural or artificial hetero-elements and detection by LA-ICP-MS looks already 
very promising. Nevertheless, instrumental and procedural improvements are required 
and are still possible. For instance, analysis of one blot membrane by LA-ICP-MS is time 
consuming. One analysis of a conventional blot membrane can take a few hours. In order 
to speed up the measurement time instrumental improvements for the laser ablation 
system are needed. The present instrumental software of the ICP-MS system used can not 
handle easily the huge amounts of data generated nor is directly able to support data 
handling. Here the manufacturers are challenged.  
Concerning procedural improvements, we have measured 31P+ intensity 
distributions on blot membranes and thus can quantify phosphorylated proteins but were 
not able to investigate unphosphorylated or dephosphorylated proteins. In principle this 
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problem can be solved by detection of sulphur isotopes being present in most proteins, 
but this could not be applied here due to high sulphur blank from the SDS chemical. This 
problem can be partially overcome with a native PAGE separation for instance of 
metalloproteins or alternatively by the methods developed here just by labelling a whole 
proteome, but the latter has to be investigated in more detail. Alternatively new staining 
methods should be elaborated for this purpose. In this work it was shown that Indian ink 
staining of protein spots on blot membranes can already be used for the determination of 
the total amount of a protein. In future, other staining techniques based on Au or Ag 
colloids look more promising due to the very high number of atoms being present in the 
colloids, which can be used to improve the sensitivity of the ICP-MS detection 
significantly. 
So far, limits of detection at pmol levels have been realized in this work for 
phospho-proteins. Further improvements can be expected either by application of 
selective phospho-protein preconcentration techniques or alternatively by reduction of the 
limiting blank value in cell culture experiments by use of improved sample preparation 
methods. 
As already mentioned in one of the previous chapters, postulating the changes in 
the phosphoproteome without identification of the specific protein involved has little 
meaning. Once a phosphorylated protein is detected, purified and quantified by the ICP-
MS methods described in this work, identification of the peptide pattern after a tryptic 
digest and separation by HPLC can be performed. Thus the phospho-protein studies of a 
cancer cell line discussed in this work can now in a next step be used to select the most 
highly phosphorylated proteins in a signalling pathway for identification by use of 
organic mass spectrometry such as ESI-MS and MALDI-MS.94,142 Of course, the 
developed labelling methods can be easily extended to protein digests and labelling of 
polypeptides. LC-ICP-MS can then be used for detection and quantification to 
complement organic mass spectrometric techniques as it was discussed recently by 
Navaza et al.143 
After the experimental work of this thesis was finished, ESI-MS measurements of 
the intact labelled protein were performed additionally to better understand the reaction 
chemistry.108 It could be validated that labelling of amino-groups in particular of lysine 
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residues mainly take place, which was used here already for amplification of the hetero-
element signal of a protein, because most proteins contain many lysine residues. The 
resulting labelling degree was much lower than the expected number of lysine residues 
from which it can be concluded that surface lysines are labelled in case of BSA mainly. 
For quantitative proteomics calibration of proteins by standards is required, if the 
stoichiometry of the protein of interest is not known. Alternatively, the labelling of N-
terminal amino groups looks more advantageous, because each protein molecule can bind 
only one elemental label. In this case, amplification of the sensitivity can be gained by 
use of labelling with nano-particles instead of single elements, but such strategies have to 
be elaborated in future work. 
The results obtained in this work were validated with Coomassie staining and 
chemiluminescence (CL) methods. The LA-ICP-MS method allows concomitant 
determination of CYPs via labelled antibodies thereby exhibiting similar sensitivity as 
conventional CL detection via peroxidase labelled secondary antibodies. For validation of 
our quantification results of phospho-proteins still alternative methods have to be tested 
such as phospho-staining or labelling of phospho-specific antibodies. 
Although results are presented here only for labelling by use of two elements, 
iodine and europium, the same strategy can be extended in principle for many more 
lanthanides or for enriched isotopes of these elements, because of an identical chelation 
chemistry. In such a way LA-ICP-MS detection of proteins by immunostaining offers a 
new capability to elaborate highly multiplexed assays for CYP determinations via 
labelled antibodies. And maybe in future all CYP isozymes and their phosphorylation 
status can be detected simultaneously, which is still a vision of this work. Such a work, of 
course, can also be extended to other protein signalling processes or expression studies. 
In this investigation two dimensional intensity distributions have been measured 
with a very good local resolution which is nothing else than imaging of elemental 
distributions. Quantitative elemental bio-imaging for the determination of the distribution 
of metals and metallo-drugs is a very new and promising application area of LA-ICP-MS 
as it has been shown already for instance in investigations of brain tissues samples to 
understand the biological processes occurring in certain diseases such as Parkinson’s or 
Alzheimer’s disease. Such studies combined with the immunostaining staining developed 
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in this work look very promising for cancer detection in tissue sections by use of highly 
specific labelled biomarkers.144 Indirectly, cancer detection might become possible, if 
labelled antibody arrays are designed for LA-ICP-MS detection.145 
In conclusion this work employing ICP-MS in combination with gel 
electrophoresis offers a new valuable, versatile and complementary tool for novel 
applications in quantitative proteomics. 
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Chemicals, Reagents and materials Manufacturer 
3-methylcholanthrene Fluka, Buchs, Switzerland 
Acetic acid Sigma Aldrich, Taufkirchen, Germany 
Acrylamide / Bis Bio-Rad, Munich, Germany 
Ammonia Merck, Darmstadt, Germany 
Ammonium acetate Merck, Darmstadt, Germany 
Ammonium peroxodisulphate Carl Roth, Karlsruhe, Germany 
Benzene Merck, Darmstadt, Germany 
Bovine Serum Albumin  Sigma Aldrich, Taufkirchen, Germany 
Bromophenol blue Merck, Darmstadt, Germany 
Centriprep ultra filtration column Millipore, Schwalbach, Germany 
Colloidal Coomassie  Fluka, Buchs, Switzerland; Carl Roth, 
Karlsruhe, Germany 
Coomassie Roti Blue Carl Roth, Karlsruhe, Germany 
Copper sulphate Merck, Darmstadt, Germany 
Diethylenediaminepentaacetic Acid Sigma Aldrich, Taufkirchen, Germany 
Dithio-DL-threitol Carl Roth, Karlsruhe, Germany 
Dual colour molecular weight marker Bio-Rad, Munich, Germany 
Ethanol Carl Roth, Karlsruhe, Germany 
Europium chloride Sigma-Aldrich, Taufkirchen, Germany 
Folin-Ciocalteu’s phenol reagent (FCP) Sigma Aldrich, Taufkirchen, Germany 
Fountain pen ink Pelikan, Hannover, Germany 
Glycerol Carl Roth, Karlsruhe, Germany 
Glycine Applichem, Darmstadt, Germany 
Holmium chloride Acros-Organics BVBA, Geel, Belgium 
Hydrogen chloride Merck, Darmstadt, Germany 
Hydrogen peroxide Sigma Aldrich, Taufkirchen, Germany 
Immobilon membrane Millipore, Schwalbach, Germany 
Iodo-beads Perbio Science, Niederkassel, Germany 
Isonicotinic acid hydrazide (isoniazid) Sigma-Aldrich, Taufkirchen, Germany 
Long epidermal growth factor IBT, Reutlingen, Germany 
Lysozyme Sigma Aldrich, Taufkirchen, Germany 
Methanol Carl Roth, Karlsruhe, Germany 
Milk powder GE, Munich, Germany 
N,N,N’,N’-tetramethylethylene diamine Riedel-de Haen, Seelze, Germany 
N’N’-bis-methylene-acrylamide Merck, Darmstadt, Germany 
Nitric acid Merck, Darmstadt, Germany 
Nitro cellulose membrane Schleicher and Schuell, Dassel, Germany 
PD-10 column GE Healthcare, Munich, Germany 
Pencillin/streptomycin Invitrogen, Karlsruhe, Germany 
Pepsin Dunn Labortechnik, Asbach, Germany 
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Peroxide coupled secondary goat anti-
mouse IgG 
Sigma Aldrich, Taufkirchen, Germany 
Phosphoric acid Sigma-Aldrich, Taufkirchen, Germany 
Potassium hydrogen phosphate Merck, Darmstadt, Germany 
Precast CleanGels ETC, Kirchentellinsfurt, Germany 
p-SCN-Bn-DOTA (2-(4-
isothiocyanatobenzyl)- 
1,4,7,10-tetraazacyclododecane-1,4,7,10-
tetraacetic 
Macrocyclics, Dallas,USA 
Rhodium and cerium  VWR International, Langenfeld, Germany 
Roti-Blue Carl Roth, Karlsruhe, Germany 
RPMI 1640 Invitrogen, Karlsruhe, Germany 
Sodium azide Serva, Heidelberg, Germany 
Sodium carbonate Merck, Darmstadt, Germany 
Sodium chloride Merck, Darmstadt, Germany 
Sodium Dodecyl Sulphate  Applichem, Darmstadt, Germany 
Sodium hydrogen carbonate Merck, Darmstadt, Germany 
Sodium iodide Fluka, Buchs, Switzerland 
TEMED Riedel de Haën AG, Seelze, Germany 
Terbium chloride Acros-Organics BVBA, Geel, Belgium 
Tris (hydroxymethyl) amino-methane 
(Tris) hydrochloride 
Applichem, Darmstadt, Germany 
Tris-HCl (Tris(hydroxymethyl)-
aminomethane) 
Applichem, Darmstadt, Germany 
TritonX   Acros-Organics BVBA, Geel, Belgium 
Tween 20 Carl Roth, Karlsruhe, Germany 
ultrapure water Synergy and Milli-Q water purification 
systems, Millipore, Bedford, MA 
Western Lightning Chemiluminescence 
Reagent Plus 
Perkin Elmer, Waltham, USA 
α-casein, β-casein, ovalbumin Sigma Aldrich, Taufkirchen, Germany 
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